http://www.thedirectorylive.com/rss_feeds/directory_new_and_featuresThe Directorylive RSS Feed.http://www.thedirectorylive.com/__data/assets/image/0008/332747/logo.jpghttp://www.thedirectorylive.com/rss_feeds/directorylive_news04 Jan 2011http://www.pmlive.com/pharma_news/endo_testosterone_gel_approved_253409The US Food and Drug Administration has approved Endo Pharmaceuticals' Fortesta testosterone gel as a treatment for men with hypogonadism04 Jan 2011http://www.pmlive.com/pharma_news/centocor_seeks_new_use_for_remicade_253417Centocor Ortho Biotech has filed a supplemental application with the US Food and Drug Administration to expand the approved indications of Remicade04 Jan 2011http://www.pmlive.com/pharma_news/cephalon_jet_lag_application_rejected_253424Cephalon has dropped its bid to get sleep disorder drug Nuvigil approved as a treatment for jet lag after a second rejection from the US FDA04 Jan 2011http://www.pmlive.com/pharma_news/cystic_fibrosis_drug_disappoints_in_trial_253730Shares of Inspire Pharma have fallen by 58 per cent after its cystic fibrosis drug denufosol tetrasodium failed to meet expectations in a phase III trial04 Jan 2011http://www.pmlive.com/pharma_news/gsk_responds_to_suggestions_of_patient_harm_253731GSK has issued a response to the <EM>60 Minutes</EM>&nbsp;TV programme aired in the US that focused on&nbsp;a former manufacturing facility in Puerto Rico05 Jan 2011http://www.pmlive.com/pharma_news/dr_veronique_walsh_joins_bms_uk_253999Bristol-Myers Squibb UK has appointed Dr Véronique Walsh to the role of business unit director, neuroscience and immunoscience 05 Jan 2011http://www.pmlive.com/pharma_news/stroke_drug_submitted_for_euus_approval_254000Rivaroxaban has been submitted for marketing approval in the EU by Bayer and the US by J&amp;J for the prevention of stroke in patients with AF05 Jan 2011http://www.pmlive.com/pharma_news/pfizer_expands_rna_development_deal_254003Pfizer has signed a development and commercialisation deal potentially worth more than $600m with the Danish firm Santaris Pharma05 Jan 2011http://www.pmlive.com/pharma_news/fda_grants_orphan_status_for_two_drugs_254004Senesco has won US orphan drug status&nbsp;for a multiple myeloma drug, while Optimer has&nbsp;won orphan status for a potential drug for paediatric CDI05 Jan 2011http://www.pmlive.com/pharma_news/advanced_life_sciences_may_be_for_sale_254005Advanced Life Sciences has announced that it is exploring strategies, including a possible sale of the company, in order to improve its finances05 Jan 2011http://www.pmlive.com/pharma_news/merck_expands_in_emerging_markets_254006Merck has acquired a supplier to the biopharma industry in China as it opens a new technology centre in India06 Jan 2011http://www.pmlive.com/pharma_news/tablet_splitting_may_cause_wrong_dosage_254067Researchers have recommended pharma companies introduce a wider range of doses after a study suggested splitting tablets may result in an incorrect level of medication for patients06 Jan 2011http://www.pmlive.com/pharma_news/fda_approves_extended_use_of_actemra_254069<div>The US Food and Drug Administration (FDA) has extended the label on Genentech's Actemra (tocilizumab) to include three additional uses</div> 06 Jan 2011http://www.pmlive.com/pharma_news/merck_hepatitis_c_drug_gets_priority_review_254082Merck has won expedited reviews in both the US and the EU for boceprevir, an investigational oral hepatitis C virus protease inhibitor06 Jan 2011http://www.pmlive.com/pharma_news/ligand_forms_partnership_in_china_254086Ligand Pharmaceuticals has formed a development partnership with the US affiliate of Chinese company Chiva Pharmaceuticals07 Jan 2011http://www.pmlive.com/pharma_news/fda_launches_industry_basics_website_254309The US Food and Drug Administration has launched a new website designed to improve communication between the agency and industry07 Jan 2011http://www.pmlive.com/pharma_news/amgen_signs_deal_on_autoimmune_therapy_254310Amgen has signed a deal potentially worth more than $500m&nbsp;with Xencor regarding the licensing of a potential therapy for autoimmune diseases10 Jan 2011http://www.pmlive.com/pharma_news/sanofi-aventis_in_merger_talks_with_genzyme_254423Sanofi-aventis has announced that it is in discussions with Genzyme, and has offered to acquire the company for $18.5bn, or $69 a share10 Jan 2011http://www.pmlive.com/pharma_news/diagnostic_breath-test_analysis_developed_254443Oxford Medical Diagnostics has developed a technology that enables diagnostics for various illnesses through breath analysis10 Jan 2011http://www.pmlive.com/pharma_news/endo_abuse-resistant_pain_drug_rejected_254507The US FDA has told Endo Pharmaceuticals that the marketing application for the new formulation of Opana ER is not approvable in its current form10 Jan 2011http://www.pmlive.com/pharma_news/pain_drug_approved_under_new_rems_254508ProStraken's Abstral for breakthrough cancer pain has been granted US approval under a new kind of risk evaluation and mitigation strategy10 Jan 2011http://www.pmlive.com/pharma_news/bms_pharmasset_hepatitis_c_collaboration_254511Bristol-Myers Squibb and Pharmasset have entered an agreement to investigate a combination of oral antivirals in patients with hepatitis C10 Jan 2011http://www.pmlive.com/pharma_news/gsk_forms_alliance_with_epizyme_254526GlaxoSmithKline and Epizyme have&nbsp;signed a deal&nbsp;to develop a class of small molecule therapeutics for the treatment of diseases including cancer11 Jan 2011http://www.pmlive.com/pharma_news/new_uk_research_agency_recommended_254607The UK's Academy of Medical Sciences has recommended the creation of a Health Research Agency as part of changes to&nbsp;research regulation11 Jan 2011http://www.pmlive.com/pharma_news/takeda_signs_alzheimers_deal_for_actos_254686Japan's Takeda has entered into a partnership aimed at developing its diabetes medication Actos as a treatment for Alzheimer's disease11 Jan 2011http://www.pmlive.com/pharma_news/medication_adherence_lowers_costs_254690A new study shows that medication adherence can significantly cut costs when it comes to managing chronic disease11 Jan 2011http://www.pmlive.com/pharma_news/lillyboehringer_diabetes_deal_254702Eli Lilly and Boehringer Ingelheim have announced a deal to develop and market several diabetes products including oral agents and basal insulins11 Jan 2011http://www.pmlive.com/pharma_news/pharmexx_get_cqc_accreditation_254719Pharmexx is the first UK CSO to be awarded accreditation by the CQC for its health management services business unit12 Jan 2011http://www.pmlive.com/pharma_news/veevas_irep_combines_crm_and_clm_on_ipad_254797Veeva Systems has announced the launch of iRep, an innovative CRM and CLM solution developed specifically for the iPad 12 Jan 2011http://www.pmlive.com/pharma_news/s-a_collaborates_with_us_university_254860Partnerships aim to promote innovative research and oncology projects12 Jan 2011http://www.pmlive.com/pharma_news/k-v_pharmas_gestiva_delayed_again_254896The US Food and Drug Administration has again pushed back its decision on Gestiva for the prevention of preterm birth13 Jan 2011http://www.pmlive.com/pharma_news/combined_hypertension_drug_recommended_254952A study published in <EM>The Lancet</EM> has recommended a combination of two drugs for the treatment of high blood pressure13 Jan 2011http://www.pmlive.com/pharma_news/merck_parexel_biosimilar_alliance_255022Merck and Parexel have announced a strategic alliance to develop biosimilar candidates13 Jan 2011http://www.pmlive.com/pharma_news/oregon_sues_j_and_j_over_motrin_recall_255210 A lawsuit has been filed against J&amp;J charging that the company exposed consumers to defective supplies of OTC painkiller Motrin (ibuprofen) by delaying a full public recall of the drug13 Jan 2011http://www.pmlive.com/pharma_news/lilly_drug_rejected_by_fda_advisory_panel_255231An FDA advisory committee has voted to recommend against approval of Lilly's liprotamase pancreatic enzyme replacement therapy as a treatment of exocrine pancreatic insufficiency13 Jan 2011http://www.pmlive.com/pharma_news/web_tool_allows_comments_on_any_website_255246Pushnote, a new web browser plug-in, allows web users to leave comments and ratings on any website, including those run by pharma companies 14 Jan 2011http://www.pmlive.com/pharma_news/fda_tightens_safety_rules_for_painkiller_255407The US Food and Drug Administration is to limit the amount of acetaminophen that can be used in combination products, with a new boxed warning also required17 Jan 2011http://www.pmlive.com/pharma_news/merck_serono_domain_parkinsons_deal_255601Merck Serono and Domain Therapeutics are to partner in a deal to develop drugs to target neurodegenerative diseases such as Parkinson's17 Jan 2011http://www.pmlive.com/pharma_news/pharma_market_research_community_launched_255614eVillage, an online pharmaceutical market research community, has been launched by Insight Research Group 17 Jan 2011http://www.pmlive.com/pharma_news/information_seen_as_main_future_health_issue_255628A forum headed by WPP has highlighted 'information proliferation' as the main issue in the future of healthcare in the EU17 Jan 2011http://www.pmlive.com/pharma_news/more_recalls_by_j_and_js_mcneil_255647J&amp;J's McNeil Consumer Healthcare Division has announced the recall of about 47m units of over-the-counter medicines including Tylenol18 Jan 2011http://www.pmlive.com/pharma_news/alexza_schizophrenia_drug_delayed_255835The US Food and Drug Administration has refused to accept Alexza Pharmaceuticals' new drug application for an inhaled schizophrenia therapy in its current form 18 Jan 2011http://www.pmlive.com/pharma_news/ipsos_health_appoints_mike_holland_255836Ipsos Health has appointed Mike Holland as research director in their pharmaceutical practice 18 Jan 2011http://www.pmlive.com/pharma_news/transcept_resubmits_sleep_drug_255837Transcept Pharmaceuticals has resubmitted the US new drug application for Intermezzo, potentially the first drug cleared in the US specifically for a certain type of insomnia18 Jan 2011http://www.pmlive.com/pharma_news/2.2bn_legal_charge_for_gsk_255842GlaxoSmithKline has said it expects legal charges of £2.2bn to be recorded when it announces its results for the fourth quarter of 201019 Jan 2011http://www.pmlive.com/pharma_news/next_steps_for_former_head_of_ema_255885Dr Thomas Lönngren joins new European regulatory and market access company19 Jan 2011http://www.pmlive.com/pharma_news/boehringer_to_buy_amgens_california_facility_255899Boehringer Ingelheim is to purchase the rights to all assets at Amgen's development and manufacturing facility in Fremont, California19 Jan 2011http://www.pmlive.com/pharma_news/parapro_lice_drug_approved_255991ParaPRO has won approval from the US Food and Drug Administration for Natroba a topical treatment of head lice infestation 20 Jan 2011http://www.pmlive.com/pharma_news/cross-border_healthcare_ruling_for_europe_256114The European Parliament has passed a directive allowing EU residents to seek healthcare treatment in any of the 27 member states 20 Jan 2011http://www.pmlive.com/pharma_news/bleeding_warning_in_merck_drug_trial_256120Merck has published details of safety recommendations made as a result of an increased risk of bleeding in stroke patients involved in clinical trials of vorapaxar 20 Jan 2011http://www.pmlive.com/pharma_news/genzyme_grows_in_europe_256122Genzyme is to expand its operations in Europe with a new manufacturing plant in Geel, Belgium, producing its Pompe disease treatment Myozyme/ Lumizyme20 Jan 2011http://www.pmlive.com/pharma_news/mannkind_inhaled_insulin_delayed_again_256149The US Food and Drug Administration has declined for a second time to approve the new drug application for MannKind's inhaled insulin product Afrezza20 Jan 2011http://www.pmlive.com/pharma_news/fda_issues_new_plan_for_medical_devices_256151The US Food and Drug Administration has issued an action plan listing 25 steps it intends to take to make the path to market more efficient for medical devices21 Jan 2011http://www.pmlive.com/pharma_news/panel_rejects_lilly_alzheimers_imaging_agent_256344An advisory committee to the US FDA has voted against approval of Amyvid, developed by Lilly as a diagnostic tool to help rule out Alzheimer’s disease in patients experiencing cognitive decline21 Jan 2011http://www.pmlive.com/pharma_news/vivus_obesity_drug_delayed_256345The US Food and Drug Administration has asked Vivus for more safety information regarding Qnexa, which the company is hoping to market as a treatment for obesity24 Jan 2011http://www.pmlive.com/pharma_news/multiple_approvals_for_novartis_ms_drug_256539Novartis has received approval in Switzerland and Australia for its MS drug Gilenya, and a recommendation from CHMP for its use in the EU 24 Jan 2011http://www.pmlive.com/pharma_news/novartis_to_acquire_genoptix_256540Novartis is buy the diagnostics services company Genoptix for $470m in order to obtain technologies that will support programmes in oncology24 Jan 2011http://www.pmlive.com/pharma_news/fda_approves_clinical_data_depression_drug_256541Clinical Data has received marketing approval from the US Food and Drug Administration for Viibryd, a treatment for major depressive disorder24 Jan 2011http://www.pmlive.com/pharma_news/s-a_extends_genzyme_deadline_further_256619Sanofi-aventis has said it is to extend its tender offer for all outstanding shares of Genzyme to February 1525 Jan 2011http://www.pmlive.com/pharma_news/eu_to_simplify_research_funding_256804The European Commission has said research and innovation in the EU will be simplified with a focus on attracting smaller companies25 Jan 2011http://www.pmlive.com/pharma_news/amgen_to_buy_biovex_256809Amgen has said it is to acquire the US-based biotech BioVex in a deal potentially worth up to $1bn25 Jan 2011http://www.pmlive.com/pharma_news/eisai_sepsis_drug_fails_phase_iii_trial_256833Eisai has said it will delay the submission of regional marketing applications for investigational sepsis drug eritoran due to disappointing trial results25 Jan 2011http://www.pmlive.com/pharma_news/president_of_lilly_oncology_resigns_256835John H Johnson, president of Lilly Oncology has resigned effective January 28, citing personal considerations26 Jan 2011http://www.pmlive.com/pharma_news/j_and_j_sales_fall_0.5_per_cent_for_2010_256971Johnson &amp; Johnson has reported an annual decrease in sales of 0.5 per cent for 2010, due in part to a series of recalls for OTC products and suspension of manufacturing at a US plant26 Jan 2011http://www.pmlive.com/pharma_news/s-as_allegra_to_be_otc_257037Sanofi-aventis has won approval from the US Food and Drug Administration to market its allergy drug Allegra as an OTC medicine26 Jan 2011http://www.pmlive.com/pharma_news/imclone_ceo_to_take_over_at_savient_257038Former ImClone CEO John H Johnson, who this week said that he was leaving his post at Lilly, will take over as CEO at Savient Pharmaceuticals26 Jan 2011http://www.pmlive.com/pharma_news/europabio_helps_biotech_smes_257048European biotech organisation launches publication to assist growth27 Jan 2011http://www.pmlive.com/pharma_news/increase_in_use_of_hpv_vaccine_257181Use of the HPV vaccine in England to protect against cervical cancer has continued to increase since its introduction to the country's immunisation programme in 200827 Jan 2011http://www.pmlive.com/pharma_news/az_sees_decrease_in_q4_profit_257215AstraZeneca has reported a decrease in profit before tax of two per cent for the fourth quarter of 201027 Jan 2011http://www.pmlive.com/pharma_news/pharma_firms_form_coalition_on_aging_257231Pfizer, Novartis and J&amp;J have partnered with companies from other industries to form the Global Coalition on Aging27 Jan 2011http://www.pmlive.com/pharma_news/fda_rejects_new_use_for_gsks_avodart_257232The US Food and Drug Administration has declined to approve a new indication for GSK's Avodart for reducing the risk of prostate cancer28 Jan 2011http://www.pmlive.com/pharma_news/tibotec_licences_generic_hiv_drug_257455Tibotec Pharmaceuticals, a division of J&amp;J's Janssen-Cilag subsidiary, has granted licenses to several generic manufacturers for its yet-to-be-approved HIV drug rilpivirine28 Jan 2011http://www.pmlive.com/pharma_news/s-a_cancer_drug_fails_in_phase_iii_trial_257456Sanofi-aventis' investigational oncology drug iniparib has failed to meet the efficacy goals of a phase III clinical trial in patients with a hard-to-treat form of breast cancer31 Jan 2011http://www.pmlive.com/pharma_news/bms_wins_six_more_months_for_plavix_257632 Bristol-Myers Squibb and sanofi-aventis have won an additional six months of US marketing exclusivity for their blood-thinner Plavix 31 Jan 2011http://www.pmlive.com/pharma_news/senator_urges_pregnancy_labelling_overhaul_257635US Senator Herb Kohl, is pushing the FDA to revamp the way it handles the communication of drug risk information for pregnant and breastfeeding mothers 31 Jan 2011http://www.pmlive.com/pharma_news/pm_society_advertising_awards_2010_257639 Celebrating their 25th anniversary, The PM Society Advertising Awards 2010 took place on Friday January 28 at the Grosvenor House, Park Lane 01 Feb 2011http://www.pmlive.com/pharma_news/onyx_multiple_myeloma_drug_fast-tracked_257941Onyx Pharmaceuticals has received a fast-track designation from the US Food and Drug Administration for its multiple myeloma drug carfilzomib01 Feb 2011http://www.pmlive.com/pharma_news/takeda_obesity_drug_rejected_257951The US Food and Drug Administration has declined to approve obesity drug Contrave, developed by Takeda and Orexigen Therapeutics01 Feb 2011http://www.pmlive.com/pharma_news/pfizer_to_close_kent_plant_258005Pfizer is to close its R&amp;D facility in Kent, England, with the loss of 2,400 jobs01 Feb 2011http://www.pmlive.com/pharma_news/pfizer_revenue_increase_for_2010_258006Pfizer&nbsp;has announced an increase in revenue of 36 per cent for 2010, reflecting sales of&nbsp;drugs acquired after the company's takeover of Wyeth02 Feb 2011http://www.pmlive.com/pharma_news/valeant_acquires_swiss_pharma_company_258113Canada's Valeant Pharmaceuticals has signed a deal to acquire Swiss firm PharmaSwiss S.A. for €350m in a move to strengthen its European presence02 Feb 2011http://www.pmlive.com/pharma_news/study_ranks_top_pharma_websites_258114The websites for the drugs Levitra, Cialis and Chantix are among the most effective at getting consumers to ask doctors for prescriptions, according to a survey02 Feb 2011http://www.pmlive.com/pharma_news/brain_tumour_studies_approved_in_asia_258244South Korean and Taiwanese health agencies have given the go-ahead to Antisense Pharma for phase III trials of cancer drug02 Feb 2011http://www.pmlive.com/pharma_news/research_identifies_leaders_in_oncology_258255New research by Cegedim Customer Information has collated the opinions of physicians to identify key opinion leaders in oncology03 Feb 2011http://www.pmlive.com/pharma_news/fda_awards_grant_for_cancer_drug_study_258436 The US FDA has awarded a $1.6m grant under its orphan drugs programme to a&nbsp;Alabama-based biotech company&nbsp;Egen&nbsp;to help the company with clinical trials of a potential new therapy for ovarian cancer 03 Feb 2011http://www.pmlive.com/pharma_news/lilly_and_bms_halt_cancer_study_enrolment_258445Lilly and BMS have halted enrolment in a late-stage clinical study of an investigational treatment for advanced non-small cell lung cancer due to safety concerns 03 Feb 2011http://www.pmlive.com/pharma_news/nestle_acquires_cm_and_d_pharma_258550Nestlé Health Science has acquired CM&amp;D Pharma, a small UK company specialising in kidney disease, inflammatory bowel disease and colon cancer 03 Feb 2011http://www.pmlive.com/pharma_news/report_reveals_record_patent_expiries_258559A report from <i>EvaluatePharma</i> shows that 13 US blockbuster drugs will lose patent exclusivity in the next two years 03 Feb 2011http://www.pmlive.com/pharma_news/merckmsd_posts_$531m_loss_for_q4_2010_258590Merck/MSD has announced a $531m loss in the final quarter of 2010, however the company posted worldwide sales of £46bn for the year 04 Feb 2011http://www.pmlive.com/pharma_news/valeant_acquires_gsks_zovirax_258796Valeant Pharmaceuticals' Biovail Laboratories has signed a deal under which it will acquire all US and Canadian rights to certain formulations of GSK's Zovirax04 Feb 2011http://www.pmlive.com/pharma_news/lilly_partners_with_diabetes_group_258797Lilly has formed a partnership with the Juvenile Diabetes Research Foundation aimed at using regenerative medicine to treat type 1 diabetes07 Feb 2011http://www.pmlive.com/pharma_news/bayer_gist_drug_wins_us_orphan_status_258952Bayer has been granted orphan status by the US Food and Drug Administration for an investigational treatment for gastrointestinal stromal tumours07 Feb 2011http://www.pmlive.com/pharma_news/k-v_preterm_birth_drug_approved_258964K-V Pharmaceutical's Makena has received US approval as the first drug indicated to reduce the risk of preterm birth in women pregnant with one child who have a history of spontaneous preterm birth07 Feb 2011http://www.pmlive.com/pharma_news/phrma_appoints_new_evp_of_public_affairs_259128The Pharmaceutical Research and Manufacturers of America has appointed Josephine Martin as executive vice president, public affairs 07 Feb 2011http://www.pmlive.com/pharma_news/ema_widens_access_to_eudragmp_database_259129The European Medicines Agency has increased access to its EudraGMP database, which keeps track of manufacturing inspections from regulatory authorities, to the general public07 Feb 2011http://www.pmlive.com/pharma_news/early_end_for_az_zibotentan_study_259130AstraZeneca has announced an early end to its phase III trial investigating zibotentan in prostate cancer patients due to negative results from an efficacy review07 Feb 2011http://www.pmlive.com/pharma_news/positive_results_from_s-a_diabetes_trial_259142Sanofi-aventis has announced positive results from a phase III efficacy trial of once-daily lixisenatide versus twice-daily exenatide 08 Feb 2011http://www.pmlive.com/pharma_news/salix_licenses_progenics_relistor_259292Salix Pharmaceuticals has licensed worldwide rights excluding Japan to the opioid-induced constipation drug Relistor from Progenics Pharmaceuticals08 Feb 2011http://www.pmlive.com/pharma_news/pfizer_to_buy_danish_consumer_health_firm_259293Pfizer has entered into an agreement to purchase the Danish firm Ferrosan's consumer healthcare business08 Feb 2011http://www.pmlive.com/pharma_news/teva_doubles_q4_profit_259389Teva Pharmaceutical has announced a jump in net profit of over 100 per cent to $771m for the final quarter of 201008 Feb 2011http://www.pmlive.com/pharma_news/avandia_label_data_revised_in_us_259399GlaxoSmithKline's diabetes drug Avandia is to have its label information revised in the US following recent regulatory restrictions09 Feb 2011http://www.pmlive.com/pharma_news/pervasis_renal_disease_drug_fast-tracked_259599Pervasis Therapeutics has been granted fast-track status by the US Food and Drug Administration for Vascugel, a potential new drug for renal disease09 Feb 2011http://www.pmlive.com/pharma_news/fda_priority_review_programme_for_devices_259606The US Food and Drug Administration has proposed a new programme under which medical devices would be eligible for a priority review to half the time for premarket approval applications09 Feb 2011http://www.pmlive.com/pharma_news/uk_research_institute_gets_220m_funding_259623The UK government has approved £220m of funding for the new Centre for Medical Research and Innovation (UKCMRI)09 Feb 2011http://www.pmlive.com/pharma_news/sanofi-aventis_posts_solid_2010_figures_259795Sanofi-aventis has reported a 2.6 per cent increase in net income to €9.2bn for 2010, despite net sales for the year slipping by 0.8 per cent to €30.4bn 10 Feb 2011http://www.pmlive.com/pharma_news/orexigen_cuts_jobs_259945Orexigen Therapeutics has cut 40 per cent of its workforce following the recent refusal to approve obesity drug Contrave in the US10 Feb 2011http://www.pmlive.com/pharma_news/fda_places_hold_on_aids_drug_259953The US FDA has placed a clinical hold on an experimental HIV/AIDS drug being developed by GSK under a licence from Idenix Pharmaceuticals10 Feb 2011http://www.pmlive.com/pharma_news/the_pharma_summit_2011_259966 The Economist's Pharma Summit 2011 conference: "Reinventing pharma for a new generation" is took place on February 10. &nbsp;Catch-up with PMLiVE's post-conference report10 Feb 2011http://www.pmlive.com/pharma_news/boehringer_elan_antibody_deal_260128Boehringer Ingelheim has announced a partnership with Elan to develop and manufacture antibody-based therapeutics11 Feb 2011http://www.pmlive.com/pharma_news/new_head_of_lilly_oncology_260382Eli Lilly has appointed Sue Mahony to the role of senior vice president and president of Lilly Oncology 11 Feb 2011http://www.pmlive.com/pharma_news/mannkind_cuts_workforce_260384Mannkind Corporation is cutting about 41 per cent of its workforce in the wake of the US Food and Drug Administration's refusal to approve the company's inhaled insulin for diabetes Afrezza14 Feb 2011http://www.pmlive.com/pharma_news/fda_clears_test_for_novartis_zortress_260565The US Food and Drug Administration has cleared a test that monitors blood levels of Novartis' recently approved immunosuppressant Zortress14 Feb 2011http://www.pmlive.com/pharma_news/first_3-d_mammogram_system_approved_260566The US Food and Drug Administration has approved the first X-ray mammography device that provides three-dimensional images of the breast14 Feb 2011http://www.pmlive.com/pharma_news/ucb_launches_epilepsy_campaign_260590UCB has launched 'Epilepsy In Our Time' – a video campaign to mark the first European Epilepsy Day14 Feb 2011http://www.pmlive.com/pharma_news/sinclair_and_is_plan_to_merge_260591Sinclair Pharma has announced plans for a potential merger with IS Pharma to create a new Europe-wide speciality pharma company15 Feb 2011http://www.pmlive.com/pharma_news/survey_shows_comms_barriers_for_hispanics_260776A new survey from The Jeffrey Group and KCI Partners shows most doctors believe pharma companies do a poor job of communicating with Hispanic patients 15 Feb 2011http://www.pmlive.com/pharma_news/merck_wins_fosamax_case_260778 Merck has won the first US state court case to go to trial over whether the company's osteoporosis drug Fosamax&nbsp;(alendronate)&nbsp;causes serious dental and jaw problems 15 Feb 2011http://www.pmlive.com/pharma_news/watson_pharma_reports_positive_q4_results_260791Watson Pharmaceuticals has reported a 21 per cent increase in net revenue to $952.7m for Q4 201015 Feb 2011http://www.pmlive.com/pharma_news/lillys_mirror_portfolio_secures_molecules_260801Eli Lilly and Company has announced that its Mirror Portfolio has acquired two molecules 15 Feb 2011http://www.pmlive.com/pharma_news/s-a_and_boehringer_team_up_for_af_campaign_260802Sanofi-aventis and Boehringer Ingelheim are to work with the World Heart Federation to raise awareness of atrial fibrillation16 Feb 2011http://www.pmlive.com/pharma_news/s-a_to_buy_genzyme_for_$20.1bn_260881Sanofi-aventis is to acquire biotech Genzyme for an upfront payment of $20.1bn following nine months of discussions16 Feb 2011http://www.pmlive.com/pharma_news/astellas_withdraws_drug_application_in_japan_260945Astellas Pharma has withdrawn the marketing application for its venous thromboembolism preventative darexaban in Japan16 Feb 2011http://www.pmlive.com/pharma_news/european_parliament_votes_on_counterfeits_260946The European Parliament is meeting today to vote on legislation which aims to limit the entry of counterfeit medicines across the EU16 Feb 2011http://www.pmlive.com/pharma_news/lloydspharmacy_hires_new_managing_director_260963Lloydspharmacy has announced the appointment of former Woolworths executive, Tony Page as managing director16 Feb 2011http://www.pmlive.com/pharma_news/europe_takes_action_on_obesity_261014Stakeholders pledge to step up action to combat overweight and obesity-related health problems17 Feb 2011http://www.pmlive.com/pharma_news/astellas_regains_bladder_drug_from_gsk_261061Astellas Pharma US has exercised its right under a co-promotion agreement with GlaxoSmithKline to take back commercial responsibility in the US for overactive bladder treatment Vesicare17 Feb 2011http://www.pmlive.com/pharma_news/novo_subpoenaed_over_marketing_practices_261072Novo Nordisk has been ordered to turn over documents concerning potential criminal offences in the marketing and promotion of several diabetes products17 Feb 2011http://www.pmlive.com/pharma_news/large_rise_in_pharma_spend_on_apps_and_web_261141A report shows that in 2010 pharmaceutical companies increased their investment in digital, including mobile phone apps, social media and educational websites, by 78 per cent 18 Feb 2011http://www.pmlive.com/pharma_news/inspire_drops_cystic_fibrosis_programme_261279Inspire Pharmaceuticals has announced that it is dropping its pulmonary therapeutic drug development programme, cutting 65 jobs, to focus on eye-care18 Feb 2011http://www.pmlive.com/pharma_news/report_shows_slowing_fda_review_times_261280The US FDA's review times for drugs, biologics and medical devices have substantially increased in recent years, according to a new report21 Feb 2011http://www.pmlive.com/pharma_news/fda_clears_corifact_for_rare_disorder_261698The US Food and Drug Administration has granted approval to CSL Behring's new product to prevent bleeding in people with a rare genetic disorder21 Feb 2011http://www.pmlive.com/pharma_news/upsher-smith_expands_recall_261699Upsher-Smith Laboratories is voluntarily recalling a number of products after a bottle of warfarin was found to contain tablets at a higher dosage than labelled21 Feb 2011http://www.pmlive.com/pharma_news/khk_bid_for_prostrakan_261758Scotland-based speciality biotech ProStrakan has said Japanese firm Kyowa Hakko Kiri has placed a bid of £292m to acquire the company22 Feb 2011http://www.pmlive.com/pharma_news/forest_to_buy_clinical_data_261933Forest Laboratories has signed a $1.2bn agreement to acquire Clinical Data, which recently received US approval for the novel antidepressant Viibryd22 Feb 2011http://www.pmlive.com/pharma_news/gilead_to_acquire_calistoga_261934Gilead Sciences has entered into an agreement to acquire the biotech company Calistoga Pharmaceuticals in a deal worth up to $600m22 Feb 2011http://www.pmlive.com/pharma_news/j_and_j_complete_acquisition_of_crucell_261989 Johnson &amp; Johnson (J&amp;J) has completed its tender offer for Crucell at an agreed price of €24.75 per share and declared the offer as unconditional 23 Feb 2011http://www.pmlive.com/pharma_news/bayer_hires_consumer_product_leader_262114Bayer HealthCare has hired former Pfizer executive Erica L Mann to serve as the new president of its Consumer Care Division23 Feb 2011http://www.pmlive.com/pharma_news/regeneron_files_wet_amd_drug_262133Regeneron has submitted its wet age-related macular degeneration treatment, VEGF Trap-Eye, to the US Food and Drug Administration for approval23 Feb 2011http://www.pmlive.com/pharma_news/us_prescribing_info_update_for_onglyza_262190The FDA has approved an update to prescribing information for Onglyza, a type 2 diabetes therapy from AstraZeneca and Bristol-Myers Squibb 23 Feb 2011http://www.pmlive.com/pharma_news/us_supreme_court_rules_in_pharmas_favour_262204The US Supreme Court has ruled 6-2 in favour of Pfizer's Wyeth unit upholding a previous ruling preventing civil suits against manufacturers of vaccines24 Feb 2011http://www.pmlive.com/pharma_news/appeals_court_overturns_j_and_j_patent_win_262240Abbott has won a patent battle with Johnson &amp; Johnson's Centocor, overturning a 2009 federal court jury verdict that found Abbott liable for infringement24 Feb 2011http://www.pmlive.com/pharma_news/takeda_files_combination_blood_pressure_drug_262244Takeda has submitted a new drug application to the US Food and Drug Administration for an investigational combination therapy for high blood pressure24 Feb 2011http://www.pmlive.com/pharma_news/sanofi_pasteur_raises_polio_awareness_262327Sanofi-aventis division to raise awareness of polio with stock exchange 'bell-ringing'24 Feb 2011http://www.pmlive.com/pharma_news/uk_deal_to_boost_research_collaborations_262328The UK's newly launched research collaboration model, involving the life sciences industry, universities and the NHS, has been well received24 Feb 2011http://www.pmlive.com/pharma_news/norgine_increases_prostrakan_stake_262329Norgine has increased its stake in Scotland-based biotech ProStrakan sparking speculation that it could be to set to make a counter bid to KHK25 Feb 2011http://www.pmlive.com/pharma_news/pfizer_gaucher_disease_drug_delayed_262560The US Food and Drug Administration has declined to approve Protalix's taliglucerase alfa for the rare genetic disorder Gaucher disease25 Feb 2011http://www.pmlive.com/pharma_news/celgene_settles_with_elan_over_cancer_drug_262564Celgene has agreed to pay $76m to settle patent infringement litigation filed by Elan involving the breast cancer drug Abraxane28 Feb 2011http://www.pmlive.com/pharma_news/international_rare_disease_day_262711Today sees the fourth International Rare Disease Day, organised by the European Organisation for Rare Diseases28 Feb 2011http://www.pmlive.com/pharma_news/ucb_forms_alliance_with_harvard_262742UCB is to collaborate with Harvard University on the research of therapies for conditions related to the central nervous system and immunology28 Feb 2011http://www.pmlive.com/pharma_news/gsks_promacta_granted_full_us_approval_262747The US Food and Drug Administration has granted approval to GSK's Promacta, used to raise platelet counts in patients with a rare blood disorder28 Feb 2011http://www.pmlive.com/pharma_news/fda_approves_takeda_antihypertensive_262748The US Food and Drug Administration has approved Takeda's Edarbi tablets to treat high blood pressure in adults28 Feb 2011http://www.pmlive.com/pharma_news/pfizer_gives_evidence_for_closure_of_plant_262752Pfizer is to give evidence to the UK's Science and Technology Committee over the closure of its Kent plant01 Mar 2011http://www.pmlive.com/pharma_news/pharma_emarketing_europe_2011_262810The annual eMarketing Europe conference opens today (March 1) in Munich. Follow the conference live with commentary from delegates and other observers 01 Mar 2011http://www.pmlive.com/pharma_news/side_effects_major_hurdle_for_heart_drugs_262824Study finds even relatively mild side effects can be enough to keep older patients from taking drugs designed to prevent heart attacks 01 Mar 2011http://www.pmlive.com/pharma_news/new_use_cleared_for_shire_adhd_drug_262825 The FDA has approved Shire's ADHD drug Intuniv for the new indication of adjunctive therapy to stimulants in children and adolescents aged six to 17 02 Mar 2011http://www.pmlive.com/pharma_news/daiichi_sankyo_buys_plexxikon_262969The Japanese pharmaceutical company Daiichi Sankyo has agreed to buy the US drug developer Plexxikon in a deal that could be worth $935m02 Mar 2011http://www.pmlive.com/pharma_news/forest_copd_drug_wins_us_approval_262970Forest Laboratories has won approval from the US Food and Drug Administration for its chronic obstructive pulmonary disease (COPD) drug Daliresp02 Mar 2011http://www.pmlive.com/pharma_news/gsk_to_pay_fees_for_graduate_recruits_263007GlaxoSmithKline plans to pay the tuition fees of undergraduates the company hires in the UK in order to drive recruitment02 Mar 2011http://www.pmlive.com/pharma_news/bms_appoints_elliott_sigal_to_board_263075Bristol-Myers Squibb has appointed Dr Elliott Sigal to its Board of Directors and to the Board's science and technology committee 03 Mar 2011http://www.pmlive.com/pharma_news/fda_moves_against_unapproved_cold_drugs_263242The US Food and Drug Administration has announced it is to take action against companies that market unapproved prescription oral cough, cold, and allergy products03 Mar 2011http://www.pmlive.com/pharma_news/merck_ms_drug_denied_fda_approval_263282Merck KGaA's marketing application for the investigational oral formulation of cladribine has not been approved by the FDA as a treatment for relapsing-remitting multiple sclerosis03 Mar 2011http://www.pmlive.com/pharma_news/nycomed_results_hit_by_patent_issues_263349Nycomed 2010 figures hit by patent losses, but company says it is in a good position to benefit from pharma trends03 Mar 2011http://www.pmlive.com/pharma_news/ipsen_posts_fall_in_profit_263357Ipsen reports disappointing figures for 2010 following the decision to stop clinical trials of a hormone treatment04 Mar 2011http://www.pmlive.com/pharma_news/lilly,_amylin_diabetes_drug_disappoints_263408Bydureon, a longer-acting version of Lilly and Amylin's Byetta, was not as effective as Novo Nordisk's Victoza in a newly released 900-patient study04 Mar 2011http://www.pmlive.com/pharma_news/targacept_and_gsk_end_partnership_263410Targacept is to end a partnership with GlaxoSmithKline to create drugs in the therapeutic areas including pain, smoking cessation and obesity07 Mar 2011http://www.pmlive.com/pharma_news/warning_dropped_from_gilead_pah_drug_263686Gilead Sciences' hypertension drug Letairis will no longer be required to carry information about the risk of liver injury in its boxed warning in the US07 Mar 2011http://www.pmlive.com/pharma_news/fda_warns_on_j_and_js_topamax_263690The US FDA has warned that J&amp;J's epilepsy drug Topamax increases the risk of the birth defects cleft lip and cleft palate if taken during pregnancy07 Mar 2011http://www.pmlive.com/pharma_news/az_discontinues_asthma_medicine_263765AstraZeneca is to discontinue production of an inhaled version of its asthma medication Pulmicort due to 'manufacturing issues'07 Mar 2011http://www.pmlive.com/pharma_news/pfizer_s-a_vaccines_halted_in_japan_263766Separate vaccines from sanofi-aventis and Pfizer have had their use suspended in Japan following the deaths of four children08 Mar 2011http://www.pmlive.com/pharma_news/s-a_extends_offer_for_genzyme_shares_263901Sanofi-aventis on Monday extended its offer for Genzyme's outstanding shares until April 1 from an original deadline of March 1608 Mar 2011http://www.pmlive.com/pharma_news/repligen_bipolar_drug_fails_in_study_263902An oral form of uridine being developed by Repligen as a potential treatment for bipolar depression failed to show efficacy in a late-stage clinical trial08 Mar 2011http://www.pmlive.com/pharma_news/protests_against_indias_healthcare_tax_263969India's Union Government may withdraw its proposed healthcare service tax proposed for 2011-12, further to protests08 Mar 2011http://www.pmlive.com/pharma_news/fda_accepts_new_diabetes_compound_nda_264049The US FDA has accepted a new drug application for dapagliflozin, an investigational type 2 diabetes compound, from AstraZeneca and Bristol-Myers Squibb09 Mar 2011http://www.pmlive.com/pharma_news/eisai_cuts_us_workforce_by_20_percent_264270Eisai, the US pharmaceutical operation of Japan's Eisai, plans to cut its workforce by about 20 per cent across all US functions09 Mar 2011http://www.pmlive.com/pharma_news/fda_panel_backs_novartis_copd_drug_264271An advisory committee has voted to recommend that the US Food and Drug Administration approve Novartis' QAB149 (indacaterol) 09 Mar 2011http://www.pmlive.com/pharma_news/major_setback_for_eu_single_patent_264317European Court of Justice rejects proposal for unified patent litigation system and a European and Community Patents Court 09 Mar 2011http://www.pmlive.com/pharma_news/topra_awards_open_for_2011_264319Regulatory Affairs organisation launches second annual awards programme 10 Mar 2011http://www.pmlive.com/pharma_news/lilly_names_plowman_as_oncology_research_chief_264516 Eli Lilly has selected Greg Plowman, formerly senior director at Roche Group's Genentech, to lead its oncology research efforts 10 Mar 2011http://www.pmlive.com/pharma_news/raps_calls_for_awards_entries_264517The Regulatory Affairs Professionals Society seeks candidates for its 2011 fellowship and awards programmes as the deadline approaches 10 Mar 2011http://www.pmlive.com/pharma_news/nice_launches_kidney_quality_standard_264518UK's NICE introduces quality standard for chronic kidney disease, developed with the NHS and healthcare providers to highlight excellent patient care 10 Mar 2011http://www.pmlive.com/pharma_news/eu_ministers_back_ageing_partnership_264522European Union ministers have backed proposals to launch an innovation partnership on active and healthy ageing 10 Mar 2011http://www.pmlive.com/pharma_news/fda_approves_gsk_lupus_drug_264559GSK and Human Genome Sciences have  announced US Food and Drug Administration approval of their lupus drug Benlysta11 Mar 2011http://www.pmlive.com/pharma_news/fda_issues_consent_decree_for_j_and_js_mcneil_264771Johnson &amp; Johnson McNeil barred from manufacturing drugs at Fort Washington plant until FDA determines operations are in compliance with a consent decree14 Mar 2011http://www.pmlive.com/pharma_news/japanese_pharmacos_aid_earthquake_efforts_265158Several Japanese pharma companies have offered donations of both money and medical supplies to help with aid efforts following the Tohoku earthquake14 Mar 2011http://www.pmlive.com/pharma_news/amgen_buys_irish_pfizer_plant_265242Amgen is to purchase an Irish manufacturing facility from Pfizer, with the jobs of 280 workers set to be retained14 Mar 2011http://www.pmlive.com/pharma_news/astrazeneca_partners_with_cooking_website_265261AstraZeneca has entered into a partnership with Food University, a web-based culinary platform, to discuss healthy eating in support of the company's cholesterol drug Crestor14 Mar 2011http://www.pmlive.com/pharma_news/gsk_diabetes_drug_fails_phase_iii_study_265267A therapy for diabetes being developed by GlaxoSmithKline in partnership with Tolerx failed to meet the primary efficacy endpoint in a phase III clinical trial15 Mar 2011http://www.pmlive.com/pharma_news/abpi_backs_value_based_pricing_265331UK industry organisation voices its support for government proposals on valuing medicines as consultation period comes to a close15 Mar 2011http://www.pmlive.com/pharma_news/novartis_myelofibrosis_drug_shows_promise_265379Novartis has announced that a phase III trial of ruxolitinib has met its primary endpoint of significantly reducing spleen size in patients with myelofibrosis 16 Mar 2011http://www.pmlive.com/pharma_news/impax_shares_rise_on_parkinsons_drug_data_265533Share value of Impax Laboratories climbed 16 per cent after the company announced positive results from a phase III study of an investigational therapy for Parkinson's disease16 Mar 2011http://www.pmlive.com/pharma_news/phrma_report_shows_increased_r_and_d_spend_265570US pharmaceutical companies spent $67.4bn in 2010 on developing new drugs and vaccines, according to Pharmaceutical Research and Manufacturers of America17 Mar 2011http://www.pmlive.com/pharma_news/fda_and_ema_co-operate_on_drug_reviews_266024The US Food and Drug Administration has announced a pilot partnership with the European Medicines Agency to ensure consistent implementation of certain guidelines when reviewing marketing applications for new drugs17 Mar 2011http://www.pmlive.com/pharma_news/amylin_and_takeda_halt_obesity_drug_study_266050Amylin and Takeda have suspended a phase II clinical study of an investigational obesity treatment that combines pramlintide, the active ingredient in&nbsp;Symlin, with metreleptin, an analogue of the hormone leptin17 Mar 2011http://www.pmlive.com/pharma_news/wellcome_trust_bids_for_olympic_park_266054Wellcome Trust has said that it is interested in purchasing the 2012 Olympic Park, with intentions to build a science research centre17 Mar 2011http://www.pmlive.com/pharma_news/novartis_set_to_cut_uk_workforce_266092Novartis is consulting with staff at its Horsham plant on proposals to reduce the workforce by 55017 Mar 2011http://www.pmlive.com/pharma_news/gsk_closes_site_earlier_than_planned_266112GlaxoSmithKline has brought forward the closure of its Dartford plant as planning permission is sought for the site17 Mar 2011http://www.pmlive.com/pharma_news/r_and_d_centre_proposed_for_northern_ireland_266196The €4.7bn Global Pharmaceutical Centre of Excellence could create thousands of jobs in Northern Ireland18 Mar 2011http://www.pmlive.com/pharma_news/fda_advisors_back_oncology_device_266333Advisors to the US FDA have voted in favour of Novocure's noninvasive medical device designed to slow tumour growth 18 Mar 2011http://www.pmlive.com/pharma_news/fda_approves_bayer_contrast_agent_266342 The US FDA has approved Bayer HealthCare's Gadavist (gadobutrol for use in patients aged two and over undergoing MRI scanning of the central nervous system 18 Mar 2011http://www.pmlive.com/pharma_news/efpia_appoints_richard_bergstrom_as_dg_266380 The European Federation of the Pharmaceutical Industries and Associations (EFPIA) has appointed Richard Bergström as its new director general (DG) 18 Mar 2011http://www.pmlive.com/pharma_news/genesis_adoration_celebrate_25_years_266526Healthcare event management company Genesis Adoration is this month celebrating 25 years in business 21 Mar 2011http://www.pmlive.com/pharma_news/quest_diagnostics_to_buy_celera_266673Quest Diagnostics has agreed to buy Celera in a deal worth about $344m, strengthening the company’s molecular diagnostics development programme21 Mar 2011http://www.pmlive.com/pharma_news/fda_rejects_lilly_imaging_agent_266681The US Food and Drug Administration has informed Lilly that it cannot approve the company's new drug application for Amyvid, an imaging agent to help rule out Alzheimer's disease21 Mar 2011http://www.pmlive.com/pharma_news/eu_approval_for_gilenya_266933Novartis' oral multiple sclerosis drug Gilenya has been approved as the first treatment of its kind for use in the European Union21 Mar 2011http://www.pmlive.com/pharma_news/approval_for_s-as_prostate_cancer_drug_266934Sanofi-aventis has been granted EU approval to market its advanced prostate cancer treatment, Jevtana22 Mar 2011http://www.pmlive.com/pharma_news/novartis_expands_chinese_presence_267129Novartis has completed its acquisition of an 85 per cent share in Chinese vaccines company Zhejiang Tianyuan Bio-Pharmaceutical Co, expanding the company's presence in the Chinese vaccines market 22 Mar 2011http://www.pmlive.com/pharma_news/cephalon_to_buy_cancer_drug_developer_267146Cephalon has entered into an agreement to acquire the cancer drug development company Gemin X Pharmaceuticals in a deal that could be worth up to $525m22 Mar 2011http://www.pmlive.com/pharma_news/bms_melanoma_drug_meets_goal_267161Bristol-Myers Squibb has announced that its investigational melanoma drug ipilimumab has performed well in a phase III study23 Mar 2011http://www.pmlive.com/pharma_news/xoma,_servier_diabetes_drug_fails_trial_267289A potential therapy for diabetes being developed by the biotech company Xoma in partnership with the French pharma firm Servier failed to meet the primary endpoint in a phase IIb study23 Mar 2011http://www.pmlive.com/pharma_news/pozen_files_to_block_generic_migraine_drug_267307Pozen has filed a motion to block Par Pharmaceutical from launching a generic version of the migraine drug Treximet, which is marketed in the US by GlaxoSmithKline23 Mar 2011http://www.pmlive.com/pharma_news/gileads_hiv_drug_meets_phase_iii_endpoint_267442A phase III clinical trial has shown Gilead's investigational antiretroviral agent elvitegravir is as effective as Merck's Isentress after 48 weeks 23 Mar 2011http://www.pmlive.com/pharma_news/uk_budget_2011_100m_for_science_centres_267443The UK's Chancellor of the Exchequer George Osborne has announced extra funding of £100m to finance four science research centres as part of the coalition government's 2011 budget24 Mar 2011http://www.pmlive.com/pharma_news/gsk_gives_up_on_avodart_for_cancer_risk_267509GlaxoSmithKline has given up on efforts to secure marketing approval for the use of its benign prostatic hyperplasia drug Avodart for the new indication of reducing the risk of prostate cancer24 Mar 2011http://www.pmlive.com/pharma_news/novartis_copd_drug_delayed_267517The US Food and Drug Administration has pushed back making a decision on the marketing application for Novartis' QAB149 for chronic obstructive pulmonary disease by three months24 Mar 2011http://www.pmlive.com/pharma_news/allergan_and_cephalon_breach_abpi_code_267643Allergan and Cephalon (UK) have been found to have breached the ABPI Code of Practice and will be named in adverts in the medical press24 Mar 2011http://www.pmlive.com/pharma_news/s-a_signs_ophthalmology_deal_267644Sanofi-aventis has signed a co-operation agreement with one of the main eye disease research centres in Europe24 Mar 2011http://www.pmlive.com/pharma_news/eu_register_of_clinical_trials_launched_267645The EC and the European Medicines Agency has&nbsp;launched a database of thousands of trials that are underway in Europe25 Mar 2011http://www.pmlive.com/pharma_news/p_and_g_and_teva_form_consumer_venture_267757Procter &amp; Gamble and Teva Pharmaceutical have agreed to combine their portfolios of&nbsp;OTC medicines in all markets outside North America to create a consumer healthcare joint venture25 Mar 2011http://www.pmlive.com/pharma_news/targacept_adhd_drug_fails_phase_ii_study_267761An investigational treatment for adults with attention deficit/hyperactivity disorder that is being developed between AstraZeneca and Targacept has failed to meet the primary endpoint of a phase II trial28 Mar 2011http://www.pmlive.com/pharma_news/pfizer_unit_recalls_generic_drugs_268017Greenstone LLC, Pfizer's generic drugs unit, has announced a voluntary recall affecting two products due to the possibility that a third-party manufacturer may have placed incorrect labels on the pill bottles28 Mar 2011http://www.pmlive.com/pharma_news/mercks_shingles_vaccine_use_expanded_268022The US Food and Drug Administration has approved expanded usage of Merck's shingles prevention vaccine Zostavax, clearing the company to market the product for use in younger patients28 Mar 2011http://www.pmlive.com/pharma_news/live_digital_pharma_europe_268084The 3rd Annual Digital Pharma Europe conference is being held today at Boehringer Ingelheim's headquarters in Ingelheim, Germany28 Mar 2011http://www.pmlive.com/pharma_news/fda_approves_bms_skin_cancer_drug_268178The US Food and Drug Administration has approved Bristol-Myers Squibb's Yervoy for the treatment of unresectable or metastatic melanoma28 Mar 2011http://www.pmlive.com/pharma_news/gsk_plans_to_be_carbon_neutral_by_2050_268179GlaxoSmithKline has published its 2010 Corporate Responsibility Report, with plans for the company to be carbon neutral by 205029 Mar 2011http://www.pmlive.com/pharma_news/cephalon_to_make_bid_for_chemgenex_268207Cephalon has announced its intention to make a $231m takeover bid for the Australian biotech company ChemGenex, which has a potential therapy for chronic myeloid leukaemia in late-stage development29 Mar 2011http://www.pmlive.com/pharma_news/medtronic_heart_devices_approved_268208The US Food and Drug Administration has approved a new family of implantable cardiac devices from Medtronic that are intended to reduce the number of inappropriate therapeutic shocks that are delivered29 Mar 2011http://www.pmlive.com/pharma_news/astrazeneca_to_pay_$1.1bn_tax_settlement_268312AstraZeneca has reached an agreement with UK and US authorities to pay $1.1bn to resolve all US transfer pricing and related valuation matters covering 2000 to 2010 30 Mar 2011http://www.pmlive.com/pharma_news/merck_commits_10m_to_israeli_biotechs_268489 Merck Serono, a division of Merck, is to support biotech start-ups in Israel with its Israel Bioincubator Fund, a strategic and corporate initiative31 Mar 2011http://www.pmlive.com/pharma_news/live_diabetes_uk_annual_conference_268495Live coverage from Diabetes UK's Annual Professional Conference 2011 at London's ExCel conference centre from March 30 to April 130 Mar 2011http://www.pmlive.com/pharma_news/fda_scientist_charged_with_insider_trading_268496The US Department of Justice and Securities and Exchange Commission have charged an FDA chemist alleging that he traded pharmaceutical stocks based on confidential information about drug approval decisions 30 Mar 2011http://www.pmlive.com/pharma_news/survey_shows_doctors_find_sales_reps_useful_268497A study sponsored by PhRMA has found that the majority of doctors believe that pharma companies and their sales representatives are useful sources of information about medicines30 Mar 2011http://www.pmlive.com/pharma_news/valeant_makes_hostile_bid_for_cephalon_268507Valeant Pharmaceutical has made a $5.7bn hostile bid for biotech firm Cephalon, a cash offer of $73 per share 31 Mar 2011http://www.pmlive.com/pharma_news/prostrakan_takeover_moves_a_step_closer_268656Japanese conglomerate Kyowa Hakko Kirin has bought one share in ProStrakan, taking it a step closer to completing a takeover 31 Mar 2011http://www.pmlive.com/pharma_news/amgen_and_takeda_lung_drug_fails_trial_268667Amgen and Takeda have revealed that its lung cancer drug motesanib has failed to meet its endpoint in a phase III trial 31 Mar 2011http://www.pmlive.com/pharma_news/lilly_launches_global_service_programme_268704Lilly has launched a new CSR programme through which 200 of the company’s employees will serve as volunteer "ambassadors" to regions that lack basic resources 31 Mar 2011http://www.pmlive.com/pharma_news/nile_therapeutics_heart_drug_fast-tracked_268708The US Food and Drug Administration (FDA) has awarded fast-track status to Nile Therapeutics' development programme for heart drug cenderitide 04 Apr 2011http://www.pmlive.com/pharma_news/supreme_court_urged_to_invalidate_data_law_269194A coalition of parties, including PhRMA, is asking the US Supreme Court to invalidate a state law that curtails the use of a physician's prescribing history in pharma marketing04 Apr 2011http://www.pmlive.com/pharma_news/omeros_phase_iii_knee_surgery_drug_fails_269196A Omeros Corporation drug developed to increase mobility and reduce pain in patients who have undergone arthroscopic knee surgery has failed to meet the primary endpoints of a phase III programme04 Apr 2011http://www.pmlive.com/pharma_news/informal_pmcpa_digital_guidance_269211The UK's Prescription Medicines Code of Practice Authority has published 'informal guidance' on digital communications and launched an e-learning module as part of an awareness week for the ABPI Code of Practice04 Apr 2011http://www.pmlive.com/pharma_news/s-a_completes_takeover_of_genzyme_269447Sanofi-aventis is to complete its takeover of Genzyme after the company announced it had finalised its exchange offer for all outstanding shares of common stock of the US-based biotech04 Apr 2011http://www.pmlive.com/pharma_news/fda_reviewers_support_optimer_antibiotic_269454Reviewers from the US Food and Drug Administration have issued a positive memo on Optimer Pharmaceuticals'&nbsp;C. difficile treatment fidaxomicin&nbsp;ahead of an advisory committee meeting04 Apr 2011http://www.pmlive.com/pharma_news/fda_delays_social_media_guidance_again_269468The US Food and Drug Administration has again delayed draft guidance on social media, citing the complicated nature of the issue and the limited time and money at its disposal05 Apr 2011http://www.pmlive.com/pharma_news/stephen_whitehead_appointed_as_abpi_ceo_269667Stephen Whitehead will take up the role of ABPI CEO with effect from June 1, taking over from Richard Barker who steps down as director general on May 25 05 Apr 2011http://www.pmlive.com/pharma_news/pfizer_sells_capsugel_business_for_$2.4bn_269690Pfizer has entered into an agreement to sell its hard capsule business Capsugel to Kohlberg Kravis Roberts &amp; Co (KKR) for a cash sum of $2.375bn 05 Apr 2011http://www.pmlive.com/pharma_news/fda_refuses_to_file_pfizer_nda_269691The US Food and Drug Administration has refused to accept Pfizer's new drug application for a potential treatment for a rare, progressively fatal genetic neurodegenerative disease05 Apr 2011http://www.pmlive.com/pharma_news/march_of_dimes_cuts_ties_with_kv_pharma_269692The March of Dimes has severed ties with KV Pharmaceuticals and its subsidiary Ther-Rx Corp. in protest over the company's pricing for Maken, a drug to prevent preterm birth06 Apr 2011http://www.pmlive.com/pharma_news/msd_to_acquire_inspire_pharmaceuticals_269832MSD (Merck in the US and Canada) has entered into a deal worth $430m to acquire Inspire Pharmaceuticals, a speciality pharma company focused on ophthalmic products06 Apr 2011http://www.pmlive.com/pharma_news/uks_gmc_updates_guidance_for_doctors_269869For the first time, the UK's General Medical Council is proposing that doctors can prescribe a cheaper off-label alternative to a licensed medicine under certain conditions06 Apr 2011http://www.pmlive.com/pharma_news/gsk_tops_uk_reputation_ratings_269870GlaxoSmithKline (GSK) is the most reputable company in the UK pharmaceuticals sector, according to the latest UK RepTrak Pulse 2011 survey, published today by Reputation Institute06 Apr 2011http://www.pmlive.com/pharma_news/fda_clears_boehringers_once-daily_hiv_pill_269871The US Food and Drug Administration has granted marketing approval for Boehringer Ingelheim's Viramune XR extended-release tablets, a one-pill, once-daily formulation of the HIV drug Viramune06 Apr 2011http://www.pmlive.com/pharma_news/cephalon_rejects_valeant_bid_269873Cephalon's board of directors has formally rejected Valeant Pharmaceuticals' unsolicited bid to acquire the biotech company for $5.7bn or $73 per share07 Apr 2011http://www.pmlive.com/pharma_news/astrazenecas_orphan_drug_wins_fda_approval_270173AstraZeneca's medullary thyroid cancer drug vandetanib has secured approval from the US Food and Drug Administration07 Apr 2011http://www.pmlive.com/pharma_news/supergen_and_astex_to_merge_270174Cancer specialists SuperGen and Astex Therapeutics have agreed to merge07 Apr 2011http://www.pmlive.com/pharma_news/gsk_restless_legs_syndrome_drug_approved_270176GlaxoSmithKline and XenoPort have won marketing approval from the US Food and Drug Administration for Horizant, a treatment for moderate-to-severe primary Restless Legs Syndrome11 Apr 2011http://www.pmlive.com/pharma_news/hhs_unveils_minority_health_plans_270372The US Department of Health and Human Services (HHS) has unveiled two strategic plans aimed at reducing health disparities among racial and ethnic minority groups11 Apr 2011http://www.pmlive.com/pharma_news/j_and_j_names_mcneil_consumer_leader_270382Johnson &amp; Johnson has named Denice Torres, a former Lilly executive, to lead its McNeil Consumer Healthcare division, which recently has faced dozens of high-profile product recalls11 Apr 2011http://www.pmlive.com/pharma_news/j_and_j_settles_bribery_charges_for_$70m_270383Johnson &amp; Johnson has agreed to pay more than $70m in fines and other fees to settle corruption charges brought against the company by the US Department of Justice and the US Securities and Exchange Commission11 Apr 2011http://www.pmlive.com/pharma_news/ucb_launches_parkinsons_campaign_270846To coincide with World Parkinson's Day, UCB has launched the "Today I will…" campaign, inviting people affected by Parkinson's disease to share personal commitments online11 Apr 2011http://www.pmlive.com/pharma_news/astellas_europe_appoints_ken_jones_as_ceo_270847Ken Jones, chief operating officer of Astellas Pharma Europe, has been appointed president and CEO of the company12 Apr 2011http://www.pmlive.com/pharma_news/novartis_and_merck_halt_late-stage_studies_271164Novartis is discontinuing a phase III trial of an investigational treatment for gastrointestinal stromal tumours (GIST) based on the recommendation of an independent data monitoring committee12 Apr 2011http://www.pmlive.com/pharma_news/merck_melanoma_drug_approved_271173The US Food and Drug Administration has granted marketing approval to Merck's Sylatron (peginterferon alfa-2b) melanoma treatment12 Apr 2011http://www.pmlive.com/pharma_news/msd_forms_joint_venture_with_sun_pharma_271235MSD (Merck in US and Canada) has entered into a joint venture with India's Sun Pharma to develop, manufacture and commercialise branded generics in the emerging markets 12 Apr 2011http://www.pmlive.com/pharma_news/novartis_gains_licence_for_gws_sativex_271238GW Pharmaceuticals has entered into an exclusive licence agreement for Novartis to commercialise Sativex in several key territories 13 Apr 2011http://www.pmlive.com/pharma_news/medivir_buys_biophausia_271471Medivir acquires BioPhausia in €62m deal as it looks to market new hepatitis C drug13 Apr 2011http://www.pmlive.com/pharma_news/f-star_wins_15m_investment_271472Antibody specialist f-star secures funding from existing investors and adds new members to its supervisory board13 Apr 2011http://www.pmlive.com/pharma_news/takeda_files_us_patent_case_271473Takeda sues Dr Reddy's over patent infringements related to Dexilant drug13 Apr 2011http://www.pmlive.com/pharma_news/novartis_plans_media_shake_up_271520Swiss firm Novartis could be about to embark on a review of its global media business, according to reports13 Apr 2011http://www.pmlive.com/pharma_news/setback_for_mannkinds_inhaled_insulin_271541The US Food and Drug Administration has cancelled its end-of-review meeting with MannKind Corporation regarding the company's Afrezza inhaled insulin13 Apr 2011http://www.pmlive.com/pharma_news/fda_panel_backs_novartis_cancer_drug_271542Advisors to the US Food and Drug Administration have voted&nbsp; unanimously in favour of recommending that the federal agency grant marketing approval to Novartis' Afinitor to treat patients with pancreatic cancer14 Apr 2011http://www.pmlive.com/pharma_news/uk_and_india_collaborate_on_mobile_health_271654New project to explore the potential of mobile technologies in improving the management of chronic diseases in rural areas of the UK and India14 Apr 2011http://www.pmlive.com/pharma_news/j_and_j_ortho-mcneil_division_recalls_topamax_271656 Johnson &amp; Johnson's (J&amp;J) Ortho-McNeil Neurologics Division has recalled two batches of its anti-seizure drug Topamax (topiramate) due to reports of an odour 14 Apr 2011http://www.pmlive.com/pharma_news/joint_ownership_for_indigenus_network_271657Thirteen agencies pool resources to provide global creative services to healthcare clients14 Apr 2011http://www.pmlive.com/pharma_news/gsk_plans_to_sell_off_non-key_otc_products_271662GlaxoSmithKline is to sell off several over-the-counter brands, including weight-management drug Alli, as part of efforts to streamline its Consumer Healthcare business15 Apr 2011http://www.pmlive.com/pharma_news/what_the_code_means_for_you..._271710Following the PMCPA's publication of its informal guidance on digital communications, we asked key digital experts, what it really means for them... and for you 15 Apr 2011http://www.pmlive.com/pharma_news/phrma_honours_merck_scientists_272055Pharmaceutical Research and Manufacturers of America has announced that it will present its 2011 Discoverers Award to two Merck scientists who were behind the discovery of the Januvia diabetes pill15 Apr 2011http://www.pmlive.com/pharma_news/merck_and_j_and_j_reach_remicade_deal_272059Merck and Johnson &amp; Johnson have reached a deal in their dispute over distribution rights to Remicade and the follow-on drug Simponi in markets outside the US18 Apr 2011http://www.pmlive.com/pharma_news/fda_rejects_lilly_enzyme_replacement_272189The US Food and Drug Administration has declined to approve Lilly's marketing application for liprotamase pancreatic enzyme replacement therapy as a treatment of exocrine pancreatic insufficiency18 Apr 2011http://www.pmlive.com/pharma_news/new_use_cleared_for_genentech_arthritis_drug_272202The US Food and Drug Administration has approved Genentech's Actemra for the new indication of the treatment of active systemic juvenile idiopathic arthritis, a rare paediatric form of arthritis18 Apr 2011http://www.pmlive.com/pharma_news/ema_updates_gsk_flu_vaccine_guidance_272251The European Medicines Agency has recommended the product label for GlaxoSmithKline's flu vaccine Pandemrix be revised to include information about a possible increased risk of narcolepsy in children18 Apr 2011http://www.pmlive.com/pharma_news/lillys_q1_profit_falls_by_$200m_272252Eli Lilly has announced a net income loss of 15 per cent for the first quarter of 2011, due in part to severance costs and expenses related to a deal with Boehringer Ingelheim to develop diabetes products19 Apr 2011http://www.pmlive.com/pharma_news/novartis_posts_strong_q1_2011_results_272453Novartis has announced net sales of $14bn for the first quarter of 2011, due in part to positive demand for the company's new multiple sclerosis treatment Gilenya 19 Apr 2011http://www.pmlive.com/pharma_news/baxter_to_acquire_prism_pharma_for_$338m_272454Baxter International has entered into an agreement to acquire Prism Pharmaceuticals, a speciality pharma company based in King of Prussia, Pennsylvania 19 Apr 2011http://www.pmlive.com/pharma_news/synthes_confirms_j_and_j_talks_272455The medical device maker Synthes, which trades on the Swiss exchange but has its global headquarters in Pennsylvania, has confirmed that it is in talks to be bought by Johnson &amp; Johnson19 Apr 2011http://www.pmlive.com/pharma_news/s-a_enters_research_deal_with_stanford_272458Sanofi-aventis has entered into a research collaboration with Stanford University that is aimed at early-stage science20 Apr 2011http://www.pmlive.com/pharma_news/forest_laboratories_earnings_rise_272504Forest Laboratories has reported a major increase in fiscal Q4 profit compared to the same period last year20 Apr 2011http://www.pmlive.com/pharma_news/j_and_j_profit_falls_on_recall_woes_272505Johnson &amp; Johnson has reported a 23 per cent decline in profit for Q1 2011 in spite of increased revenues, as the company experienced high costs related to product recalls and lawsuit 20 Apr 2011http://www.pmlive.com/pharma_news/circassia_gets_60m_for_allergy_products_272530Phase III funding represents second largest amount raised by a privately held European biopharma company in 2011 20 Apr 2011http://www.pmlive.com/pharma_news/abbott_reports_global_sales_of_$9bn_272533Strong sales in emerging markets boost business growth to over 12 per cent 21 Apr 2011http://www.pmlive.com/pharma_news/fda_approves_rituxan_for_rare_diseases_272605<div>The US FDA has approved Genentech's marketed cancer and arthritis drug Rituxan (rituximab) for two new indications aimed at treating rare diseases</div> 21 Apr 2011http://www.pmlive.com/pharma_news/fda_releases_strategic_priorities_272606The US Food and Drug Administration (FDA) has released a 50-page document outlining its strategic priorities for the next five years 21 Apr 2011http://www.pmlive.com/pharma_news/takeda_promotes_trevor_smith_to_ceo_272607Takeda Pharmaceuticals has appointed Trevor Smith as chief executive for Europe following the departure of Dr Erich Brunn 21 Apr 2011http://www.pmlive.com/pharma_news/pfizer_agrees_mou_with_chinese_firm_272608<div>Pfizer has signed a memorandum of understanding (MoU) with Shanghai Pharmaceuticals Co</div> 21 Apr 2011http://www.pmlive.com/pharma_news/valeant_chases_cephalon_acquisition_272622Valeant Pharmaceuticals is to write to Cephalon shareholders in a bid to gain support 26 Apr 2011http://www.pmlive.com/pharma_news/mercks_rwandan_cervical_cancer_programme_272961Merck has announced the launch of Africa's first comprehensive cervical cancer protection programme in Rwanda, including HPV testing and HPV vaccination using Gardasil 26 Apr 2011http://www.pmlive.com/pharma_news/sun_merck_enter_indian_diabetes_deal_272962Merck has teamed up with Sun Pharmaceutical to co-market Merck's diabetes drugs sitagliptin and sitagliptin plus metformin in India 26 Apr 2011http://www.pmlive.com/pharma_news/fda_declines_approval_for_eisais_aricept_272963Eisai has received a complete response letter from the US Food and Drug Administration declining approval for the transdermal patch formulation of Eisai's Alzheimer's treatment Aricept 27 Apr 2011http://www.pmlive.com/pharma_news/daiichi_sankyo_vte_drug_approved_272964 Japan has granted first marketing approval for Lixiana (edoxaban) for the prevention of venous thromboembolism (VTE) 27 Apr 2011http://www.pmlive.com/pharma_news/lilly_and_medtronic_to_work_on_parkinsons_272966Collaboration combines companies' expertise in neuroscience and targeted drug delivery to develop a new approach to treat Parkinson's disease 27 Apr 2011http://www.pmlive.com/pharma_news/millennium_submits_new_velcade_applications_272968Millennium has submitted applications to the US Food and Drug Administration seeking approval of two new indications for its injectable cancer drug Velcade 27 Apr 2011http://www.pmlive.com/pharma_news/columbiawatson_preterm_birth_nda_272969 Columbia Laboratories has submitted a new drug application to the US Food and Drug Administration for Prochieve, a potential therapy to reduce the risk of preterm birth that it is developing with Watson Pharmaceuticals 28 Apr 2011http://www.pmlive.com/pharma_news/lilly_wins_cymbalta_exclusivity_272970 Lilly has won a court victory that could provide US marketing exclusivity for the company's blockbuster antidepressant Cymbalta until at least the middle of 2013, according to the company 28 Apr 2011http://www.pmlive.com/pharma_news/fda_advisors_back_merck_hcv_drug_272971A committee of outside advisors to the US Food and Drug Administration has voted unanimously in favour of recommending marketing approval for Merck's investigational hepatitis C therapy Victrelis 28 Apr 2011http://www.pmlive.com/pharma_news/gsk_sales_fall_for_first_quarter_of_2011_272973First quarter revenue for GlaxoSmithKline has dropped by 10 per cent, with the company continuing to be affected by marketing restrictions for diabetes drug Avandia28 Apr 2011http://www.pmlive.com/pharma_news/j_and_j_to_pay_$21.3bn_for_synthes_272976Johnson &amp; Johnson has announced it has entered a definitive agreement to buy medical device maker Synthes for $21.3bn – the biggest purchase in the company's history28 Apr 2011http://www.pmlive.com/pharma_news/ucb_reveals_positive_q1_figures_272977UCB's first-quarter figures boosted by core products Cimzia, Vimpat and Neupro28 Apr 2011http://www.pmlive.com/pharma_news/astrazeneca_posts_disappointing_q1_figures_272978AstraZeneca reveals fall in first-quarter sales and profit following increased generic competition and government price intervention28 Apr 2011http://www.pmlive.com/pharma_news/sanofi-aventis_q1_hit_by_h1n1_272979Sanofi-aventis has seen its&nbsp;first-quarter financial results hit by lack of flu vaccine and generic competition28 Apr 2011http://www.pmlive.com/pharma_news/shire_makes_strong_start_to_2011_272981Shire reports rise in operating profit and sales in the first half of 201103 May 2011http://www.pmlive.com/pharma_news/centocor_pulls_cancer_drug_application_273160Centocor has decided not to pursue US approval of ovarian cancer drug trabectedin, with the&nbsp;FDA stating that the company would need to conduct an additional phase III clinical trial before approval could be granted03 May 2011http://www.pmlive.com/pharma_news/fda_advisors_back_vertex_hcv_drug_273161An advisory committee to the US Food and Drug Administration has unanimously backed Vertex Pharmaceuticals' investigational new therapy for hepatitis C03 May 2011http://www.pmlive.com/pharma_news/teva_to_acquire_cephalon_for_$6.8bn_273189The world's largest generic drug maker, Teva Pharmaceutical, has entered into an agreement to acquire global biopharmaceutical company Cephalon for $6.8bn 03 May 2011http://www.pmlive.com/pharma_news/pfizer_reports_q1_revenue_of_$16.5bn_273206Pfizer has announced Q1 2011 revenue of $16.5bn, consistent with&nbsp;the same period in 201004 May 2011http://www.pmlive.com/pharma_news/mylan_q1_profit_increases_273892Mylan has reported a major increase in first-quarter profit, due mainly to robust sales in North America 04 May 2011http://www.pmlive.com/pharma_news/lillyboehringer_diabetes_drug_approved_273896The US Food and Drug Administration has granted marketing approval to a type 2 diabetes drug developed through a partnership between Lilly and Boehringer Ingelheim04 May 2011http://www.pmlive.com/pharma_news/onyx_reports_q1_loss_of_$14.2m_274089Onyx Pharmaceuticals has reported a non-GAAP net loss of $14.2m for the first quarter 2011 compared with a non-GAAP net loss of $1.5m for the same period last year 05 May 2011http://www.pmlive.com/pharma_news/almirall_nycomed_copd_co-branding_deal_274134Almirall and Nycomed have entered into a co-branding agreement for the commercialisation of roflumilast, a once-daily tablet for patients with chronic obstructive pulmonary disease, in Spain05 May 2011http://www.pmlive.com/pharma_news/s-a_agrees_malaria_research_project_274147Sanofi-aventis and Medicines for Malaria Venture (MMV) are to work together on Orthology Malaria – a project to research malaria treatments05 May 2011http://www.pmlive.com/pharma_news/lundbeck_reports_profit_fall_274148Danish drugs manufacturer Lundbeck has posted a 1.6 per cent fall in first-quarter net profit to DKK930m (€124.7m)05 May 2011http://www.pmlive.com/pharma_news/astellas_multiple_myeloma_partnership_274235Astellas Pharma Global Development is partnering with the non-profit Multiple Myeloma Research Foundation (MMRF) on the clinical development of a potential new treatment for relapsed multiple myeloma05 May 2011http://www.pmlive.com/pharma_news/fda_cracks_down_on_bogus_std_drugs_274236The US Food and Drug Administration is partnering with the US Federal Trade Commission on an effort to get unapproved products for sexually transmitted diseases (STDs) off the market06 May 2011http://www.pmlive.com/pharma_news/fda_approves_afinitor_for_pancreatic_cancer_274464Novartis has won US Food and Drug Administration (FDA) approval of its marketed cancer drug Afinitor (everolimus) for the treatment of pancreatic cancer 06 May 2011http://www.pmlive.com/pharma_news/pfizer_returns_asthma_drug_to_rigel_274465Pfizer is returning full rights to a clinical-stage inhaled asthma drug to Rigel Pharmaceuticals09 May 2011http://www.pmlive.com/pharma_news/j_and_j_files_new_concerta_suit_against_impax_274606Impax Laboratories has been sued for the second time by Johnson &amp; Johnson in connection with a generic version of the attention deficit hyperactivity disorder drug Concerta09 May 2011http://www.pmlive.com/pharma_news/abbott_stent_approval_expanded_274609The US Food and Drug Administration has approved&nbsp;Abbott's RX Acculink carotid stent for use in patients at standard risk of stroke09 May 2011http://www.pmlive.com/pharma_news/sanofi-aventis_rebrands_as_sanofi_274825Sanofi-aventis has rebranded itself as Sanofi following approval from its shareholders at the company's combined general shareholder meeting09 May 2011http://www.pmlive.com/pharma_news/alkermes_to_buy_elan_unit_274845Alkermes is to acquire Elan's drug formulation and manufacturing unit for $960m, with company headquarters to be moved to Ireland10 May 2011http://www.pmlive.com/pharma_news/cns_drug_wins_orphan_status_275041Drug-development company Mithridion has won orphan status from the US Food and Drug Administration for a potential treatment for brain disease progressive supranuclear palsy10 May 2011http://www.pmlive.com/pharma_news/merck_launches_hcv_awareness_campaign_275044Merck has launched a new programme to increase awareness and diagnosis of hepatitis C virus, while Endo Pharmaceuticals has&nbsp;initiated a pain&nbsp;awareness campaign&nbsp;for sufferers of osteoarthritis10 May 2011http://www.pmlive.com/pharma_news/2011_bobi_awards_-_winners_and_pictures_275109The British Healthcare Business Intelligence Association (BHBIA) has announced the winners of the 2010-11 Best of British Intelligence (BOBI) awards10 May 2011http://www.pmlive.com/pharma_news/doctors.net.uk_launches_network_of_networks_275127Doctors.net.uk has launched Networks in Health, an international alliance of online physician communities11 May 2011http://www.pmlive.com/pharma_news/humira_success_in_ulcerative_colitis_study_275261Abbott's Humira has been successful in a phase III study testing the product as a therapy for ulcerative colitis, according to the company11 May 2011http://www.pmlive.com/pharma_news/new_chamberlain_health_agency_275262Chamberlain Communications Group has launched a new agency called SharedVoice Public Relations, which will focus on providing integrated communications services to mid- to-small sized healthcare companies11 May 2011http://www.pmlive.com/pharma_news/spain_launches_biotech_platform_275329Initiative aims to improve communications between stakeholders to hasten the uptake of advances in biotechnology11 May 2011http://www.pmlive.com/pharma_news/new_uk_cell_therapy_centre_275344The UK Technology Strategy Board is calling for expressions of interest in a new technology and innovation centre for cell therapy12 May 2011http://www.pmlive.com/pharma_news/tourette_group_enters_research_partnership_275404The US national Tourette Syndrome Association (TSA) has entered into its first-ever clinical research collaboration with a pharmaceutical company 12 May 2011http://www.pmlive.com/pharma_news/daiichi_submits_melanoma_drug_applications_275406Daiichi Sankyo has submitted US and European marketing applications for a potential new drug to treat metastatic melanoma 12 May 2011http://www.pmlive.com/pharma_news/astellas_signs_cns_deal_with_biofocus_275408Astellas Pharma is to focus on central nervous system (CNS) disorders with the help of BioFocus 12 May 2011http://www.pmlive.com/pharma_news/rapidscange_healthcare_distribution_deal_275420Rapidscan choses GE Healthcare to distribute coronary artery disease treatment in the UK and Germany 12 May 2011http://www.pmlive.com/pharma_news/almirall_sees_q1_profit_fall_275422Almirall says its first-quarter profit has been hit by generic competition 13 May 2011http://www.pmlive.com/pharma_news/medication_adherence_campaign_275838The National Consumers League, a nonprofit membership organisation, has launched a new awareness campaign to encourage patients to adhere to their medication regimens13 May 2011http://www.pmlive.com/pharma_news/new_executive_at_phrma_275842Pharmaceutical Research and Manufacturers of America, the industry's main US trade group, has confirmed former IBM executive Rod Hunter as the organisation's new senior vice president of international advocacy16 May 2011http://www.pmlive.com/pharma_news/fda_approves_merck_hcv_drug_276064The US Food and Drug Administration has approved Merck's hepatitis C therapy Victrelis, making it the first new drug to be cleared for the disease in 20 years16 May 2011http://www.pmlive.com/pharma_news/biomimetic_bone_graft_wins_panel_support_276068A US Food and Drug Administration committee has voted in support of BioMimetic Therapeutics' Augment Bone Graft for use as an alternative to autograft in hindfoot and ankle fusion procedures16 May 2011http://www.pmlive.com/pharma_news/abpi_bia_relocate_together_276147The UK's Association of the British Pharmaceutical Industry and the BioIndustry Association are to relocate to shared offices in London by the end of May16 May 2011http://www.pmlive.com/pharma_news/takeda_denies_nycomed_takeover_talks_276161Takeda&nbsp;has denied reports that&nbsp;it is to&nbsp;buy Swiss company Nycomed16 May 2011http://www.pmlive.com/pharma_news/teva_takes_majority_stake_in_taiyo_276189Israel's Teva is to take 57 per cent share in Japanese generic medicines manufacturer Taiyo16 May 2011http://www.pmlive.com/pharma_news/early_identification_key_for_healthcare_276190Biomarkers will help global healthcare systems survive financially, an event in London has heard17 May 2011http://www.pmlive.com/pharma_news/gsk_launches_first-in-class_epilepsy_drug_276484GSK introduces Trobalt for the adjunct treatment of adults with partial-onset seizures17 May 2011http://www.pmlive.com/pharma_news/amylin_takes_lilly_to_court_276485Amylin files lawsuit against Eli Lilly over alleged breaches of its agreements for the commercialisation of exenatide17 May 2011http://www.pmlive.com/pharma_news/fda_seeks_input_on_biosimilars_user_fees_276566The US Food and Drug Administration is seeking written comments from stakeholders and the public on the agency's efforts to develop a user fee programme for biosimilars18 May 2011http://www.pmlive.com/pharma_news/shire_lines_up_advanced_biohealing_deal_276665 Shire is to acquire Advanced BioHealing, a US-based regenerative medicine company, for $750m in cash18 May 2011http://www.pmlive.com/pharma_news/takeda_will_acquire_nycomed,_reports_say_276666 Takeda Pharmaceutical Company has agreed to buy Swiss drugmaker Nycomed in a deal worth around 1trn yen ($12bn), according to a report in Japanese newspaper, Nikkei18 May 2011http://www.pmlive.com/pharma_news/merck_and_roche_sign_hcv_deal_276668Merck and Roche sign HCV deal 19 May 2011http://www.pmlive.com/pharma_news/german_partners_find_diabetes_biomarker_276945Helmholtz Zentrum München and Boehringer Ingelheim have identified a biomarker for diabetes-relevant protein19 May 2011http://www.pmlive.com/pharma_news/astellas_posts_positive_bladder_therapy_data_277013Astellas has reported positive data from a phase III trial for its overactive bladder therapy candidate mirabegron19 May 2011http://www.pmlive.com/pharma_news/iroko_cadio_adopts_veeva_cmr_277015Switzerland based Iroko Cardio International has switched to Veeva's cloud-based customer relationship management system19 May 2011http://www.pmlive.com/pharma_news/takeda_acquires_nycomed_277017Takeda Pharmaceutical Company has completed a €9.6bn takeover of Nycomed23 May 2011http://www.pmlive.com/pharma_news/pfizers_sutent_wins_new_fda_approval_277795Pfizer's cancer drug Sutent has received US Food and Drug Administration approval for the additional indication of the treatment of pancreatic neuroendocrine tumours in certain patients23 May 2011http://www.pmlive.com/pharma_news/uk_invests_in_personalised_medicines_277811The UK's Technology Strategy Board and the Medical Research Council are to jointly invest more than £3.7m in seven major new research projects into personalised medicine23 May 2011http://www.pmlive.com/pharma_news/lab21_buys_myconostica_277817Personalised medicine firm Lab21 has acquired Myconostica, a molecular diagnostic company focusing on the diagnosis of fungal infections, for an undisclosed sum23 May 2011http://www.pmlive.com/pharma_news/cephalon_wins_injunction_against_mylan_277820Cephalon has won a court restraining order in its efforts to keep Mylan Pharmaceuticals from selling a low-cost generic version of the extended-release muscle relaxant Amrix23 May 2011http://www.pmlive.com/pharma_news/tibotec_hiv_drug_approved_277828The US Food and Drug Administration has approved Tibotec Therapeutics' HIV drug Edurant for use in combination with other antiretroviral drugs for the treatment of HIV-1 infection in adults23 May 2011http://www.pmlive.com/pharma_news/fda_warning_letter_for_aurobindo_277876India based generics manufacturer, Aurobindo Pharma, has received warning letters from the US Food and Drug Administration calling for changes at two of the company's facilities24 May 2011http://www.pmlive.com/pharma_news/par_to_acquire_indian_generics_firm_278179US-based Par Pharmaceutical has entered into a definitive agreement to acquire India's Edict Pharmaceuticals, a privately held developer and manufacturer of solid oral dosage generic pharmaceuticals24 May 2011http://www.pmlive.com/pharma_news/fda_panel_wants_new_trilipix_data_278186An advisory committee to the US FDA has voted to recommend the agency retain the current indication for Abbott's cholesterol drug Trilipix statin but also require Abbott to gather more clinical data to support additional use24 May 2011http://www.pmlive.com/pharma_news/shire_set_to_make_move_for_cubist_278192Shire Pharmaceuticals&nbsp;is planning a&nbsp;takeover of US-based Cubist Pharmaceuticals in a multi-billion pound deal, according to a UK media report24 May 2011http://www.pmlive.com/pharma_news/venus_secures_eu_patent_for_achnil_278269Venus Remedies has been granted a patent by the European Patent Office for its research drug Achnil, a once-daily painkiller injection24 May 2011http://www.pmlive.com/pharma_news/astrazeneca_co-promotes_bone_cancer_drug_278270AstraZeneca is to co-promote Amgen's drug denosumab in Japan as a treatment for bone cancer disorders alongside Daiichi Sankyo24 May 2011http://www.pmlive.com/pharma_news/abpi_real_world_value_guidance_278271The UK's Association of the British Pharmaceutical Industry has published guidance on the use of data from real life situations to demonstrate the value of a product25 May 2011http://www.pmlive.com/pharma_news/vertex_hcv_drug_approved_278360The US Food and Drug Administration FDA has approved Vertex Pharmaceuticals' new therapy for hepatitis C, a tablet known as Incivek25 May 2011http://www.pmlive.com/pharma_news/elan_and_proteostasis_partnership_278400Elan Corporation has announced it is to partner with Proteostasis Therapeutics on a platform to discover and develop small molecule drugs and diagnostics for the treatment of neurodegenerative disorders25 May 2011http://www.pmlive.com/pharma_news/glenmark_settles_with_astellas_triax_278401Glenmark has settled a US patent infringement suit with Triax Pharmaceuticals and Astellas over a generic version of a cream for inflammation of the skin25 May 2011http://www.pmlive.com/pharma_news/survey_reveals_need_for_ms_work_support_278431A survey commissioned by Merck Serono for World Multiple Sclerosis Day has revealed the need for support from employers and physicians to make continued employment a viable option for people with MS26 May 2011http://www.pmlive.com/pharma_news/shire_adhd_scholarship_programme_278626Shire has partnered with a non-profit foundation to offer scholarships and coaching to support US students with attention-deficit/hyperactivity disorder during the transition from high school to college26 May 2011http://www.pmlive.com/pharma_news/small_device_firms_file_in_eu_first_278627Two-thirds of small medical device and diagnostic companies are seeking marketing clearance for new products in Europe before the US, according to an industry survey about the FDA's 510(k) product review process26 May 2011http://www.pmlive.com/pharma_news/watson_expands_in_europe_with_specifar_deal_278664Watson Pharmaceuticals has acquired Greece-based Specifar Pharmaceuticals, the generic pharmaceutical developer, manufacturer and marketer for €400m ($562m)26 May 2011http://www.pmlive.com/pharma_news/nycomed_reports_increased_q1_earnings_278665Nycomed has posted a 38 per cent&nbsp;increase in pre-tax earnings to €294.4m in the first quarter of 2011, boosted by a one off-payment of €131.1m from its marketing partner Forest Laboratories following the US approval of Daliresp26 May 2011http://www.pmlive.com/pharma_news/valeant_acquires_ab_sanitas_278669Canada-based Valeant Pharmaceuticals International is to acquire Lithuanian speciality pharmaceutical company AB Sanitas in a two-stage deal worth €314m26 May 2011http://www.pmlive.com/pharma_news/eisai_ucl_partnership_grows_278671Eisai is to extend its partnership with University College London, a UK-based university with which the company has been collaborating with for more than 20 years27 May 2011http://www.pmlive.com/pharma_news/abbotts_niaspan_disappoints_in_trial_278855Abbott's blood lipid treatment Niaspan has failed to meet the primary objective in a study testing whether the drug reduced risk of cardiovascular events in certain patients already receiving Merck's Zocor27 May 2011http://www.pmlive.com/pharma_news/amylin_wins_order_against_lilly_278860Amylin has won a court order preventing Eli Lilly from using the same sales force to sell both the diabetes drugs Byetta, which Lilly comarkets with Amylin, and linagliptin, which Lilly comarkets with Boehringer Ingelheim31 May 2011http://www.pmlive.com/pharma_news/j_and_j_positive_about_pipeline_279488Johnson &amp; Johnson has released an encouraging update on its pipeline with marketing applications in the US and EU for 11 new drugs, including treatments for Alzheimer's and type 2 diabetes31 May 2011http://www.pmlive.com/pharma_news/optimer_antibiotic_approved_279492Optimer Pharmaceuticals has won US Food and Drug Administration approval for its orally delivered antibacterial drug Dificid as a first-line treatment of Clostridium difficile-associated diarrhoea in adults31 May 2011http://www.pmlive.com/pharma_news/fda_clears_faecal_incontinence_gel_279511The US Food and Drug Administration has approved Oceana Therapeutics' Solesta, an injectable treatment for faecal incontinence in adult patients who have failed other treatments31 May 2011http://www.pmlive.com/pharma_news/astrazeneca_teams_with_heptares_279524AstraZeneca has teamed up with UK-based drug discovery company Heptares in a four-year collaboration to develop new therapies that target proteins linked to nervous system and cardiovascular disorders31 May 2011http://www.pmlive.com/pharma_news/sanofi_signs_neglected_diseases_deal_279547Sanofi and Drugs for Neglected Diseases <EM>initiative</EM> have agreed a three-year collaboration deal to research new treatments for nine neglected tropical diseases31 May 2011http://www.pmlive.com/pharma_news/abpi_names_latest_code_breaches_279558Bayer Healthcare, Chiesi and Eli Lilly and Company have been called out for breaches of the Association of the British Pharmaceutical Industry's Code of Practice, while Bayer Schering Pharma has been publicly reprimanded01 Jun 2011http://www.pmlive.com/pharma_news/eli_lilly_appoints_liam_english_for_ace_region_279587Liam English is to join Eli Lilly &amp; Company as an associate director for the Australian, Canadian and European (ACE) region01 Jun 2011http://www.pmlive.com/pharma_news/tevapfizer_settle_neurontin_suit_279700Teva Pharmaceutical has announced it has settled a patent dispute with Pfizer concerning generic versions of Pfizer's Neurontin (gabapentin) – a drug marketed for pain management and the treatment of epilepsy01 Jun 2011http://www.pmlive.com/pharma_news/azs_brilinta_approved_in_canada_279701Health Canada has approved AstraZeneca's Brilinta to prevent blood clots in patients with acute coronary syndrome01 Jun 2011http://www.pmlive.com/pharma_news/fda_warns_about_birth_control_pills_279703The US Food and Drug Administration has issued a safety review following links between birth control pills containing drospirenone and an increase in blood clots01 Jun 2011http://www.pmlive.com/pharma_news/ema_drug_communication_reviewed_279709The European Medicines Agency's (EMA) communication strategy concerning the benefits and risks of medicines has been put under the spotlight by an independent report01 Jun 2011http://www.pmlive.com/pharma_news/gsk_and_mars_launch_innovation_fund_279713GlaxoSmithKline and MaRS Innovation have set up a development fund that will support the commercialisation of translational research from 16 academic health science centres, hospitals and universities in Canada01 Jun 2011http://www.pmlive.com/pharma_news/aveo_pens_cancer_development_deal_279732AVEO Pharmaceuticals has agreed a deal with Centocor Ortho Biotech for the development of AVEO's internally-discovered antibodies targeting the RON receptor, which is responsible in several aspects of cancer01 Jun 2011http://www.pmlive.com/pharma_news/bric_doctors_increase_social_networking_279742Physicians in the&nbsp;emerging&nbsp;BRIC countries are incorporating social networks and online communities into their professional resources, according to a study from Manhattan Research02 Jun 2011http://www.pmlive.com/pharma_news/pharmacoepidemiology_standards_published_279946The European Medicines Agency and the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance have published guidance on methodological standards in studying the effects of drugs in large groups of people02 Jun 2011http://www.pmlive.com/pharma_news/emahma_set_drug_application_guidance_279949The European Medicines Agency and Heads of Medicines Agencies have released draft guidance detailing what information included in marketing authorisation applications for drugs can be released02 Jun 2011http://www.pmlive.com/pharma_news/pharma_urged_to_tackle_non-compliance_279954The pharma industry must act to combat patient non-compliance, which averages at 50 per cent for long-term conditions, such as HIV and arthritis, according to a Capgemini report02 Jun 2011http://www.pmlive.com/pharma_news/fda_approves_tevas_alzheimers_drug_279955The US Food and Drug Administration has approved Teva Pharmaceutical's application to sell a generic version of&nbsp;Pfizer's Alzheimer's drug Aricept06 Jun 2011http://www.pmlive.com/pharma_news/pfizerhisun_to_collaborate_in_china_280178Pfizer has announced it is to work with Zhejiang Hisun Pharmaceuticals to develop and market generic drugs in China06 Jun 2011http://www.pmlive.com/pharma_news/bmsroche_deal_for_skin_cancer_drug_280179Bristol-Myers Squibb and Roche have entered into an agreement to research the combination of ipilimumab and vemurafenib for metastatic melanoma06 Jun 2011http://www.pmlive.com/pharma_news/new_european_approval_for_lucentis_280180Novartis has announced that its vision loss treatment Lucentis has been approved for a new indication by the European Commission as GIST treatment Glivec shows success in trials06 Jun 2011http://www.pmlive.com/pharma_news/gsk_offers_unicef_rotavirus_vaccine_280214GSK has offered its rotavirus vaccine Rotarix to the GAVI Alliance at a reduced price following a UNICEF request06 Jun 2011http://www.pmlive.com/pharma_news/uks_abpi_rejects_gmc_off-label_suggestions_280245The ABPI has responded to the GMC's consultation on prescribing off-label drugs06 Jun 2011http://www.pmlive.com/pharma_news/sanofi_reveals_successful_lyxumia_studies_280251Sanofi reports successful phase III trial results for diabetes treatment Lyxumia07 Jun 2011http://www.pmlive.com/pharma_news/astrazeneca_pays_out_in_discrimination_case_280588AstraZeneca has been found to have paid female sales representatives on average $1,700 less than their male counterparts07 Jun 2011http://www.pmlive.com/pharma_news/cancer_data_presented_at_asco_280592Pharma companies, including Sanofi, Takeda and Eisa, have continued to present data from drug trials at the annual meeting for the American Society of Clinical Oncology07 Jun 2011http://www.pmlive.com/pharma_news/cancer_groups_call_for_epidemic_response_280593Major cancer organisations, including the American Society of Clinical Oncology,&nbsp;have announced renewed efforts to tackle the 'cancer epidemic' in developing countries, and called for world leaders to take action07 Jun 2011http://www.pmlive.com/pharma_news/study_into_birth_risks_of_epilepsy_drugs_280595New research reveals that four of the most prescribed epilepsy drugs increase the risk of serious birth defects07 Jun 2011http://www.pmlive.com/pharma_news/sanofi_partners_with_qic_diabetes_280611Sanofi has confirmed as an industry partner for QiC Diabetes – the first of PMGroup's new Quality in Care programmes recognising good healthcare practice and collaboration in the UK08 Jun 2011http://www.pmlive.com/pharma_news/merck_seronoaffectis_agree_p2x7_deal_280840Affectis Pharmaceutical and Merck Serono have signed a deal for the development and commercialisation of oral compounds targeting P2X7 receptors08 Jun 2011http://www.pmlive.com/pharma_news/roche_sponsors_smear_test_blog_280846Roche is supporting a UK-based blog aimed at helping overcome women's fears of cervical smear tests08 Jun 2011http://www.pmlive.com/pharma_news/eli_lilly_board_under_investigation_280847Eli Lilly's board is under investigation in the US for alleged breaches of fiduciary duties in connection with allegations violations of the Foreign Corrupt Practices Act08 Jun 2011http://www.pmlive.com/pharma_news/ema_geriatric_expert_group_280850The European Medicines Agency has established an expert group to provide advice on issues related to the elderly as part of the agency's Committee for Medicinal Products for Human Use08 Jun 2011http://www.pmlive.com/pharma_news/pfizer_to_conduct_virtual_trial_280851Pfizer has launched pharma's first 'virtual' clinical trial, allowing patients to participate in a study to assess overactive bladder treatment, Detrol, using only mobile and online technology09 Jun 2011http://www.pmlive.com/pharma_news/ema_board_selects_new_leader_281101The European Medicines Agency's management board has nominated Guido Rasi as executive director09 Jun 2011http://www.pmlive.com/pharma_news/ipsen_reveals_new_strategy_281105Ipsen has published a comprehensive review of its future corporate strategy09 Jun 2011http://www.pmlive.com/pharma_news/amgen_launches_oncology_website_281107Amgen introduces oncology website for the international community09 Jun 2011http://www.pmlive.com/pharma_news/label_update_for_simvastatin_281108The US Food and Drug Administration has announced changes to the prescribing information for cholesterol medication, simvastatin, after the drug was linked to an elevated risk of muscle injury or myopathy09 Jun 2011http://www.pmlive.com/pharma_news/lilly_hires_new_ace_president_281109Eli Lilly & Company veteran, Andrew Hotchkiss, is to become the company's president for the Australia, Canada and Europe (ACE) region13 Jun 2011http://www.pmlive.com/pharma_news/gilead_evp,_kevin_young,_receives_cbe_281648Kevin Young, executive vice president, Gilead Sciences has been awarded a CBE 13 Jun 2011http://www.pmlive.com/pharma_news/fda_approves_gskvaleant_anti-seizure_drug_281697The US Food and Drug Administration (FDA) has approved Potiga (ezogabine) tablets as adjunctive treatment of partial-onset seizures in adults 13 Jun 2011http://www.pmlive.com/pharma_news/european_commission_outlines_r_and_d_future_281712The European Commission has outlined the region's direction on the framework for research and innovation 13 Jun 2011http://www.pmlive.com/pharma_news/france_withdraws_takeda_diabetes_drug_281724France and Germany have suspended the use of Takeda’s diabetes drug Actos after concerns that they could increase the risk of bladder cancer 13 Jun 2011http://www.pmlive.com/pharma_news/roche_teams_up_with_californian_university_281750Roche has signed a deal with the University of California Los Angeles to work together on biomarker discovery projects 13 Jun 2011http://www.pmlive.com/pharma_news/vertex_acts_on_successful_cf_trials_281755Vertex Pharmaceuticals is to submit regulatory applications for it VX-770 cystic fibrosis drug following successful trials 13 Jun 2011http://www.pmlive.com/pharma_news/ucb_admits_keppra_misbranding_offence_281756UCB is to pay $34m after admitting to off-label marketing of its epilepsy drug Keppra as a treatment for migraine 14 Jun 2011http://www.pmlive.com/pharma_news/gsk_buys_shenzhen_neptunus_stake_281880GSK is set to become the sole owner of joint venture company Shenzhen GSK-Neptunus Biologicals 14 Jun 2011http://www.pmlive.com/pharma_news/gilead_sciences_in_us_investigation_281885Gilead Sciences is having its manufacturing and distribution practices investigated by the US Attorney's Office 14 Jun 2011http://www.pmlive.com/pharma_news/servier_agrees_deal_with_cortex_281886Cortex is to sell its remaining rights to the AMPAKINE compound CX1632 15 Jun 2011http://www.pmlive.com/pharma_news/imi_teams_with_c-path_282210Europe’s Innovative Medicines Initiative is to work with US-based C-Path to encourage information sharing&nbsp; 15 Jun 2011http://www.pmlive.com/pharma_news/lundbeck_finishes_alcohol_dependency_trials_282211Lundbeck completes phase III trials for alcohol dependency drug nalmefene15 Jun 2011http://www.pmlive.com/pharma_news/nycomed_markets_bonviva_drug_in_asia_282212Nycomed has become marketing authorisation holder of osteoporosis treatment Bonviva in key Asia-Pacific countries 15 Jun 2011http://www.pmlive.com/pharma_news/tevacephalon_deal_faces_delay_282213Teva and Cephalon have been asked to provide additional information regarding the proposed takeover 15 Jun 2011http://www.pmlive.com/pharma_news/abbott_wins_fda_approval_for_infant_cf_dose_282214Abbott has secured approval for an infant-specific dose of CREON (pancrelipase) to treat exocrine pancreatic insufficiency caused by cystic fibrosis (CF) 16 Jun 2011http://www.pmlive.com/pharma_news/boehringer_and_zealand_focus_on_diabetes_282384Zealand Pharma and Boehringer Ingelheim have agreed an exclusive global licence and collaboration agreement for a treatment for patients with type 2 diabetes and obesity 16 Jun 2011http://www.pmlive.com/pharma_news/cevec_and_catalent_partner_on_cell_lines_282404CEVEC Pharmaceuticals and Catalent Pharma Solutions have launched a joint commercial cell line development service for pharma and biotech customers worldwide 16 Jun 2011http://www.pmlive.com/pharma_news/ec_gives_viropharma_cinryze_go-ahead_282407The European Commission has granted ViroPharma Centralised Marketing Authorisation for Cinryze (C1 inhibitor [human]) in adults and adolescents with hereditary angioedema 16 Jun 2011http://www.pmlive.com/pharma_news/reneuron_and_schepens_stem_cell_patent_282410ReNeuron Group has signed a patent and know-how license agreement with Schepens Eye Research Institute16 Jun 2011http://www.pmlive.com/pharma_news/sanofi_and_audion_in_hearing_partnership_282411 Sanofi has entered into a two-year research collaboration with the Audion Therapeutics to develop potential treatments for hearing loss16 Jun 2011http://www.pmlive.com/pharma_news/fda_approves_bms_kidney_rejection_drug_282517The US FDA has approved Bristol-Myers Squibb’s Nulojix to prevent acute rejection in adult patients who have had a kidney transplant 20 Jun 2011http://www.pmlive.com/pharma_news/ipa_2011_best_of_health_awards_shortlist_283108Agencies shortlisted for the 2011 Institute of Practitioners in Advertising (IPA) Best of Health Awards have been announced 20 Jun 2011http://www.pmlive.com/pharma_news/first_application_for_fdaema_review_pilot_283200Pfizer has submitted the first application for the European Medicines Agency's and the US Food and Drug Administration's 'quality by design' pilot for increased co-operation in drug evaluations20 Jun 2011http://www.pmlive.com/pharma_news/j_and_j_risperdal_recall_283269Johnson and Johnson's Ortho-McNeil-Janssen subsidiary has voluntarily recalled one unit each of schizophrenia drugs Risperdal and risperidone 2mg tablets following consumer reports of an 'uncharacteristic odour'http://www.thedirectorylive.com/smart_thinking/smart_thinking_archive/thought_leaders/the_role_of_digital_283289Effective use of digital communication will help agencies best represent their clients in times of reform30 Jun 2011http://www.thedirectorylive.com/smart_thinking/smart_thinking_archive/thought_leaders/growing_patient_influence_283295Changing communication style to portray drugs and devices realistically04 Jul 2011http://www.thedirectorylive.com/smart_thinking/smart_thinking_archive/thought_leaders/whatever_happened_to_long_agency_lunches_283296Digital communication may be simpler, but is it the best way to do business?01 Jul 2011http://www.thedirectorylive.com/smart_thinking/smart_thinking_archive/thought_leaders/the_beguiling_world_of_digital_283301Digital media changes the way we communicate, and needs consistent strategy to ensure its relevance 06 Jul 201121 Jun 2011http://www.pmlive.com/pharma_news/fda_encourages_import_collaboration_283793The US Food and Drug Administration has announced a 'global strategy' to work with other regulatory agencies to increase the safety and quality of imported products21 Jun 2011http://www.pmlive.com/pharma_news/fda_approves_pfizers_pain_drug_283795Pfizer has announced that the US Food and Drug Administration has approved its drug Oxecta for use in the management of acute and chronic moderate to severe pain21 Jun 2011http://www.pmlive.com/pharma_news/china_recalls_gsk_antibiotic_283804Chinese authorities have recalled GlaxoSmithKline's antibiotic Augmentin after traces of a compound used to make plastics more flexible were found in the treatment's syrup form22 Jun 2011http://www.pmlive.com/pharma_news/merck_serono_pulls_ms_drug_284247Merck Serono has said it is to no longer pursue global approval for the use of cladribine in the treatment of multiple sclerosis22 Jun 2011http://www.pmlive.com/pharma_news/az_to_sell_astra_tech_for_$1.8bn_284249AstraZeneca is to sell Sweden-based dental and devices business Astra Tech to Dentsply for $1.8bn23 Jun 2011http://www.pmlive.com/pharma_news/pharmafutures_reports_on_unmet_need_285507The global pharma industry must work with healthcare providers to ensure that vital medical research translates into affordable drugs for priority health needs, according to a report by the PharmaFutures project 23 Jun 2011http://www.pmlive.com/pharma_news/watson_expands_in_utah_285567Watson Pharmaceuticals is set to expand Watson Laboratories' R&amp;D and manufacturing facility in Salt Lake City, Utah in a $44m investment 23 Jun 2011http://www.pmlive.com/pharma_news/boehringer_and_ashoka_focus_on_communities_285583Boehringer Ingelheim and Ashoka will launch a three-year global initiative to improve health in communities around the world 23 Jun 2011http://www.pmlive.com/pharma_news/bms_and_pfizers_eliquis_in_trial_success_285634Bristol-Myers Squibb and Pfizer have revealed successful topline results of the phase III ARISTOTLE trial of Eliquis (apixaban) for atrial fibrillation&nbsp; 23 Jun 2011http://www.pmlive.com/pharma_news/vertex_and_tibotec_reveal_telaprevir_results_285655Vertex Pharmaceuticals and Tibotec have revealed positive phase III results for telaprevir to treat chronic genotype 1 hepatitis C27 Jun 2011http://www.pmlive.com/pharma_news/roche_and_evotec_form_biomarker_alliance_293333Roche and Evotec are to collaborate on protein-activity based biomarkers for Roche's oncology drugs under development27 Jun 2011http://www.pmlive.com/pharma_news/big_pharma_limits_deliveries_to_greece_293334A number of big pharma, including Roche and Sanofi, have started limiting drug deliveries to some hospitals in Greece because of unpaid bills, according to the UK newspaper the Times27 Jun 2011http://www.pmlive.com/pharma_news/pfizer_considers_icagen_options_293336Pfizer is considering a "strategic transaction" with Icagen, a US biotechnology company, in which it holds a 14 per cent stake in27 Jun 2011http://www.pmlive.com/pharma_news/pharma_r_and_d_spend_down_on_2009_293412According to new research, annual pharma spending in research and development fell for the first time ever from 2009 to 201027 Jun 2011http://www.pmlive.com/pharma_news/ada_presents_diabetes_studies_293414Studies involving diabetes products from several pharma companies, including Sanofi, Novo Nordisk and Bristol-Myers Squibb, have been presented at the American Diabetes Association's Scientific Sessions28 Jun 2011http://www.pmlive.com/pharma_news/ema_considers_two_epilepsy_treatments_293729The European Medicines Agency has accepted for review the marketing authorisation application for Eisai's perampanel while the agency's CHMP has recommended the approval of ViroPharma's Buccolam28 Jun 2011http://www.pmlive.com/pharma_news/extra_funding_for_uk_dementia_research_293732The UK's Department of Health has launched the 'Route Map for Dementia Research' pledging to increase funding for neurodegeneration research by ten per cent to £150m over the next four years28 Jun 2011http://www.pmlive.com/pharma_news/j_and_j_to_bring_subsidiaries_under_one_name_293733Johnson &amp; Johnson is to bring its autonomous pharmaceutical subsidiaries under the name Janssen Pharmaceuticals by the end of 2011, with further plans to link its consumer and prescription marketing28 Jun 2011http://www.pmlive.com/pharma_news/janssenjubilant_alliance_293794Janssen Pharmaceutica and Jubilant Discovery Services have agreed a drug discovery partnership covering the field of neuroscience28 Jun 2011http://www.pmlive.com/pharma_news/sanofi_appoints_new_svp_for_europe_293836Sanofi has announced the appointment of Peter Guenter as senior vice president, Europe, effective July 15, 201129 Jun 2011http://www.pmlive.com/pharma_news/lilly_invests_in_biotechnology_294201Eli Lilly &amp; Company has announced a multi-million dollar investment to expand its existing biotechnology capabilities in the US29 Jun 2011http://www.pmlive.com/pharma_news/medivir_and_meda_in_xerese_renegotiation_294202Medivir has renegotiated the terms of its financial arrangement with Meda for Xerese, its marketed product for herpes labialis, in North America29 Jun 2011http://www.pmlive.com/pharma_news/further_tylenol_recall_for_j_and_j_294235Johnson & Johnson's McNeil Consumer Healthcare division has announced the voluntary recall of one product lot of Tylenol extra strength caplets in the US following reports of a 'mouldy odour'30 Jun 2011http://www.pmlive.com/pharma_news/astellas_sells_diabetes_patents_294695Prosidion, a subsidiary of Astellas Pharma, has sold its patent estate relating to the use of dipeptidyl peptidase IV (DPP-IV) inhibitors for the treatment of type 2 diabetes to Royalty Pharma for $609m30 Jun 2011http://www.pmlive.com/pharma_news/ablynx_reaches_third_alzheimers_milestone_294696Boehringer Ingelheim has made a €5m milestone payment to Ablynx following the continued development of its nanobody candidate30 Jun 2011http://www.pmlive.com/pharma_news/fda_advises_withdrawal_of_avastin_approval_294703Advisers to the US Food and Drug Administration have recommended to withdraw approval of the metastatic breast cancer indication for Roche's Avastin as EU extends the drug's label30 Jun 2011http://www.pmlive.com/pharma_news/sanofi_in_tb_partnership_with_cornell_294705Sanofi is to enter a research collaboration with Weill Cornell Medical College to identify new anti-infective treatments for the treatment of tuberculosis01 Jul 2011http://www.pmlive.com/pharma_news/2011_ipa_best_of_health_awards_winners_295088The IPA Best of Health Awards showcasing and rewarding the best in creativity in healthcare advertising from all mediums took place yesterday, June 30 04 Jul 2011http://www.pmlive.com/pharma_news/gsk_wins_sports_contract_296295GSK has signed a contract with the World Anti-Doping Agency to help detect drugs that have performance-enhancing potential in sport04 Jul 2011http://www.pmlive.com/pharma_news/shire_acts_against_sandoz_and_amneal_296311Shire is taking legal action against Amneal and Sandoz for patent infringements04 Jul 2011http://www.pmlive.com/pharma_news/nycomed_wins_ec_approval_for_instanyl_296323The EC has granted Nycomed marketing authorisation for its Instanyl single-dose nasal spray04 Jul 2011http://www.pmlive.com/pharma_news/ema_publishes_drug_information_format_296364The European Medicines Agency has published the format in which pharmaceutical companies are to submit information on all medicines registered in the European Union05 Jul 2011http://www.pmlive.com/pharma_news/range_of_approvals_in_japan_296747Several major drug companies, including Merck, GSK and Novartis have had marketing approvals in Japan for products in a variety of therapy areas including COPD, bipolar disorder and cancer05 Jul 2011http://www.pmlive.com/pharma_news/novartis_to_submit_afinitor_for_approval_296758Novartis is to submit its advanced breast cancer drug Afinitor for marketing approval following positive results from a phase III study05 Jul 2011http://www.pmlive.com/pharma_news/new_eu_rules_on_falsified_medicines_296759The European Union has published a new directive to prevent falsified or counterfeit medicines entering the legal supply chain05 Jul 2011http://www.pmlive.com/pharma_news/merck_serono_reveals_fertility_successes_296794Merck Serono has named the recipients of its second Grant for Fertility Innovation05 Jul 2011http://www.pmlive.com/pharma_news/first_predictive_biomarker_for_lung_cancer_296799High EGFR expression is a predictor for improved survival with cetuximab and chemotherapy, according to new research06 Jul 2011http://www.pmlive.com/pharma_news/amgenucb_space_shuttle_test_297052Amgen and UCB are partnering with NASA to conduct a preclinical test researching the effects of a sclerostin antibody on bone loss during the final mission of space shuttle Atlantis06 Jul 2011http://www.pmlive.com/pharma_news/sanofirib-x_antibiotic_collaboration_297053Sanofi has announced it is to partner with Rib-X Pharmaceuticals to research new classes of antibiotic therapies06 Jul 2011http://www.pmlive.com/pharma_news/antisense_secures_funding_297054Germany-based Antisense Pharma has secured new funding as it begins an international trial of its pancreatic cancer treatment06 Jul 2011http://www.pmlive.com/pharma_news/moscow-based_companies_searched_297076The Moscow offices of Akrikhin, Novartis, Teva Pharmaceuticals and Valenta have been searched by Russian police as part of an investigation into distributors06 Jul 2011http://www.pmlive.com/pharma_news/takeda_uk_launches_new_prostap_format_297077Takeda has launched a simpler, more efficient presentation of its prostate cancer and endometriosis treatment07 Jul 2011http://www.pmlive.com/pharma_news/pfizer_phase_iii_lyrica_success_297206Pfizer has recorded positive results in a phase III trial of fibromyalgia treatment Lyrica07 Jul 2011http://www.pmlive.com/pharma_news/gsk_changes_sales_rep_pay_in_us_297209GlaxoSmithKline has implemented the next phase of its new incentive compensation programme for professional sales representatives07 Jul 2011http://www.pmlive.com/pharma_news/gsk_to_restructure_waterford_plant_297323GSK to meet with staff at Irish plant about restructure plans07 Jul 2011http://www.pmlive.com/pharma_news/eu_drops_boehringer_ingelheim_patent_probe_297324The EU has closed antitrust investigations regarding Boehringer Ingelheim's COPD drugs11 Jul 2011http://www.pmlive.com/pharma_news/valeant_buys_sanofis_dermatology_unit_297814Sanofi has said it is to sell its Dermik dermatology unit to Canada-based Valeant Pharmaceuticals for $425m11 Jul 2011http://www.pmlive.com/pharma_news/eu_patent_extension_for_pfizers_lipitor_297824The European patent for Pfizer's blockbuster cholesterol drug, Lipitor, could be extended by six months due to new paediatric data concerning the treatment11 Jul 2011http://www.pmlive.com/pharma_news/diabetes_support_kit_during_ramadan_297841MSD has launched a patient support kit to provide advice and guidance to people with type 2 diabetes who are fasting during Ramadan 11 Jul 2011http://www.pmlive.com/pharma_news/lilly_chief_biopharma_hampered_by_policies_297843Dr John C Lechleiter, CEO, Eli Lilly has called for greater involvement from the biopharma industry in transatlantic trade and economic discussions, with short-term government cost pressures&nbsp;'hampering' the sector12 Jul 2011http://www.pmlive.com/pharma_news/ema_reviews_multaqs_cvd_risk_298164The European Medicines Agency is to review the cardiovascular risk of Sanofi's anti-arrhythmic medicine Multaq following serious adverse events in the company's discontinued PALLAS study12 Jul 2011http://www.pmlive.com/pharma_news/gilead_agrees_hiv_patent_pool_deal_298165Gilead Sciences has become the first pharmaceutical company to agree to improve access to HIV and hepatitis B treatments in developing countries by signing a deal with the Medicines Patent Pool12 Jul 2011http://www.pmlive.com/pharma_news/lonza_to_buy_arch_chemicals_for_$1.4bn_298183Life science industry suppliers, Lonza, are to acquire outstanding shares of biocides company Arch Chemicals for $47.20 per share – around $1.4bn in total12 Jul 2011http://www.pmlive.com/pharma_news/positive_phase_iii_ms_results_from_sanofi_298544Sanofi and its subsidiary Genzyme have announced positive results from a phase III trial of investigational MS therapy alemtuzumab 12 Jul 2011http://www.pmlive.com/pharma_news/lilly_launches_weekly_diabetes_therapy_299801Lilly UK has launched Bydureon, the first once-weekly glucagon-like peptide (GLP-1) receptor agonist, for the treatment of type 2 diabetes13 Jul 2011http://www.pmlive.com/pharma_news/report_highlights_areas_for_hta_improvement_300248A new report on Health Technology Assessment processes has shown improvements are needed to accelerate patients' access to new technologies and innovative medicines 13 Jul 2011http://www.pmlive.com/pharma_news/eisai_in_chinese_marketing_deal_with_orion_300301Eisai has entered into a comprehensive marketing agreement with Orion relating to Orion's breast cancer drug Fareston and its Parkinson’s disease treatment Eldepry 13 Jul 2011http://www.pmlive.com/pharma_news/fda_rejects_transcepts_insomnia_drug_300305The US Food and Drug Administration has told Transcept Pharmaceuticals its insomnia drug, Intermezzo, is not ready for marketing approval13 Jul 2011http://www.pmlive.com/pharma_news/positive_results_in_sanofi_ra_trial_300359Sarilumab, developed by Sanofi and Regeneron, has shown positive results for the treatment of rheumatoid arthritis in a phase IIb trial, although the drug failed to show great benefit in ankylosing spondylitis patients14 Jul 2011http://www.pmlive.com/pharma_news/astellas_files_patent_suit_against_sandoz_300560Astellas Pharma has filed a lawsuit against generics manufacturer Sandoz relating to a version of Astellas' organ transplantation drug, Prograf, which Sandoz plans to market in Canada14 Jul 2011http://www.pmlive.com/pharma_news/inventiv_health_aquires_pharmanet_300750Contract research organisation inVentiv Health has completed the acquisition of PharmaNet Development Group, a global drug development service provider to the pharma sector 14 Jul 2011http://www.pmlive.com/pharma_news/teva_acquires_taiyo_for_almost_$1bn_300771Teva Pharmaceutical has completed the full acquisition of Japanese generics manufacturer Taiyo in a cash deal worth $934mhttp://www.thedirectorylive.com/smart_thinking/smart_thinking_archive/thought_leaders/navigating_uncharted_waters_301040The changing face of the industry means agencies must be prepared to change tack at any moment 28 Jul 2011http://www.thedirectorylive.com/smart_thinking/smart_thinking_archive/thought_leaders/growing_digital_influence_301077Agencies must embrace digital technology, but remember the importance of traditional research methods 25 Jul 2011http://www.thedirectorylive.com/smart_thinking/smart_thinking_archive/thought_leaders/new_commercial_landscape_301080Marketing will be the main focus of any changes made to companies' commercial approaches 22 Jul 2011http://www.thedirectorylive.com/smart_thinking/smart_thinking_archive/thought_leaders/try_co-creation_for_increased_insights_at_less_cost_301105Moving away from traditional techniques can lead to greater customer understanding and buy-in 29 Jul 201118 Jul 2011http://www.pmlive.com/pharma_news/trial_success_for_forests_depression_drug_301569Forest Laboratories has said preliminary results from a phase III trial of major depressive disorder treatment, levomilnacipran, indicate the drug achieved a statistically significant improvement in patients compared to placebo18 Jul 2011http://www.pmlive.com/pharma_news/label_change_for_lillys_livalo_301570The US Food and Drug Administration has said Eli Lilly &amp; Company can update the label of cholesterol drug Livalo to remove a warning against the use of the drug together with HIV treatment lopinavir/ritonavir19 Jul 2011http://www.pmlive.com/pharma_news/novartis_profits_up_by_almost_a_third_301824Second quarter profit for Novartis increased by 29 per cent from 2010, with major launches and approvals overcoming sales lost to generic competition19 Jul 2011http://www.pmlive.com/pharma_news/j_and_j_sales_up_8.3_per_cent_301825Johnson &amp; Johnson has reported total sales of $16.60bn for the second quarter of 2011, with strong international pharma growth countering a decline in US consumer products due in part to several recalls19 Jul 2011http://www.pmlive.com/pharma_news/roche_buys_mtm_laboratories_301826Roche has completed the full acquisition of Germany-based mtm laboratories, a company specialising in products for cervical cancer diagnosis20 Jul 2011http://www.pmlive.com/pharma_news/msdroche_expand_hepatitis_c_partnership_301976MSD and Roche have signed a deal for the global promotion and marketing of Victrelis as part of a combination therapy for the hepatitis C virus20 Jul 2011http://www.pmlive.com/pharma_news/fda_advises_against_bmsaz_diabetes_drug_301977An advisory committee to the US Food and Drug Administration has recommended against the marketing approval for dapagliflozin, a diabetes drug developed by AstraZeneca and Bristol-Myers Squibb21 Jul 2011http://www.pmlive.com/pharma_news/pfizer_to_buy_icagen_for_$56m_302326Pfizer has entered a definitive agreement to purchase pain research specialists Icagen for $56m21 Jul 2011http://www.pmlive.com/pharma_news/profits_down_for_eli_lilly_302327In its second quarter financial results, Eli Lilly &amp; Company has recorded a net income decrease of 11 per cent, although revenue was up nine per cent to $6.25bn21 Jul 2011http://www.pmlive.com/pharma_news/us_approval_for_azs_brilinta_302333The US Food and Drug Administration has approved AstraZeneca's revised marketing application for blood-thinning drug Brilinta25 Jul 2011http://www.pmlive.com/pharma_news/bms_to_buy_amira_pharmaceuticals_314164Bristol-Myers Squibb is to purchase inflammatory and fibrotic disease specialists Amira Pharmaceuticals in an acquisition potentially worth $475m25 Jul 2011http://www.pmlive.com/pharma_news/senior_pharma_appointments_at_sanofi_314166Sanofi has appointed GSK senior vice president, Anne C Whitaker, as president, North America Pharmaceuticals, while CEO of Sanofi's US operations, Greg Irace, is to become senior vice president, Global Services25 Jul 2011http://www.pmlive.com/pharma_news/ucbs_vimpat_recalled_over_quality_defect_316234UCB's epilepsy treatment Vimpat is to be recalled because of a quality defect, which has led to an uneven distribution of its active ingredient25 Jul 2011http://www.pmlive.com/pharma_news/allergan_acquires_vicept_316418Allergan has entered into an agreement to buy privately-owned Vicept Therapeutics25 Jul 2011http://www.pmlive.com/pharma_news/indian_generic_drug_firm_expands_in_russia_318597India-based Dr Reddy's Laboratories is to acquire the pharmaceutical prescription portfolio of JB Chemicals &amp; Pharmaceuticals in Russia and other CIS nations26 Jul 2011http://www.pmlive.com/pharma_news/fda_approves_new_version_of_diabetes_drug_319483Japanese pharmaceutical company Daiichi Sankyo's diabetes treatment Welchol has been approved in a new formulation by the US Food and Drug Administration26 Jul 2011http://www.pmlive.com/pharma_news/fda_report_recognises_need_for_improvement_319484A US Food and Drug Administration report has highlighted seven areas where the agency's regulatory efforts are in need of development or improvement26 Jul 2011http://www.pmlive.com/pharma_news/gsk_back_in_profit_for_q2_319532GlaxoSmithKline has recorded a net profit of £1.97bn in the pharmaceutical company's financial results for the second quarter of 2011 following a loss of £304m for the period in 2010 due to legal fees26 Jul 2011http://www.pmlive.com/pharma_news/watson_sales_up_24_per_cent_in_q2_319533Watson Pharmaceuticals has reported net revenue of $1.1bn in its financial results for the second quarter of 2011, an increase of 24 per cent from 201027 Jul 2011http://www.pmlive.com/pharma_news/msd_strikes_vernakalant_deal_with_astellas_319772US-based pharmaceutical company MSD has acquired the rights for heart drug vernakalant from Astellas27 Jul 2011http://www.pmlive.com/pharma_news/teva_posts_positive_q2_results_319773Teva Pharmaceutical has reported increased sales and profit figures for the second quarter of the year27 Jul 2011http://www.pmlive.com/pharma_news/meda_denies_takeover_report_319778Swedish pharmaceutical company Meda has denied a media report that Valeant has made a takeover approach for it27 Jul 2011http://www.pmlive.com/pharma_news/merck_sees_85.9m_loss_for_q2_319792German pharmaceutical firm Merck KGaA has recorded a second quarter loss of €85.9m in its financial results for 2011 and has cut its profit forecast for the year27 Jul 2011http://www.pmlive.com/pharma_news/positive_results_for_herceptin_alternative_319794Research by the US National Cancer Institute has suggested investigational breast cancer treatment affitoxin is effective in targeting HER2-positive tumours that have stopped responding to Herceptin28 Jul 2011http://www.pmlive.com/pharma_news/sanofi_sees_profit_slide_in_q2_320240Sanofi has recorded a 13 per cent decline in net income for the second quarter of 2011 despite a boost from recently acquired Genzyme28 Jul 2011http://www.pmlive.com/pharma_news/astrazeneca_reports_profit_fall_320241AstraZeneca has reported a fall in pre-tax profit in its second quarter financial results despite sales increasing28 Jul 2011http://www.pmlive.com/pharma_news/almirall_earnings_hit_by_generics_320242Spanish pharmaceutical firm Almirall has said price erosion and generic competition is responsible for a fall in earnings in its first half financial report28 Jul 2011http://www.pmlive.com/pharma_news/bms_sales_up_14_per_cent_320263Successful launches helped second-quarter sales for Bristol-Myers Squibb sales increase 14 per cent according to the pharmaceutical firm’s financial results28 Jul 2011http://www.pmlive.com/pharma_news/major_increase_for_bayers_q2_profit_320269Bayer has recorded a net income increase of 40.9 per cent in its second quarter financial results, although Bayer Healthcare sales fell 2.3 per cent29 Jul 2011http://www.pmlive.com/pharma_news/ucb_reports_h1_profit_rise_320466UCB's profit has been boosted by increased sales of core drugs29 Jul 2011http://www.pmlive.com/pharma_news/earnings_increase_for_takeda_320632Japan-based Takeda Pharmaceutical has recorded an increase in net income of 17.9 per cent in its financial report for the second quarter of 2011 01 Aug 2011http://www.pmlive.com/pharma_news/lillys_strattera_patent_upheld_in_us_321432The US court of appeals has upheld the validity of Eli Lilly &amp; Company's patent for ADHD drug Strattera01 Aug 2011http://www.pmlive.com/pharma_news/lillylupin_indian_diabetes_partnership_321433Eli Lilly &amp; Company has entered into a deal with India-based pharmaceutical firm Lupin to market Lilly's Huminsulin range of products for people with diabetes in India and Nepal01 Aug 2011http://www.pmlive.com/pharma_news/msd_to_cut_12,000_jobs_worldwide_321512MSD has said it expects to reduce its global workforce by 12 to 13 per cent before the end of 2015 in the pharmaceutical company’s financial results for the second quarter of 201101 Aug 2011http://www.pmlive.com/pharma_news/amgen_posts_decrease_in_earnings_321515Amgen's second quarter financial results hit by US healthcare reform fees01 Aug 2011http://www.pmlive.com/pharma_news/astellas_pharma_sees_drop_in_q2_income_321516Astellas reports a fall in income for the second quarter of 2011, as R&amp;D and administrative expenses rise02 Aug 2011http://www.pmlive.com/pharma_news/eu_approval_for_tevas_contraceptive_zoely_321747Teva's new combined oral contraceptive Zoely has gained approval from the European Medicines Agency (EMA) for launch in the EU02 Aug 2011http://www.pmlive.com/pharma_news/lipitor_losses_affect_pfizers_q2_sales_321812Pfizer has reported a minor decrease in revenue in its financial results for the second quarter of 2011 with the pharmaceutical firm feeling the first effects of generic competition for cholesterol-lowering drug Lipitor02 Aug 2011http://www.pmlive.com/pharma_news/tevas_ms_drug_disappoints_in_trial_321824Teva Pharmaceutical Industries has said its oral MS drug laquinimod has failed to reach its primary endpoint in a phase III trial but the company still plans regulatory submissions in the EU and US02 Aug 2011http://www.pmlive.com/pharma_news/msd_launches_hepatitis_c_drug_victrelis_in_uk_321837MSD today launched chronic hepatitis C treatment Victrelis in the UK03 Aug 2011http://www.pmlive.com/pharma_news/emafda_to_continue_collaboration_322085The US Food and Drug Administration and the European Medicines Agency are to continue to improve efforts to work together more closely following two successful pilots03 Aug 2011http://www.pmlive.com/pharma_news/study_suggests_ssri_risk_for_older_people_322152Cohort study suggests new generation antidepressants, SSRIs, may carry greater risks than alternatives for older people03 Aug 2011http://www.pmlive.com/pharma_news/earnings_down_for_cephalon_322178US-based biopharmaceutical firm Cephalon has recorded a 14 per cent decrease in net profit despite rising sales over the second quarter of 201103 Aug 2011http://www.pmlive.com/pharma_news/msdserum_vaccine_partnership_322197MSD is to form a partnership with India-based Serum Institute to develop and market a pneumococcal conjugate vaccine (PCV) for use in developing countries04 Aug 2011http://www.pmlive.com/pharma_news/gsk_increases_stake_in_theravance_322305GlaxoSmithKline has spent $2m on shares in biopharmaceutical company Theravence, increasing its stake to 19.01 per cent04 Aug 2011http://www.pmlive.com/pharma_news/novos_q2_profit_up_17_per_cent_322346Novo Nordisk has reported a net profit of 4.13bn DKK in its financial results for the second quarter of 2011, with strong sales of diabetes drug Victoza driving the company's performance04 Aug 2011http://www.pmlive.com/pharma_news/biotica_and_pfizer_end_research_partnership_322353Biotica reacquires full worldwide rights to rapamycin analogue programme after being in partnership with Pfizer since 200604 Aug 2011http://www.pmlive.com/pharma_news/vectura_to_collaborate_on_copd_therapy_322367Respiratory disease specialist Vectura has said it is to collaborate with a 'leading pharmaceutical company' to develop and market new combination asthma/COPD therapy in the US05 Aug 2011http://www.pmlive.com/pharma_news/amylin_and_takeda_discontinue_obesity_drug_322667Amylin Pharmaceuticals and Takeda Pharmaceutical Company discontinue pramlintide/metreleptin combined obesity treatment following a commercial reassessment08 Aug 2011http://www.pmlive.com/pharma_news/asthma_candidate_reaches_primary_endpoint_323108The humanised monoclonal antibody lebrikizumab, Roche’s investigational personalised asthma treatment, has met the primary endpoint of its phase II trial 08 Aug 2011http://www.pmlive.com/pharma_news/nycomed_and_orion_in_easyhaler_deal_323138Nycomed has agreed a deal with Orion Corporation for the co-marketing of Easyhaler combination products for the treatment of asthma and chronic obstructive pulmonary disease (COPD)08 Aug 2011http://www.pmlive.com/pharma_news/hospiras_oncology_drug_approved_by_fda_323143Hospira gains approval from the FDA for new oncology drug, gemcitabine injection08 Aug 2011http://www.pmlive.com/pharma_news/eu_approval_for_boehringers_pradaxa_323146Boehringer-Ingelheim’s Pradaxa (dabigatran etexilate) has become the first drug in 50 years to gain EU approval for stroke prevention in atrial fibrillation (AF) 08 Aug 2011http://www.pmlive.com/pharma_news/gsk_ramps_up_operations_in_iraq_323147GSK has begun to grow its operations in Iraq through a partnership with Baghdad-based Modern Drug Industries 09 Aug 2011http://www.pmlive.com/pharma_news/qnexa_improves_quality_of_life_in_the_obese_323293Additional data from the phase III trial of Vivus’s obesity therapy candidate Qnexa has demonstrated significantly increased quality of life compared with placebo 09 Aug 2011http://www.pmlive.com/pharma_news/pfizer_collaborates_with_us_university_323294 Pfizer and the University of California are to work together to accelerate drug discovery and development 09 Aug 2011http://www.pmlive.com/pharma_news/positive_opinion_for_allergans_ndo_treatment_323304 A positive opinion is given from the Irish Medicines Board for BOTOX treatment for neurogenic detrusor overactivity (NDO) 09 Aug 2011http://www.pmlive.com/pharma_news/gsk_and_molmed_sign_immunodeficiency_deal_323306 GlaxoSmithKline and MolMed have signed a deal to develop an investigational gene therapy for ADA-SCID, the so-called ‘bubble boy disease’ 09 Aug 2011http://www.pmlive.com/pharma_news/markets_in_free_fall_323308 The FTSE has entered a bear market as volatility continues to spread across the global money markets 09 Aug 2011http://www.pmlive.com/pharma_news/msd_forms_pneumococcal_partnership_323309MSD and Serum Institute of India have formed a partnership to develop a pneumococcal conjugate vaccine 09 Aug 2011http://www.pmlive.com/pharma_news/valeant_continues_on_acquisition_trail_323310 Canadian pharmaceutical company Valeant has reportedly made a takeover bid for Medicis Pharmaceutical 09 Aug 2011http://www.pmlive.com/pharma_news/burton_paul_appointed_to_1hqs_health_division_323339<p>Burton Paul has been appointed as new client director to global branding agency 1HQ to head up its health division </p>10 Aug 2011http://www.pmlive.com/pharma_news/genentech_and_array_enter_oncology_deal_323488Genentech and Array BioPharma have entered into an agreement to develop both companies’ small-molecule Checkpoint kinase 1 (ChK-1) programme 10 Aug 2011http://www.pmlive.com/pharma_news/pharmacos_announce_financial_results_323489As volatility continues to sweep through global financial markets, pharma companies are announcing their results for the previous quarter 10 Aug 2011http://www.pmlive.com/pharma_news/online_cancer_centre_answers_educational_need_323490 An online cancer centre, which was launched in July, has already been used by 51 per cent of all UK oncologists, according to its creator, Doctors.net.uk11 Aug 2011http://www.pmlive.com/pharma_news/mobility_product_company_acquires_biotech_323628Modern Mobility Aids Inc, a company producing and marketing mobility aids, has acquired Canadian molecular diagnostics company LumiGene 11 Aug 2011http://www.pmlive.com/pharma_news/lexicon_announces_ibs_trial_results_323629Lexicon Pharmaceuticals’ TPH inhibitor LX1031 has been shown in a phase II trial to be well tolerated and provide clinical benefit to patients with irritable bowel syndrome 11 Aug 2011http://www.pmlive.com/pharma_news/fda_approves_once-daily_hiv_treatment_complera_323630The FDA approves Johnson&Johnson/Gilead’s once daily, single tablet regime HIV-1 treatment, Complera 11 Aug 2011http://www.pmlive.com/pharma_news/fda_rejects_adventrxs_lung_cancer_drug_exelbine_323631Adventrx receives rejection from the FDA for its new non-small cell lung cancer drug, Exelbine, over authenticity issues 15 Aug 2011http://www.pmlive.com/pharma_news/mylan_launches_generic_uroxatral_324099Mylan Inc has begun to distribute a generic version of Uroxatral, a treatment for benign prostatic hyperplasia made by sanofi-aventis, through its subsidiary Mylan Pharmaceuticals 15 Aug 2011http://www.pmlive.com/pharma_news/pharma_companies_announce_new_appointments_324103Robert Hoffman rejoins Arena Pharmaceuticals,&nbsp;Frank J Wright joins Marken, Mark Suto joins Southern Research&nbsp;and William M Harrison joins the board of Numira Biosciences 16 Aug 2011http://www.pmlive.com/pharma_news/effient_superior_to_plavix_in_trial_325129Effient associated with a 26 per cent relative risk reduction of cardiovascular death, myocardial infarction or stroke, compared with Plavix 16 Aug 2011http://www.pmlive.com/pharma_news/pfizer_generic_on_hold_until_2019_325130A US district court has ruled against Teva Pharmaceuticals marketing a generic version of Viagra until its Pfizer patent expires in October 2019 16 Aug 2011http://www.pmlive.com/pharma_news/healthy_living_pharmacy_pathfinder_sites_reach_20_325131Twenty areas in England, representing 30 Primary Care Trusts, have been selected to become Healthy Living Pharmacy pathfinders and are expected to inform the future direction for community pharmacy 16 Aug 2011http://www.pmlive.com/pharma_news/astellas_and_tengion_make_new_hires_325132Astellas creates a new position in its leadership team for Percival Barretto-Ko and Diane Jorkasky replaces Brenda Gavin on Tengion board 16 Aug 2011http://www.pmlive.com/pharma_news/mhp_expands_team_with_five_new_hires_325133MHP's health division has appointed five new members to its team in response to the NHS reforms and supported by the agency’s growth in 2010 and 2011 16 Aug 2011http://www.pmlive.com/pharma_news/market_turmoil_continues_325134Investors have turned to gold, one of the oldest stores of value, as global stock markets remain ravaged by massive falls 17 Aug 2011http://www.pmlive.com/pharma_news/phase_ii_jcv_infection_trial_approved_325829 Inhibikase Therapeutics has received clearance to undertake a phase II trial of IkT-001 against JCV infection, which can cause PML in immunodeficient patients 17 Aug 2011http://www.pmlive.com/pharma_news/abbott_drug_approved_for_precocious_puberty_325830 Abbott has received FDA approval for two new strengths of Lupron Depot-PED three-month administration for the treatment of central precocious puberty (CPP) 18 Aug 2011http://www.pmlive.com/pharma_news/compliance_monitor_patent_pending_326014Fuisz Pharma has a US patent pending on a system for monitoring drug compliance 18 Aug 2011http://www.pmlive.com/pharma_news/first-in-class_skin_cancer_drug_approved_326015 Daiichi Sankyo's Zelboraf, a first-in-class personalised oral treatment for patients with advanced melanoma, has received FDA approval 18 Aug 2011http://www.pmlive.com/pharma_news/ema_accepts_filings_for_crizotinib_and_bosutinib_326016European regulators have accepted Pfizer’s filings for two investigational cancer therapies 18 Aug 2011http://www.pmlive.com/pharma_news/nice_requests_more_data_on_pradaxa_326037The National Institute for Health and Clinical Excellence has requested further information on Boehringer Ingelheim’s Pradaxa (dabigatran) 18 Aug 2011http://www.pmlive.com/pharma_news/genentech_extends_deal_with_galapagos_326038Genentech has extended its drug discovery deal with Galapagos for a third time 22 Aug 2011http://www.pmlive.com/pharma_news/gsk_invests_in_biotech_autifony_326688GlaxoSmithKline is to invest £1.25m in Autifony Therapeutics, a biotech 'spin out' of the UK-based pharmaceutical company22 Aug 2011http://www.pmlive.com/pharma_news/valeant_completes_ab_sanitas_purchase_326689Canada-based Valeant Pharmaceuticals International has completed the acquisition of AB Sanitas in a deal worth €314m22 Aug 2011http://www.pmlive.com/pharma_news/nycomed_wins_moviprep_deal_in_russia_326690Nycomed and Norgine have signed a licence agreement for MoviPrep in Russia and the Commonwealth of Independent States22 Aug 2011http://www.pmlive.com/pharma_news/bms_launches_yervoy_in_the_uk_326694Bristol-Myers Squibb has secured a licence for Yervoy (ipilimumab), the UK's first new treatment for metastatic melanoma since the 1970s22 Aug 2011http://www.pmlive.com/pharma_news/lundbeck_launches_lexapro_in_japan_326730Danish pharmaceutical company Lundbeck is to launch its antidepressant Lexapro (escitalopram oxalate) in Japan23 Aug 2011http://www.pmlive.com/pharma_news/bayers_prostate_cancer_drug_fast-tracked_327042Bayer Healthcare has said its investigational prostate cancer treatment Alpharadin has been fast-tracked for approval by the US Food and Drug Administration (FDA)23 Aug 2011http://www.pmlive.com/pharma_news/sanofi_to_buy_universal_medicares_otc_unit_327043According to reports, Sanofi is in talks to buy the majority stake in Universal Medicare's over-the-counter (OTC) business23 Aug 2011http://www.pmlive.com/pharma_news/azs_faslodex_recommended_against_in_uk_327049The UK's National Institute for health and Clinical Excellence (NICE) has issued draft guidance recommending that AstraZeneca's breast cancer drug Faslodex not be used on the NHS23 Aug 2011http://www.pmlive.com/pharma_news/flu_vaccine_subsidy_for_takeda_327050Takeda Pharmaceutical is to receive a 23.9bn Yen subsidy from the Japanese government as part of a scheme to support the development and production of new influenza vaccines24 Aug 2011http://www.pmlive.com/pharma_news/diabetes_costs_increase_for_nhs_327165Drugs to treat diabetes cost the NHS in England £725m in 2010/11, an increase of 41.1 per cent from the 2005/06 period24 Aug 2011http://www.pmlive.com/pharma_news/sanofi_acquires_otc_business_in_india_327173Aventis Pharma, part of the Sanofi Group, has said it has agreed a deal to acquire Universal Medicare's over-the-counter (OTC) unit in India24 Aug 2011http://www.pmlive.com/pharma_news/takeda_considers_india_deals,_says_report_327176India's the <EM>Economic Times</EM> has reported that Takeda is holding talks with India-based generic drug firms Cipla and Lupin24 Aug 2011http://www.pmlive.com/pharma_news/new_boehringer_ingelheim_facility_in_us_327177Germany-based pharmaceutical company Boehringer Ingelheim has started the construction of a new safety assessment building in the US25 Aug 2011http://www.pmlive.com/pharma_news/spain_passes_cost-cutting_generics_law_327432Spain has passed a law to force doctors and pharmacists to prescribe generic brands as part of measures to reduce government spend25 Aug 2011http://www.pmlive.com/pharma_news/par_buys_anchen_in_$410m_deal_327433US-based Par Pharmaceutical is to purchase generic medicines manufacturer Anchen Pharmaceuticals25 Aug 2011http://www.pmlive.com/pharma_news/fda_approves_botox_for_incontinence_327489US healthcare regulator, the Food and Drug Administration, has approved Allergan's Botox injection for the treatment of urinary incontinence in people with neurological conditions who have an overactive bladder25 Aug 2011http://www.pmlive.com/pharma_news/google_in_$500m_drug_advertising_settlement_327543Google will pay a settlement charge of $500m following a US government investigation into its advertising practices that allowed Canadian pharmacies to illegally market&nbsp;drugs to American consumershttp://www.thedirectorylive.com/ad_lib/articles/freedom_to_operate <p>It’s three low (one-star) scores from Dave Trott as he kicks off this new Ad Lib series. Find out what he feels so strongly about…</p> 08 Sep 201130 Aug 2011http://www.pmlive.com/pharma_news/new_cso_for_sanofi_328530Sanofi has appointed Dr David-Alexandre Gros as the pharmaceutical company's new chief strategy officer, effective September 1, 201130 Aug 2011http://www.pmlive.com/pharma_news/positive_trial_for_pfizerbms_blood_thinner_328531Blood thinner Eliquis, developed by Pfizer and Bristol-Myers Squibb, has shown positive data in a phase III trial comparing it to standard anticoagulant warfarin30 Aug 2011http://www.pmlive.com/pharma_news/big_pharma_pays_us_doctors_$150m_in_2011_328532A report by the <EM>Financial Times</EM> has claimed a group of pharmaceutical companies has paid doctors in the US almost $150m so far during 2011, including travel and entertainment expenses30 Aug 2011http://www.pmlive.com/pharma_news/merck_acquires_amnis_corporation_328536Merck's Millipore division is to acquire Amnis Corporation, a US-based manufacturer of cell imaging systems31 Aug 2011http://www.pmlive.com/pharma_news/cancer_therapy_deal_for_teva_and_sinclair_328575Teva Pharmaceutical and Sinclair IS Pharma are to team up to promote episil, a spray therapy for ongoing supportive cancer care31 Aug 2011http://www.pmlive.com/pharma_news/valeant_to_buy_afexa_328577Canada-based drugmaker Valeant Pharmaceuticals is to purchase Afexa Life Sciences for around C$76m in the latest of a series of major acquisitions31 Aug 2011http://www.pmlive.com/pharma_news/ipsen_reports_profit_increase_328578Ipsen has revealed a rise in profit and sales for the first half of 201131 Aug 2011http://www.pmlive.com/pharma_news/eisai_and_ucb_give_epilepsy_updates_328579Eisai and UCB have revealed the results of studies at the International Epilepsy Congress in Rome01 Sep 2011http://www.pmlive.com/pharma_news/ex-pfizer_staff_create_new_uk_firm_328678Former Pfizer employees have created a research networking firm to be based in Kent, England, at a site the pharmaceutical company had previously announced it was to vacate01 Sep 2011http://www.pmlive.com/pharma_news/astrazeneca_sells_dental_business_328680The sale of pharmaceutical firm AstraZeneca's dental business, Astra Tech, to Dentsply for $1.8bn has been completed01 Sep 2011http://www.pmlive.com/pharma_news/sanofi_to_make_generic_lipitor_328757Sanofi is to launch a generic version of Pfizer's blockbuster anticholesterol Lipitor, which is due to lose patent protection in 201201 Sep 2011http://www.pmlive.com/pharma_news/new_eu_approval_for_roches_tarceva_328758The European Commission has approved Roche's cancer treatment Tarceva for first-line use in patients with a certain type of non-small cell lung cancer15 Sep 2011http://www.communiquelive.com/news_and_analysis/archive/news_archive_2011/september/the_next_healthcare_paradigm_shiftPublic relations can help the move from a paternalistic to a patient-centric system05 Sep 2011http://www.pmlive.com/pharma_news/further_eu_approval_for_novartis_afinitor_329944Novartis' cancer therapy Afinotor has been granted an additional EU approval for use in the treatment of patients with an advanced form of pancreatic cancer05 Sep 2011http://www.pmlive.com/pharma_news/crestor_fails_to_outshine_lipitor_330007AstraZeneca's cholesterol drug Crestor has failed to show an advantage over its rival Lipitor in study data released by the pharmaceutical company05 Sep 2011http://www.pmlive.com/pharma_news/who_and_fip_sign_joint_initiative_for_tb_330048The World Health Organisation&nbsp;and the International Pharmaceutical Federation&nbsp;has&nbsp;signed a joint statement&nbsp;to strengthen&nbsp;the role of pharmacists in tuberculosis care and control05 Sep 2011http://www.pmlive.com/pharma_news/az_to_develop_partnership_prospects_330090AstraZeneca has appointed Katja Toon as communications director, externalisation, to lead the pharmaceutical company's dealings with other firms and organisations06 Sep 2011http://www.pmlive.com/pharma_news/amakem_raises_18m_for_glaucoma_treatment_330262Amakem, the Belgium-based pharmaceutical company, has raised €18m to advance its lead glaucoma candidate to clinical proof-of-concept06 Sep 2011http://www.pmlive.com/pharma_news/evotec_and_roche_in_alzheimers_partnership_330263Evotec and Roche have signed a deal for the development of a treatment for Alzheimer's disease06 Sep 2011http://www.pmlive.com/pharma_news/makrocare_and_lsk_global_sign_asia_alliance_330267MakroCare and LSK Global Pharmaceutical Services have signed a new agreement to offer services to various pharmaceutical, biotechnology and medical device companies in Asia06 Sep 2011http://www.pmlive.com/pharma_news/astellas_signs_antibody_agreement_330268Japan-based pharmaceutical firm Astellas is to enter a license agreement with biotechnology firm Evec for its antibody programme to fight infectious diseases06 Sep 2011http://www.pmlive.com/pharma_news/chiesi_extends_research_deal_with_nikem_330284Chiesi Farmaceutici is to extend its research collaboration with NiKem Research, focused on developing treatments within the respiratory therapeutic area06 Sep 2011http://www.pmlive.com/pharma_news/sanofi_plans_to_save_extra_2bn_by_2015_330323Sanofi is aiming to save an additional €2bn by 2015 as part of the pharmaceutical company's cost-cutting measures07 Sep 2011http://www.pmlive.com/pharma_news/pfizer_agrees_icagen_acquisition_330863Pfizer has completed its tender offer to purchase outstanding shares of Icagen following two extensions07 Sep 2011http://www.pmlive.com/pharma_news/alliance_pharmas_profit_up_17_per_cent_330877Alliance Pharma has recorded a net profit increase of 17 per cent for the first half of 2011, with sales up 4 per cent07 Sep 2011http://www.pmlive.com/pharma_news/barda_to_support_gsks_antibiotic_research_330890GSK and BARDA have agreed a contract supporting GSK's development of a potential novel antibiotic against hospital Gram negative and biothreat pathogens07 Sep 2011http://www.pmlive.com/pharma_news/astellas_europe_selects_veevas_crm_system_330892Astellas picks Veeva's customer relationship management system for European employees07 Sep 2011http://www.pmlive.com/pharma_news/eisai_and_sfj_pharma_form_partnership_330897Eisai has agreed a partnership with US-based SFJ Pharma in a bid to speed up development of its pipeline08 Sep 2011http://www.pmlive.com/pharma_news/aurobindo_diod_generic_venture_in_russia_331186Aurobindo and Diod have established a&nbsp;joint venture to manufacture and sell generic&nbsp;pharmaceuticals in the markets of Russia, Belarus and Kazakhstan08 Sep 2011http://www.pmlive.com/pharma_news/eu_approves_janssens_prostate_cancer_drug_331204The European Commission has approved Janssen-Cilag's Zytiga, a treatment for metastatic castration-resistant prostate cancer (mCRPC)08 Sep 2011http://www.pmlive.com/pharma_news/novo_nordisks_diabetes_programme_in_india_331296Denmark-based Novo Nordisk is to offer free insulin and diabetes care to children in India as part of the pharmaceutical firm's Changing Diabetes in Children programmehttp://www.thedirectorylive.com/smart_thinking/smart_thinking_archive/feature_articles/evolution_or_revolutionIt is five years since the IPA's Magic and Logic white paper expressed ideas on how the triumvirate of marketing, procurement and agencies could play nicer with each other in the same sand box. Has anything changed? 14 Sep 2011http://www.thedirectorylive.com/smart_thinking/smart_thinking_archive/feature_articles/are_your_objectives_driving_you_nowhereThey are the essentials to marketing but familiarity breeds complacency. Is it time to road-test your SMART-objective-setting skills? 14 Sep 2011http://www.thedirectorylive.com/smart_thinking/smart_thinking_archive/feature_articles/second_time_round_successful_brand_revitalisationWith the list of patent-expired products lengthening, marketers need to evolve strategies that produce healthy returns for mature products. We asked the sponsors of the 2008 Pharmaceutical Marketing Effectiveness Award for Brand Revitalisation how you bring them back to life 14 Sep 2011http://www.thedirectorylive.com/smart_thinking/smart_thinking_archive/feature_articles/launching_a_brand_across_europeCreating a strategy to roll out a pan-European or global campaign means engaging both local marketing affiliates and other stakeholders, as well as your customer base. What are the critical steps you need to take to respond to this major challenge?14 Sep 201112 Sep 2011http://www.pmlive.com/pharma_news/gsk_pledges_de-worming_tablets_to_who_332130GlaxoSmithKline (GSK) has signed a pledge to donate 400 million de-worming tablets (albendazole) per year for the next five years to the World Health Organisation (WHO)12 Sep 2011http://www.pmlive.com/pharma_news/roche_submits_vismodegib_for_fda_approval_332230Roche's Genentech subsidiary has submitted a new drug application to the US Food and Drug Administration for vismodegib in the treatment of people with advanced basal cell carcinoma who cannot undergo surgery12 Sep 2011http://www.pmlive.com/pharma_news/ec_approval_for_novartis_sega_drug_332232Novartis' Votubia (everolimus), a treatment for SEGA associated with TSC, has been approved by the EC12 Sep 2011http://www.pmlive.com/pharma_news/ukrussian_pharma_firm_launches_332233Global pharmaceutical company, Pro Bono Bio, has launched today with funding from UK-based Celtic Pharma and the state-owned Russian Corporation of Nanotechnologies (RusNano)http://www.thedirectorylive.com/smart_thinking/smart_thinking_archive/feature_articles/analysing_performanceA campaign that grabs the attention may not actually be what you need. Return on investment is as much about taking the long-term view and building brand loyalty. So, are you and your agency creating a lasting relationship with customers?14 Sep 2011http://www.thedirectorylive.com/smart_thinking/smart_thinking_archive/feature_articles/talkin_bout_an_evolutionWith the environment changing, there’s a need for creative agencies to take a long, hard look at how they will confront the challenges ahead? Like it or not, we’ve entered a new era14 Sep 2011http://www.thedirectorylive.com/smart_thinking/smart_thinking_archive/feature_articles/daring_to_be_different If pharma needs to be more rigorous about defining its market insights, recognising opportunities and executing its ‘big idea’, what else gives our best-known consumer brands the leading edge? The traditional tenets of successful pharmaceutical brand development might still apply, but one thing is for sure… the ‘telling and selling’ approach needs updating 14 Sep 2011http://www.thedirectorylive.com/smart_thinking/smart_thinking_archive/feature_articles/creating_a_digital_campaign<P>Are your stakeholders still stuck on rhetoric – playing the waiting game before committing fully to an online presence? Skilfully interacting with a target audience simply means a change of mindset...</P>14 Sep 201115 Sep 2011http://www.pmlive.com/pharma_news/easd_diabetes_group_demands_un_action_332626The International Diabetes Federation has called on the United Nations to take ‘real action’ with new data suggesting the number of people living with diabetes globally in 2011 has reached 366 million 13 Sep 2011http://www.pmlive.com/pharma_news/fda_lifts_hold_on_rxis_cancer_drug,_neuvax_332627The US FDA has lifted its clinical hold on RXi Pharmaceuticals’ cancer drug, NeuVax, enabling phase III trials to commence 13 Sep 2011http://www.pmlive.com/pharma_news/fda_recommends_j_and_js_stroke-prevention_drug_332628 The FDA has recommended Xarelto (rivaroxaban) for stroke prevention in patients with the heart condition nonvalvular atrial fibrillation 14 Sep 2011http://www.pmlive.com/pharma_news/mundel_to_lead_gates_global_health_programme_333235Dr Trevor Mundel, current global head of development for Novartis Pharma AG, has been named president of The Bill &amp; Melinda Gates Foundation Global Health Programme 14 Sep 2011http://www.pmlive.com/pharma_news/almirall_appoints_area_director,_alfredo_baron_333236Almirall has appointed Alfredo Barón as area director for southern and eastern Europe 15 Sep 2011http://www.pmlive.com/pharma_news/easd_positive_results_for_sanofis_lyxumia_333264 Sanofi has published phase III trial results at the European Association for the Study of Diabetes meeting that indicate lixisenatide is effective in improving glycaemic control in type 2 diabetes patients 15 Sep 2011http://www.pmlive.com/pharma_news/easd_study_supports_early_use_of_victoza_333302Novo Nordisk's GLP-1 analogue Victoza has greater benefit if used early in the treatment of type 2 diabetes according to a study presented at the European Association for the Study of Diabetes meeting 15 Sep 2011http://www.pmlive.com/pharma_news/easd_adverse_effects_need_rigorous_review_333365 The potential harm caused by drugs needs to be assessed in systematic analysis of data, according to Professor Rory Holman, University of Oxford, speaking at the EASD meeting 15 Sep 2011http://www.pmlive.com/pharma_news/cancer_drug,_oxaliplatin,_approved_for_uk_333954Colon and rectum cancer drug, Oxaliplatin, has been approved for use in the UK15 Sep 2011http://www.pmlive.com/pharma_news/vibativ_is_granted_marketing_authorisation_333955European marketing authorisation has been granted for Vibativ, a once-daily injection to treat hospital acquired nosocomial pneumonia15 Sep 2011http://www.pmlive.com/pharma_news/easd_novos_degludec_shows_promise_334208Novo Nordisk's investigational basal insulin degludec is effective when used under stressed frequencies of injection in patients with type 2 diabetes, according to a study presented at the European Association for the Study of Diabetes meeting15 Sep 2011http://www.pmlive.com/pharma_news/merck_defends_gardasil_334218Merck has responded to US Republican senator Michele Bachmann's comments that HPV vaccine Gardasil poses a threat to public safety16 Sep 2011http://www.pmlive.com/pharma_news/novo_cmo_diabetes_is_health_disaster_334561Dr Alan C Moses, chief medical officer at Novo Nordisk, discusses the global 'health disaster' that is diabetes in an exclusive video ahead of the UN Summit on Non-Communicable Diseases19 Sep 2011http://www.pmlive.com/pharma_news/roche_stops_supplies_for_greek_hospitals_336095Roche has cancelled the delivery of drugs to some hospitals in Greece over unpaid bills dating back up to four years, said the pharmaceutical company's CEO Severin Schwan 19 Sep 2011http://www.pmlive.com/pharma_news/sanofi_wins_eloxatin_patent_case_336146A US district court has ruled in favour of Sanofi retaining marketing exclusivity for colorectal cancer treatment Eloxatin until August 2012 following a patent challenge from Sun Pharmaceuticals19 Sep 2011http://www.pmlive.com/pharma_news/un_summit_tackles_chronic_disease_threat_336173World leaders, healthcare organisations and the pharmaceutical industry are debating how to prevent and control the global threat of non-communicable diseases at a UN Summit in New York City, US19 Sep 2011http://www.pmlive.com/pharma_news/trial_success_for_msds_hiv_drug_336181MSD's Isentress has demonstrated efficacy regardless of gender or race in a diverse population of adult patients with HIV-1 infection in an observational phase III studyhttp://www.thedirectorylive.com/smart_thinking/smart_thinking_archive/feature_articles/get_under_their_skin Illuminate the branding process through truly insightful research that provides a deeper understanding of physicians as real people 12 Sep 2011http://www.thedirectorylive.com/smart_thinking/smart_thinking_archive/feature_articles/digital_tactics_first,_strategy_laterPharma's spend on digital continues to grow at 20 per cent per year, according to an annual survey of the digital landscape, yet still only accounts for 7 per cent of total marketing spend 12 Sep 201120 Sep 2011http://www.pmlive.com/pharma_news/merck_acquires_experimental_ms_drug_336336The worldwide exclusive rights to PI-2301, an experimental multiple sclerosis drug, have been acquired by Merck20 Sep 2011http://www.pmlive.com/pharma_news/msd_invests_in_fkd_therapies_336375MSD has taken an equity stake in the Finland based company, FKD Therapies, owned by former CEO of Ark Therapeutics Nigel Parker20 Sep 2011http://www.pmlive.com/pharma_news/calls_for_action_on_unlicensed_medicines_336419Four European patient groups have called for more and improved measures against the use of unlicensed and off-label medicines, including the introduction of mandatory adverse event reporting20 Sep 2011http://www.pmlive.com/pharma_news/industry_pledges_action_on_global_ncd_rise_336453The International Federation of Pharmaceutical Manufacturers and Associations has said the industry plans to address the global rise of non-communicable diseases as the UN Summit on NCDs is held in New York21 Sep 2011http://www.pmlive.com/pharma_news/bmsono_enter_extended_agreement_336601Bristol-Myers Squibb and Ono Pharmaceutical have announced an agreement to develop separate therapies for cancer and rheumatoid arthritis21 Sep 2011http://www.pmlive.com/pharma_news/astellas_sponsors_pain_exhibition_336602Sponsored by Astellas Pharma Europe, The Pain Within, an exhibition of photography on the subject of peripheral neuropathic pain is currently touring Europe23 Sep 2011http://www.pmlive.com/pharma_news/industry_supports_alzheimers_day_336639Pharmaceutical companies and organisations, including the European Medicines Agency are supporting World Alzheimer's Day to raise awareness of the neurological disease22 Sep 2011http://www.pmlive.com/pharma_news/fda_supports_acute_liver_failure_treatment_336830The FDA has announced that Digna Biotech's cardiotrophin-1 (CT-1) has been granted orphan drug status for the treatment of acute liver failure22 Sep 2011http://www.pmlive.com/pharma_news/abpi_calls_for_drug_pricing_plan_changes_336920The UK's Association of the British Pharmaceutical Industry (ABPI) has requested changes to the government's plans to introduce value-based pricing for drugs in 201422 Sep 2011http://www.pmlive.com/pharma_news/calls_for_improved_medicine_adherence_in_eu_336979Several European healthcare organisations have called for action to improve patient adherence for medicines, with 194,500 deaths attributed to misdose and non-adherence in the region each year22 Sep 2011http://www.pmlive.com/pharma_news/report_highlights_impact_of_chronic_pain_336988Urgent action is needed to tackle chronic pain in Europe says report, with estimates that the condition costs the economy £12.3bn per year in the UK alone26 Sep 2011http://www.pmlive.com/pharma_news/gileads_hiv_drug_recommended_by_chmp_337486Gilead's Eviplera has received a positive opinion from the European Committee for Medicinal Products for Human Use (CHMP) for use as a once-daily, single-tablet regimen for adults with HIV-126 Sep 2011http://www.pmlive.com/pharma_news/fda_approves_j_and_js_remicade_for_children_337487Johnson &amp; Johnson's Remicade (infliximab) has received approval from the US Food and Drug Administration (FDA) for the treatment of ulcerative colitis in children over six years of age26 Sep 2011http://www.pmlive.com/pharma_news/chmp_recommends_novos_insulin_extensions_337497The European Committee for Medicinal Products for Human Use (CHMP) has recommended that approval for Novo Nordisk's insulin Levemir be expanded27 Sep 2011http://www.pmlive.com/pharma_news/novartis_submits_copd_drug_for_eu_approval_337607Pharmaceutical company Novartis has submitted an investigational chronic obstructive pulmonary disease therapy for marketing authorisation in the EU following positive phase III trial data27 Sep 2011http://www.pmlive.com/pharma_news/novo_submits_degludec_for_eu_approval_337612Novo Nordisk has submitted its long-acting insulin Degludec to the European Medicines Agency (EMA) for marketing authorisation in the EU27 Sep 2011http://www.pmlive.com/pharma_news/lilly_launches_innovation_platform_337959Eli Lilly &amp; Company has launched a drug discovery platform that aims to help boost the pharmaceutical company's R&amp;D partnerships through a unique website27 Sep 2011http://www.pmlive.com/pharma_news/valeant_counters_paladins_bid_for_afexa_337971Valeant Pharmaceuticals has increased its offer to acquire Afexa Life Sciences to $0.85 per common share in response to a rival bid from Paladin Labs.http://www.thedirectorylive.com/smart_thinking/smart_thinking_archive/eurovision/pharmaceutical_marketing_in_europe_should_we_call_a_priestWhat’s the talk in Europe? Catch up with new regulation in Spain and France, and a shelved product launch in Germany 05 Oct 201128 Sep 2011http://www.pmlive.com/pharma_news/digipharm_europe_2011_live_coverage_338167Follow live coverage of Digipharm Europe 2011 – the digital marketing conference for the pharmaceutical industry03 Oct 2011http://www.pmlive.com/pharma_news/us_generics_groups_drug_shortage_plea_338223The US Generic Pharmaceutical Association (GPhA) has blamed intensified regulation for drug shortages in the US and called for greater collaboration between stakeholders to solve the crisis28 Sep 2011http://www.pmlive.com/pharma_news/actelion_appoints_former_gsk_ceo_as_chair_338224Dr Jean-Pierre Garnier, former CEO at GlaxoSmithKline, has been appointed chairman of Swiss biopharmaceutical company Actelion28 Sep 2011http://www.pmlive.com/pharma_news/shire_backs_campaign_for_adhd_support_338248Ireland-based pharmaceutical company Shire is supporting a European campaign to increase awareness and support for ADHD in schools as part of ADHD Awareness Week29 Sep 2011http://www.pmlive.com/pharma_news/nycomedalmirall_sign_china_deal_338366Swiss firm Nycomed has signed an agreement to market Spain-based pharmaceutical company Almirall’s antihistamine Kestine (ebastine) in China and other markets in Southeast Asia29 Sep 2011http://www.pmlive.com/pharma_news/msd_sells_interest_in_joint_venture_to_j_and_j_338367Johnson &amp; Johnson has acquired MSD's 50 per cent share in the two pharmaceutical companies' OTC joint venture for $175m29 Sep 2011http://www.pmlive.com/pharma_news/pfizer_launches_counterfeit_drug_campaign_338385Pfizer has partnered with the US National Association of Boards of Pharmacy in a campaign to raise awareness of the risks of counterfeit medicines29 Sep 2011http://www.pmlive.com/pharma_news/study_gardasil_better_value_than_cervarix_338386Gardasil, the human papillomavirus vaccine developed by Sanofi and MSD, may be a more cost-effective option than GlaxoSmithKline's Cervarix in the UK according to a report 03 Oct 2011http://www.pmlive.com/pharma_news/bayer_seeks_acs_approval_for_xarelto_338683Bayer has said it intends to file Xarelto (rivaroxaban) for marketing approval in the treatment of patients with acute coronary syndrome (ACS)03 Oct 2011http://www.pmlive.com/pharma_news/takeda_buys_nycomed_and_names_ceo_338689Takeda has completed the purchase of Switzerland-based pharmaceutical firm Nycomed and named Dr Frank Morich as Nycomed's CEO03 Oct 2011http://www.pmlive.com/pharma_news/gsk_looks_to_invest_$2bn_in_india_338693Andrew Witty, CEO of GlaxoSmithKline, has said the company is looking to make significant investments in India as part of the company's plan to increase its presence in emerging markets04 Oct 2011http://www.pmlive.com/pharma_news/cst_the_gate_launches_healthcare_agency_338795New company CST The Gate Health will specialise in health and pharmaceutical brands for medical professionals and consumers under the CST The Gate banner04 Oct 2011http://www.pmlive.com/pharma_news/hikma_buys_majority_in_promopharm_338855Hikma Pharmaceuticals has acquired 63.9 per cent of Morocco-based company, Promopharm, for $111.2m with further plans for a full acquisition04 Oct 2011http://www.pmlive.com/pharma_news/merckono_collaborate_on_ms_and_cancer_338857Merck Serono and Ono Pharmaceutical are to work together to develop and market new treatments for both multiple sclerosis and cancer04 Oct 2011http://www.pmlive.com/pharma_news/msd_wins_fosamax_case_338867A US federal court has ruled in favour of MSD after a woman took the pharmaceutical company to trial based on dental problems she blamed on osteoporosis treatment Fosamax05 Oct 2011http://www.pmlive.com/pharma_news/bayer_plans_expansion_in_japan_338974Bayer has said it plans to grow at an average of six per cent per year in Japan over the next five years, with the pharmaceutical firm expecting annual revenue of €2.4bn in the country by 201505 Oct 2011http://www.pmlive.com/pharma_news/art_coverage_for_hiv_patients_on_increase_338979The proportion of eligible HIV/AIDS patients taking antiretroviral therapy (ART) in low- and middle-income countries has increased from 10 per cent to 50 per cent during the last 10 years06 Oct 2011http://www.pmlive.com/pharma_news/az_settles_seroquel_patent_case_339034AstraZeneca has entered into a settlement agreement with Accord Health and Intas regarding patent litigation for Seroquel XR in the US10 Oct 2011http://www.pmlive.com/pharma_news/mercks_chair_retires_339739Richard T Clark, chair of Merck (known as MSD outside the US and Canada) is to retire from the pharmaceutical company on December 1, 201110 Oct 2011http://www.pmlive.com/pharma_news/az_invests_in_china,_cuts_jobs_in_us_339740AstraZeneca is to build a $200m manufacturing facility in China as it cuts 400 jobs at its US headquarters10 Oct 2011http://www.pmlive.com/pharma_news/novo_launches_victoza_in_china_339741Novo Nordisk has launched its type 2 diabetes treatment Victoza in China – an increasingly important market for diabetes products10 Oct 2011http://www.pmlive.com/pharma_news/pfizerteva_settle_uk_lipitor_patent_case_339742Pfizer has settled its case against Teva regarding the launch of a generic version of cholesterol lowering medication Lipitor in the UK11 Oct 2011http://www.pmlive.com/pharma_news/call_for_improved_chronic_pain_assessment_340005The European Federation of IASP chapters has launched a campaign to highlight the "silent epidemic" of chronic back pain as part of its European Week against Pain11 Oct 2011http://www.pmlive.com/pharma_news/uk_invests_140m_in_innovation_340006The UK's Technology Strategy Board is to invest £140m in manufacturing in an attempt to reduce the risk of innovation and attract business development to the country11 Oct 2011http://www.pmlive.com/pharma_news/senior_changes_at_lilly_340008Eli Lilly &amp; Company has announced the promotions of Dave Ricks and Maria Crowe to president of Lilly Bio-Medicines and president of Lilly's manufacturing operations respectively11 Oct 2011http://www.pmlive.com/pharma_news/ec_plans_to_limit_medicine_information_340028The European Commission has adopted revised proposals to clarify the level of information that the pharmaceutical industry can supply to the public about prescription-only medicineshttp://www.thedirectorylive.com/smart_thinking/smart_thinking_archive/feature_articles/europe_sans_frontiers <p>We asked four of the leading names how their agencies are re-defining their operational business models to equip themselves with expertise across Europe. Is it all about mergers and acquisitions or do the independents still carry clout? Both sides give their views…</p> 13 Oct 201112 Oct 2011http://www.pmlive.com/pharma_news/eucomed_commits_to_value-based_innovation_340435Eucomed, the European medical technology body, has launched its five-year strategy, which includes a commitment to value-based innovation12 Oct 2011At the inaugural VitalSigns forum held this week at The King’s Fund speakers, including the founder of health-related apps and a PCT chief executive, profiled initiatives at the cutting edge of digital communications 12 Oct 2011http://www.pmlive.com/pharma_news/fda_warning_for_bms_leukaemia_drug_340450The US Food and Drug Administration has updated the label of Bristol-Myers Squibb's leukaemia drug Sprycel with a warning that the drug can increase the risk of abnormally high blood pressure in the arteries of the lungs12 Oct 2011http://www.pmlive.com/pharma_news/onyx_and_bayer_settle_claim_340467Bayer HealthCare has reached a settlement with Onyx Pharmaceuticals relating to Onyx's investigational treatment regorafeniba and revised a contract for the marketing of cancer drug Nexavar12 Oct 2011http://www.pmlive.com/pharma_news/aurobindo_joins_patent_pool_340479Aurobindo Pharma has become the first generics manufacturer to join the Medicines Patent Pool for the manufacture of HIV/AIDS treatments13 Oct 2011http://www.pmlive.com/pharma_news/ega_announces_new_president_340549The European Generic medicines Association has announced current executive board member Gudbjorg Edda Eggertsdottir as its new president13 Oct 2011http://www.pmlive.com/pharma_news/currency_rates_affect_roches_q3_results_340567Roche has recorded a 13 per cent drop in revenue in Swiss Francs for the first three quarters of 2011, although the pharmaceutical company's sales remained level at constant exchange rates13 Oct 2011http://www.pmlive.com/pharma_news/frontera_hires_creative_director_340590Former partner at McCann Healthcare, Bruno Cepollina, has joined healthcare agency Frontera as partner and creative director13 Oct 2011http://www.pmlive.com/pharma_news/pfizer_files_suit_against_merck_340684Pfizer is to sue Merck over the company's plan to launch a Lipitor-plus-Zetia combination pill in the US17 Oct 2011http://www.pmlive.com/pharma_news/eucomed_to_review_technology_conferences_341203Eucomed is to enforce a system to review and approve third-party, medical technology conferences in accordance with its Code of Practice17 Oct 2011http://www.pmlive.com/pharma_news/roche_to_buy_anadys_for_$230m_341204Roche is to acquire US-based Anadys Pharmaceuticals for $230m, developing the company's hepatitis C capabilities17 Oct 2011http://www.pmlive.com/pharma_news/teva_completes_cephalon_purchase_341244Teva Pharmaceutical has acquired US-based biopharmaceutical company Cephalon for about $6.8bn following approval from the European Union17 Oct 2011http://www.pmlive.com/pharma_news/takeda_appoints_head_of_emerging_markets_341247Takeda has named Jostein Davidsen as head of emerging markets following the pharmaceutical company's acquisition of Nycomed17 Oct 2011Campaign winners at this year’s Medical Marketing &amp; Media Awards in New York include Takeda Canada; Allergan and Abbott Nutrition, and Boehringer Ingelheim’s Drive4COPD <br>17 Oct 2011Econsultancy’s multichannel event JUMP took place on October 12 at Old Billingsgate, London. 17 Oct 2011Developed by ISBA and the IPA a new microsite looks at pitching practice, in an aim to provide a platform for people to get involved in open debate17 Oct 2011US-based Star Group Communications has launched a <a href="http://www.stargroup1.com/category/tags/healthcare-advertising" target="_blank">new social media network</a> on healthcare marketing. The blog states that it “offers to provide brands in the healthcare marketing world with ‘symptom-targeted advertising’ 18 Oct 2011http://www.pmlive.com/pharma_news/novartis_named_top_pharma_brand_in_europe_341401Novartis has been name the 20th most valuable brand in Europe by the European Brand Institute, making it the top rated company in the pharmaceutical or healthcare industry 18 Oct 2011http://www.pmlive.com/pharma_news/j_and_j_launches_online_resources_for_infections_341403Johnson &amp; Johnson's Advanced Sterilization Products division has launched new online resources as part of International Infection Prevention Week 18 Oct 2011http://www.pmlive.com/pharma_news/nice_recommends_against_bms_melanoma_drug_341404The UK's National Institute for Health and Clinical Excellence has issued draft guidance recommending against the use of Bristol-Myers Squibb's Yervoy for skin cancer http://www.thedirectorylive.com/smart_thinking/smart_thinking_archive/feature_articles/creative_genius_how_to_evaluate_creativityBeing a creative genius isn’t easy. How can everyone around the table make that creative partnering work, so that amazing gem of an idea gets enough airing and is properly evaluated? 18 Oct 201118 Oct 2011Members of the EACA Healthcare Communications Council (EACA HCC) have now signed a new Charter that sets our 16 rules for agencies and clients participating in the pitch process 19 Oct 2011http://www.pmlive.com/pharma_news/j_and_js_profit_falls_as_sales_increase_341732Johnson &amp; Johnson’s third quarter profit for 2011 has fallen 6.3 per cent despite an increase in the US-based pharmaceutical company’s sales performance19 Oct 2011http://www.pmlive.com/pharma_news/gsk_success_in_malaria_vaccine_trial_341733GlaxoSmithKline has reported that its investigational malaria vaccine RTS,S reduced the risk of malaria in children&nbsp;by half during a phase III trial conducted in Africa19 Oct 2011http://www.pmlive.com/pharma_news/forests_net_income_down_for_q3_341742Forest Laboratories has reported a decrease in net income of 10.5 per cent to $249m in its financial results for the third quarter of 2011 with R&amp;D and administration costs both increasing19 Oct 2011http://www.pmlive.com/pharma_news/takedas_diabetes_drug_enters_phase_iii_341746Takeda Pharmaceutical's TAK-875, a novel investigational therapy for diabetes, has entered phase III development 20 Oct 2011http://www.pmlive.com/pharma_news/abbott_to_split_into_two_as_q3_profit_falls_341984Abbott is to split into two companies covering diversified medical products and research-based pharmaceuticals as Depakote costs hit Q3 profit20 Oct 2011http://www.pmlive.com/pharma_news/amgen_announces_380_us_job_cuts_342024Amgen is to cut 380 R&amp;D jobs in the US as the biotechnology company aims to streamline its operationshttp://www.thedirectorylive.com/smart_thinking/smart_thinking_archive/feature_articles/work_together_to_deliver_valueThe idea of ensuring that procurement teams align fully with agencies and marketing teams is not simply a boring bullet-point in a manager’s conference presentation; it is a collaboration vital to successful marketing 20 Oct 201120 Oct 2011http://www.pmlive.com/pharma_news/lillys_income_drops_5_per_cent_342028Eli Lilly &amp; Company has reported a drop in net income of 5 per cent in the pharmaceutical company's financial results for the third quarter of 2011 due to increased operating expenses20 Oct 2011http://www.pmlive.com/pharma_news/abpi_says_uk_must_stay_strong_in_research_342106Stephen Whitehead, CEO of the ABPI, has said continued government support is needed if the UK is to remain a leader in research following a report published by the Department for Business, Innovation and Skills24 Oct 2011http://www.pmlive.com/pharma_news/ema_reviews_anti-inflammatory_safety_342597The European Medicines Agency is to review the safety of non-selective non-steroidal anti-inflammatory drugs following new evidence into their association with cardiovascular events24 Oct 2011http://www.pmlive.com/pharma_news/ec_investigates_j_and_jnovartis_over_fentanyl_342598The European Commission has launched an antitrust investigation to assess if Johnson &amp; Johnson and Novartis' generics division, Sandoz, hindered entry of generic versions of pain drug fentanyl into the Netherlands24 Oct 2011http://www.pmlive.com/pharma_news/games_for_health_europe_coverage_342608Follow coverage of the Games for Health Europe conference in Amsterdam, the Netherlands, which aims to highlight the impact games can have in healthcare24 Oct 2011http://www.pmlive.com/pharma_news/trial_success_for_novartis_psoriasis_drug_342623Novartis has presented data at the European Academy of Dermatology and Venereology Congress that demonstrates investigational psoriasis treatment AIN457 is effective in up to 81 per cent of patients25 Oct 2011http://www.pmlive.com/pharma_news/sanofi_appoints_meeker_ceo_of_genzyme_344321Current chief operating officer of Genzyme, David Meeker, will take over as CEO of the company from November 1http://www.thedirectorylive.com/smart_thinking/smart_thinking_archive/thought_leaders/digital_theres_nothing_to_be_scared_ofAre we locked in fear by the endless possibilities of digital? 25 Oct 2011http://www.thedirectorylive.com/smart_thinking/smart_thinking_archive/thought_leaders/is_pharma_really_on_board_with_social_mediaAs the ubiquity of social media increases, pharma cannot ignore the needs of stakeholders 25 Oct 2011http://www.thedirectorylive.com/smart_thinking/smart_thinking_archive/thought_leaders/zynga_doesnt_do_healthcare,_but_if_it_did…just how successful could we be in motivating people to take responsibility for their own health?25 Oct 201125 Oct 2011http://www.pmlive.com/pharma_news/generic_zyprexa_launched_in_us_344573Teva Pharmacuetical and Dr Reddy's have had a generic version of Eli Lilly &amp; Company's blockbuster schizophrenia drug Zyprexa (olanzapine) approved by the US Food and Drug Administration25 Oct 2011http://www.pmlive.com/pharma_news/amgens_q3_hit_by_$780m_settlement_charge_344574Amgen recorded a net profit drop of 63 per cent due mainly to a settlement charge of $780m related to allegations of improper sales and marketing practices25 Oct 2011http://www.pmlive.com/pharma_news/novartis_closes_three_sites,_cuts_2000_jobs_344585Novartis is to close three plants in Italy and Switzerland and restructure business in the US resulting in the loss of 2000 jobshttp://www.thedirectorylive.com/smart_thinking/smart_thinking_archive/feature_articles/effective_advertisingHow can you develop an attention-grabbing campaign that truly changes perceptions in your favour? The key is to be more radical and competitive in your thinking... 26 Oct 201126 Oct 2011http://www.pmlive.com/pharma_news/lilly_to_lose_up_to_$95m_on_xigris_withdrawal_344732Eli Lilly &amp; Company will face an impairment charge of between $75m and $95m after withdrawing sepsis treatment Xigris based on a new study demonstrating a lack of efficacy26 Oct 2011http://www.pmlive.com/pharma_news/ec_launches_new_csr_strategy_344733The European Commission has launched a new strategy for corporate social responsibility in Europe26 Oct 2011http://www.pmlive.com/pharma_news/gsks_q3_sales_grow_3_per_cent_344734GlaxoSmithKline recorded a growth in sales of 3 per cent in its financial results for the third quarter of 2011, as net income remained level27 Oct 2011http://www.pmlive.com/pharma_news/bmsgilead_hiv_deal_344790Bristol-Myers Squibb and Gilead Sciences sign licensing agreement to develop and market a new fixed-dose combination HIV treatment31 Oct 2011http://www.pmlive.com/pharma_news/novos_profit_up_on_victoza_344791Novo Nordisk's net profit increased by 17 per cent for the third quarter of 2011, boosted by strong sales for diabetes therapy Victoza 27 Oct 2011http://www.pmlive.com/pharma_news/azs_q3_income_up_as_sales_stay_flat_344792AstraZeneca's total net income jumped from $1.83bn to $3.13bn in the pharmaceutical company's financial results for the third quarter of 2011, despite sales falling by 2 per centhttp://www.thedirectorylive.com/smart_thinking/smart_thinking_archive/eurovision/is_there_a_doctor_in_the_houseWe hear much talk about the future of pharma being focused on producing more innovative medicines and reaching new markets. But the key players in the industry within Europe have something else on their minds…<br> 27 Oct 2011http://www.thedirectorylive.com/smart_thinking/smart_thinking_archive/feature_articles/add_innovative_spirit_to_the_marketing_mixInnovation has always played an important part in the pharma industry, but what are the challenges in developing innovative ideas and driving innovation into marketing plans?31 Oct 201131 Oct 2011http://www.pmlive.com/pharma_news/respiratory_and_diabetes_drugs_lift_merck_345301Third quarter sales increase 8 per cent, driven by Singulair and Januvia31 Oct 2011http://www.pmlive.com/pharma_news/oxford_biomedica_signs_glaucoma_r_and_d_deal_345312Oxford, UK-based biotech partners with the Mayo Clinic on novel gene therapy31 Oct 2011http://www.pmlive.com/pharma_news/shires_q3_net_profit_doubles_345319Net profit for Shire recovers from payment to Acceleron and impairment charges relating to the divestment of Daytrana01 Nov 2011http://www.pmlive.com/pharma_news/daiichi_sets_up_new_vaccine_research_unit_345398Japanese pharma company establishes new research facility at its Kasai R&amp;D Center in Tokyo01 Nov 2011http://www.pmlive.com/pharma_news/euro_biotech_investment_down_44_per_cent_345400Venture capitalist cash drying up for European biotechnology sector as deals across all industries hit 11-year low01 Nov 2011http://www.pmlive.com/pharma_news/sanofi_poised_to_lead_pharma_sales_in_2012_345401French pharma company predicted to overtake Pfizer to become the global pharma sales leader in 201201 Nov 2011http://www.pmlive.com/pharma_news/first_india-developed_drug_approved_345406India’s drug regulator gives conditional marketing approval to Ranbaxy’s anti-malaria drug – potentially the first non-generic drug developed by an Indian company02 Nov 2011http://www.pmlive.com/pharma_news/bms_anthony_hooper_joins_amgen_345477Amgen has appointed Anthony (Tony) Hooper as executive vice president, global commercial operations 02 Nov 2011http://www.pmlive.com/pharma_news/teva_uk_appoints_richard_daniell_managing_director_345731Teva UK promotes Richard Daniell to managing director. He&nbsp;succeeds Dipankar Bhattacharjee who has in turn been promoted to a wider European role 02 Nov 2011http://www.pmlive.com/pharma_news/pfizers_q3_lifted_by_prevenar,_enbrel_and_lyrica_345805Sales growth of 7 per cent helped US-based pharma company’s adjusted income increase 11 per cent to $4.82bn in the third quarter 02 Nov 2011http://www.pmlive.com/pharma_news/taiwan_launches_government-sponsored_biotech_incubator_345808The Supra Incubator Center (SIC) will focus on promoting the country's biotechnology sector 03 Nov 2011http://www.pmlive.com/pharma_news/prof_tevor_jones_oversees_synexus_scientific_advisory_board_345813Steps down as chairman at clinical trial research firm in favour of Alan Pilgrim03 Nov 2011http://www.pmlive.com/pharma_news/dr_angelika_bodenteich_joins_marinomed_biotechnologie_345819Dr Angelika Bodenteich takes up a role as head of development at the Austrian biotech company02 Nov 2011A recent IPA ‘swop shop’ when marketers and agency figures swopped sides to role-play the pitching process has shown just how difficult it can be to get the process right 03 Nov 2011http://www.pmlive.com/pharma_news/gsk_to_pay_$3bn_in_us_settlements_345975GlaxoSmithKline agrees terms with US government over drug marketing practices, including for&nbsp;diabetes treatment Avandia 03 Nov 2011http://www.pmlive.com/pharma_news/unconscious_behaviour_has_role_in_healthcare_345983The unconscious behaviour and associations of individuals remains an untapped influence within healthcare professional's choice of treatment and patient adherencehttp://www.thedirectorylive.com/smart_thinking/smart_thinking_archive/feature_articles/creating_a_strong_strategyThere's no such thing as a boring product – just the same boring old strategy. Why it pays to apply the 'disruption' theory, challenge the conventional and take calculated risks... 07 Nov 201104 Nov 2011http://www.pmlive.com/pharma_news/jan-uwe_claas_to_head_up_grunenthal_uk_346179Chris Matijasevic will retire and Jan-Uwe Claas take over at Grünenthal UK 04 Nov 2011http://www.pmlive.com/pharma_news/russia_to_fast-track_indian_pharmas_drug_registrations_346180Memorandum of understanding will fast-track Indian drugs to market in Russia and also boost Indian pharma companies' investment in Russian infrastructure 04 Nov 2011http://www.pmlive.com/pharma_news/fda_us_leads_with_new_drug_approvals_346237The US regulator approved more new drugs in the last 12 months than its counterparts around the world 07 Nov 2011http://www.pmlive.com/pharma_news/dia_appoints_kaushik_desai_to_head_up_indian_operations_346311The Drug Information Association (DIA) has appointed Kaushik Desai as director of DIA India 07 Nov 2011http://www.pmlive.com/pharma_news/pfizer_spares_another_300_uk_research_staff_from_cutbacks_346359Reduces the number of layoffs at its UK R&amp;D unit in Sandwich, Kent 07 Nov 2011http://www.pmlive.com/pharma_news/ex-pfizer_research_head_dr_david_roblin_joins_destiny_pharma_346364The former head of research at Pfizer's European operations will be medical director at Destiny 07 Nov 2011http://www.pmlive.com/pharma_news/j_and_js_xarelto_cleared_for_stroke_prevention_in_usa_346373FDA approves Johnson &amp; Johnson's anticoagulant for preventing stroke in patients with a common type of abnormal heart rhythm 08 Nov 2011http://www.pmlive.com/pharma_news/lundbeck_adds_regulatory_unit_to_its_research_operations_346529Appoints Jens Peter Balling to lead the product support, patient safety and quality assurance unit 08 Nov 2011http://www.pmlive.com/pharma_news/roche_appoints_pamela_carroll_as_global_head_of_pathways_biology_346543She will also act as oncology discovery site head at Roche's Nutley, New Jersey research facility 08 Nov 2011http://www.pmlive.com/pharma_news/novartis_buoyed_by_pivotal_data_on_arthritis_drug_346573Trial results will support canakinumab's application for a systemic juvenile idiopathic arthritis licence 08 Nov 2011http://www.pmlive.com/pharma_news/fda_gives_green_light_for_erbitux_in_new_cancer_indication_346576BMS and Lilly win approval to market the drug for late-stage head and neck cancer 08 Nov 2011http://www.pmlive.com/pharma_news/az_pushes_on_with_depression_drug_despite_missing_phase_iii_endpoint_346660Plans first filing in 2012 for potential first-in-class treatment TC-5214 09 Nov 2011http://www.pmlive.com/pharma_news/ge_healthcares_graham_higson_joins_nda_group_346797Higson will take up the role of managing director of NDA Advisory Services in January 09 Nov 2011http://www.pmlive.com/pharma_news/life_science_execs_concerned_about_uks_competitiveness_346961Value-based pricing, NHS reforms and the cost of research highlighted as key issues in survey 09 Nov 2011http://www.pmlive.com/pharma_news/gsk_moves_closer_to_hepatitis_c_indication_for_eltrombopag_347031 GSK has reported encouraging results from two Phase III trials of its drug eltrombopag when used to boost low blood platelet counts in patients with hepatitis C virus infection, potentially opening up a lucrative new market for the drug09 Nov 2011http://www.pmlive.com/pharma_news/amylin_and_lilly_part_company_over_exenatide_differences_347032 Amylin is ready to pay up to $1.6bn to free itself from a decade-long marketing pact with Eli Lilly for its exenatide diabetes franchise10 Nov 2011http://www.pmlive.com/pharma_news/novartis_appoints_timothy_wright_global_head_of_pharma_development_347427Wright moves to the role from the Novartis Institutes for BioMedical Research (NIBR) 10 Nov 2011http://www.pmlive.com/pharma_news/dr_georg_buchner_joins_silence_therapeutics_347438He assumes a business development role at the London-based biotech 10 Nov 2011http://www.pmlive.com/pharma_news/pfizer_licenses_seretide_generic_and_other_respiratory_drugs_to_mylan_347504The generic company will also take on some employees from Pfizer's Sandwich, UK facility 10 Nov 2011http://www.pmlive.com/pharma_news/sanofi_-_regeneron_antibody_improves_statin_therapy_in_phase_ii_347506REGN727 binds to PCSK9, a new target for lowering LDL cholesterol 10 Nov 2011http://www.pmlive.com/pharma_news/astrazeneca_fails_to_win_nice_backing_for_breast_cancer_drug_faslodex_347529Pharma company couldn't persuade UK's cost effectiveness body its drug was better than existing treatments http://www.thedirectorylive.com/smart_thinking/smart_thinking_archive/eurovision/amnog_trick_or_treatIt’s referred to as the “reorganisation of the pharma market”. What exactly are the implications of the German AMNOG legislation, adopted by Bundestag (the national parliament), and will other countries follow suit? 10 Nov 201111 Nov 2011http://www.pmlive.com/pharma_news/teva_planning_to_cut_1,500_jobs_at_cephalon_347831If confirmed the plans would see a 35 per cent reduction in Cephalon's workforce 11 Nov 2011http://www.pmlive.com/pharma_news/genzyme_appoints_ms_and_rare_diseases_business_leaders_347869William Sibold will head the multiple sclerosis business and Rogério Vivaldi will lead rare diseases 11 Nov 2011http://www.pmlive.com/pharma_news/lundbeck_forges_multi-billion_dollar_cns_alliance_with_otsuka_347874Signs deal to market a portfolio of new central nervous system drugs 11 Nov 2011http://www.pmlive.com/pharma_news/merck_says_late-stage_research_pipeline_looking_good_347878Shrugs off development disappointment after FDA declined to approve its new oral contraceptive and glaucoma drugs http://www.thedirectorylive.com/smart_thinking/smart_thinking_archive/feature_articles/the_voice_of_society_and_brand_positioningIs your brand development strategy based on individual brand values and patient needs? In this web-savvy era, your company’s corporate values may be more pivotal than ever in how your product is perceived 14 Nov 201114 Nov 2011http://www.pmlive.com/pharma_news/idea_pharma_taps_astellas_and_xention_for_new_recruits_348839 The phase II strategy consultancy appoints four new members of staff, including Astellas’ Amy Wasserman and Xention’s Calum Graham 14 Nov 2011http://www.pmlive.com/pharma_news/xarelto_prospects_boosted_by_data_in_acute_coronary_syndrome_348974Trial showed Bayer and Johnson &amp; Johnson's antithrombotic drug cut heart attacks, strokes and cardiovascular deaths 14 Nov 2011http://www.pmlive.com/pharma_news/abbott_targeted_over_pricing_of_its_aids_drug_kaletra_348985Health campaigners argue the pharma company has a 'monopolistic' hold on the drug 14 Nov 2011http://www.pmlive.com/pharma_news/apixaban_no_better_than_enoxaparin_for_vte_prevention_348986 Disappointment for Pfizer and Bristol-Myers Squibb's Eliquis (apixaban) in anticoagulant trial14 Nov 2011 Independent agency Langland has scooped 18 trophies at the prestigious CLIO Healthcare Awards, held on November 10 in New York City. Three Silvers for work on behalf of Gilead and Bayer, one Silver for LEO Pharma and 15 Bronzes across a range of clients and categories were awarded to the UK agency 15 Nov 2011http://www.pmlive.com/pharma_news/pharmalink_appoints_new_chairman_anders_wiklund_349125The Swedish specialty pharma company has also appointed Elisabeth Lindner to its board of directors 15 Nov 2011http://www.pmlive.com/pharma_news/novartis_hit_by_generic_competition_for_diovan_in_the_uk_as_the_drugs_eu_patents_fall_349154Actavis launches generic valsartan on the first day patent protection expired across a number of EU member states 15 Nov 2011http://www.pmlive.com/pharma_news/sanofis_multaq_hazardous_in_permanent_atrial_fibrillation_349161Final results of the PALLAS trial confirm risk of death and cardiovascular events 15 Nov 2011http://www.pmlive.com/pharma_news/sanofis_lemtrada_outperforms_merck_seronos_rebif_in_a_head-to-head_trial_349165Phase III trial results could see Sanofi file for US and European approvals in the first quarter of 2012 15 Nov 2011http://www.pmlive.com/pharma_news/dyax_withdraws_its_european_application_for_hereditary_angioedema_treatment_kalbitor_349172US biotech unable to provide sufficient data to support its hereditary angioedema drug for EU approval http://www.thedirectorylive.com/ad_lib/articles/e-patient_connections_streets_of_philadelphia<p> This time 700 ice sculptures hit the mark in Xavier Sanchez’s view. Three e-campaigns have caught his eye… </p>16 Nov 201115 Nov 2011http://www.pmlive.com/pharma_news/boehringer_ingelheim_to_build_$65m_us_research_facility_349197Will add new R&amp;D operations to its US headquarters in Connecticut 16 Nov 2011http://www.pmlive.com/pharma_news/merck_kgaa_appoints_joachim_christ_as_head_of_corporate_controlling_349211He will report to the German pharma company's chief financial officer Matthias Zachert http://www.thedirectorylive.com/smart_thinking/smart_thinking_archive/feature_articles/get_stuck_into_digital_the_right_way!How to execute digital: First in&nbsp;a new series&nbsp;from Faisal Ahmed&nbsp;explaining the practical steps on how pharma can use digital technology16 Nov 201116 Nov 2011http://www.pmlive.com/pharma_news/actavis_poaches_sanofis_dan_ivan_for_country_manager_role_349290Ivan will lead the generics company's operations in Romania 16 Nov 2011http://www.pmlive.com/pharma_news/crestor_cant_top_lipitor_in_head-to-head_study_349373SATURN trial finds no difference between the statins from&nbsp;AstraZeneca and Pfizer in preventing the progression of coronary atherosclerosis16 Nov 2011http://www.pmlive.com/pharma_news/sanofi_taps_curevac_expertise_in_major_vaccine_deal_349388Germany-based biotech's 'big pharma' deal&nbsp;to develop prophylactic and therapeutic vaccine projects16 Nov 2011http://www.pmlive.com/pharma_news/amgen_wins_expanded_european_licence_for_cancer_drug_vectibix_349389EMA approves drug as a primary treatment for colorectal cancer16 Nov 2011http://www.pmlive.com/pharma_news/bayer_asia_will_account_for_11bn_of_sales_by_2015_349410Company says half of its sales in Asia will come from China 16 Nov 2011Catherine Ellis is to return to agency TBWA\Paling Walters as group account director 16 Nov 2011 EACA launches first European Advertising Certificate for young agency employees<br> 16 Nov 2011Life Healthcare Communications has recently made four new appointments, developing its client service, creative and digital teams to help support its growing client base 17 Nov 2011http://www.pmlive.com/pharma_news/eisai_fails_to_win_nice_backing_for_breast_cancer_drug_halaven_349633UK cost effectiveness body says drug has unacceptable level of side-effects 17 Nov 2011http://www.pmlive.com/pharma_news/new_ema_executive_director_guido_rasi_takes_office_349676Rasi replaces Thomas Lonngren, who left the European Medicines Agency in December last year 17 Nov 2011http://www.pmlive.com/pharma_news/rare_bone_marrow_disease_drug_approved_in_us_349694FDA says Incyte Corp allowed to market Jakafi17 Nov 2011http://www.pmlive.com/pharma_news/ucb_integrates_two_cros_into_its_clinical_trial_teams_349706Belgium pharma company agrees global research outsourcing deal with Parexel and PRA 17 Nov 2011http://www.pmlive.com/pharma_news/disappointment_for_gsk_in_first_phase_iii_trial_of_albiglutide_349707Rival drug to Novo Nordisk's Victoza fails to show non-inferiority17 Nov 2011http://www.pmlive.com/pharma_news/diabetes_care_honoured_at_quality_in_care_awards_349716Winners at the first Quality in Care Diabetes Awards included NHS organisations from across the UK 18 Nov 2011http://www.pmlive.com/pharma_news/emas_appoints_dr_neil_murray_349853He joins the UK-based contract research organisation as senior VP medicines development 18 Nov 2011http://www.pmlive.com/pharma_news/pfizer_gets_eu_approval_for_neurodegenerative_disease_drug_349918Vyndaqel authorised for the treatment of transthyretin familial amyloid polyneuropathy in Europe18 Nov 2011http://www.pmlive.com/pharma_news/european_regulator_wants_abbotts_loftyl_suspended_349921EMA says risk of serious cardiological and neurological side effects of peripheral arterial occlusive disease treatment too great 18 Nov 2011http://www.pmlive.com/pharma_news/chmp_recommends_azs_thyroid_cancer_drug_caprelsa_for_approval_349922EMA's advisory committee backs the drug's use against aggressive and symptomatic medullary thyroid cancer 18 Nov 2011http://www.pmlive.com/pharma_news/novartis_compounds_treat_malaria_in_blood_and_liver_349923New class of antimalarial compound discovered by pharma company21 Nov 2011http://www.pmlive.com/pharma_news/ema_appoints_new_head_of_finance_and_budget_349926Michael Lenihan's appointment follows the confirmation of the EMA’s new executive director Guido Rasi 21 Nov 2011http://www.pmlive.com/pharma_news/pharma_r_and_d_productivity_still_declining,_says_deloitte_350031Survey of top 12 drugmakers reveals average price of bringing drug to market increases to over $1bn with increased collaboration and transparency needed to cut costs21 Nov 2011http://www.pmlive.com/pharma_news/fda_reverses_approval_for_avastin_in_breast_cancer_350032Side effects outweigh any positive benefits of Roche’s drug according to&nbsp;US regulator21 Nov 2011http://www.pmlive.com/pharma_news/european_regulators_back_wider_indication_for_merck_seronos_rebif_350034CHMP recommends new early use indication for Merck Serono’s multiple sclerosis drug 21 Nov 2011http://www.pmlive.com/pharma_news/ema_clears_boehringers_pradaxa_despite_patient_deaths_350037Regulator won't add further restrictions to use of the anticoagulant 21 Nov 2011http://www.pmlive.com/pharma_news/chmp_recommends_early_use_of_roches_herceptin_350038EMA advisors recommend breast cancer treatment's use at an earlier stage on the condition’s progression<br> http://www.thedirectorylive.com/smart_thinking/smart_thinking_archive/feature_articles/perfect_pitchCompetitive pitches are now a fact of life that must be managed efficiently to achieve the best outcomes for clients and mitigate the risks for agencies 21 Nov 201122 Nov 2011http://www.pmlive.com/pharma_news/lilly_uk_appoints_new_corporate_affairs_director_350208Thomas Thorp promoted after field-based assignment as regional access manager 22 Nov 2011http://www.pmlive.com/pharma_news/gilead_pays_$11bn_for_pharmasset_and_its_hepatitis_c_drugs_350304US-based pharma company's acquisition will give it control of three promising oral hepatitis C drugs 22 Nov 2011http://www.pmlive.com/pharma_news/ferring_outlines_us_expansion_plans_350307Swiss pharma company to develop corporate centre in New Jersey 22 Nov 2011http://www.pmlive.com/pharma_news/pfizer_settles_overseas_bribery_allegations_350317Agrees to pay around $60m to bring federal investigations to a close 22 Nov 2011http://www.pmlive.com/pharma_news/fda_starts_review_of_lundbecks_antipsychotic_aripiprazole_350328Major milestone reached in CNS alliance between Danish pharma company and Otsuka22 Nov 2011http://www.pmlive.com/pharma_news/ema_begins_review_of_pfizers_new_rheumatoid_arthritis_drug_350329If approved tofacitinib might be used ahead of anti-TNF drugs like Humira<br>http://www.thedirectorylive.com/smart_thinking/smart_thinking_archive/feature_articles/creating_a_digital_campaign2Are your stakeholders still stuck on rhetoric – playing the waiting game before committing fully to an online presence? Skilfully interacting with a target audience simply means a change of mindset... 27 Jan 201223 Nov 2011http://www.pmlive.com/pharma_news/astrazeneca_appoints_leaders_for_its_americas_business_350427Makes Rich Fante regional VP, Americas and Marion McCourt chief operating officer of its US business 23 Nov 2011http://www.pmlive.com/pharma_news/pfizer_to_purchase_skin_care_specialist_excaliard_350572Will gain control of the US biotech's drug targets in the treatment of skin fibrosis 23 Nov 2011http://www.pmlive.com/pharma_news/andreas_pott_appointed_deputy_director_at_the_european_medicines_agency_350630He previously served as acting executive director until the appointment of Guido Rasi 23 Nov 2011http://www.pmlive.com/pharma_news/celgene_stops_trial_of_revlimid_in_prostate_cancer_350632Phase III study halted after no overall survival benefit found 23 Nov 2011http://www.pmlive.com/pharma_news/regenerons_eye_disorder_drug_eylea_wins_us_approval_350639FDA licences Lucentis competitor to treat patients with wet age-related macular degeneration http://www.thedirectorylive.com/smart_thinking/smart_thinking_archive/feature_articles/is_pharmas_mobile_budget_going_down_the_drainIt’s looking good – your app is ticking the right box in your digital strategy. But does it reflect best practice? Does it, in fact, offer value for its audience… or indeed for you? 23 Nov 201124 Nov 2011http://www.pmlive.com/pharma_news/nice_against_new_indication_for_novartis_lucentis_350794Draft guidance says the eye drug should not be used to treat visual impairment caused by macular oedema 24 Nov 2011http://www.pmlive.com/pharma_news/pmgroup_appoints_dominic_tyer_as_managing_editor_350800He joins as managing editor for Pharmaceutical Market Europe and PMLiVE 24 Nov 2011http://www.pmlive.com/pharma_news/glyn_edwards_appointed_interim_ceo_at_the_bioindustry_association_350807He takes on a leadership role at the UK industry body following the departure of Nigel Gaymond 24 Nov 2011http://www.pmlive.com/pharma_news/transcept_wins_us_approval_for_new_insomnia_drug_intermezzo_350812FDA finally clears the drug after two earlier knockbacks 24 Nov 2011http://www.pmlive.com/pharma_news/takeda_files_diabetes_combination_product_in_us_350816Seeks FDA approval for a combination of alogliptin and metformin 25 Nov 2011http://www.pmlive.com/pharma_news/astrazeneca_uk_wins_top_industry_award_at_pmea_350845In total the Anglo-Swedish pharma company took home four awards at the Pharmaceutical Marketing Excellence Awards 25 Nov 2011http://www.pmlive.com/pharma_news/patent_system_shake-up_will_follow_eu_ruling_on_spcs_350880Verdict will have 'dramatic consequences' for the pharma industry in Europe 25 Nov 2011http://www.pmlive.com/pharma_news/nice_rejects_three_bowel_cancer_drugs_350885Merck's Erbitux, Roche's Avastin and Amgen's Vectibix fail to win backing of UK's cost-effectiveness watchdog 25 Nov 2011http://www.pmlive.com/pharma_news/ex-pfizer_and_az_employees_launch_start-ups_at_biocity_nottingham_350899European bioscience business centre also appoints Louis Nisbet as chairman 25 Nov 2011http://www.pmlive.com/pharma_news/uk_personalised_cancer_treatment_initiative_begins_patient_recruitment_350900Stratified Medicine Programme has pharma industry backing from Pfizer and AstraZeneca 25 Nov 2011http://www.pmlive.com/pharma_news/russia_signs_healthcare_reform_bill_into_law_350902Changes set to make a considerable impact on the country's pharmaceutical sector 28 Nov 2011http://www.pmlive.com/pharma_news/ucb_appoints_peter_theil_head_of_non-clinical_development_351000He joins the Belgium pharma company from Genentech 28 Nov 2011http://www.pmlive.com/pharma_news/uk_switches_from_gsks_cervarix_to_mercks_gardasil_for_hpv_vaccine_351026Department of Health opts to replace GSK’s Cervarix with vaccine that offers protection against both cervical cancer and genital warts28 Nov 2011http://www.pmlive.com/pharma_news/novartis_wins_european_approval_for_triple_blood_pressure_pill_351131Rasitrio combines the pharma company's Rasilez/Tekturna (aliskiren) with two generic antihypertensive drugs 28 Nov 2011http://www.pmlive.com/pharma_news/phase_iii_trial_of_bayer_and_regenerons_eye_drug_begins_in_china_351135VEGF-Trap-Eye (aflibercept) drug candidate to be studied in patients with wet age-related macular degeneration (AMD)28 Nov 2011http://www.pmlive.com/pharma_news/elan_launches_neuroscience_research_centre_with_cambridge_university_351144Says UK venture could lead to a therapeutic class 'no one has thought possible before'28 Nov 2011http://www.pmlive.com/pharma_news/roche_opens_$271m_research_plant_in_basel_351145Swiss pharma company's new centre will investigate and develop pharmaceutical formulations for new active ingredients 29 Nov 2011http://www.pmlive.com/pharma_news/gsk_adds_diagnostic_test_for_lung_cancer_vaccine_candidate_351357Extends personalised medicine deal with Abbott, adding an additional companion diagnostic test for early-stage candidate 29 Nov 2011http://www.pmlive.com/pharma_news/az-bms_win_new_eu_indication_for_diabetes_drug_onglyza_351359 AstraZeneca and Bristol-Myers Squibb's treatment approved for use as a combination therapy with insulin to improve blood sugar control in adult patients with type 2 diabetes29 Nov 2011http://www.pmlive.com/pharma_news/gileads_triple_hiv_pill_cleared_in_europe_351416Eviplera recommended by EMA for use as a single, once-daily tablet29 Nov 2011http://www.pmlive.com/pharma_news/ipsen_stake_in_inspiration_reaches_41_per_cent_as_haemophilia_trial_starts_351417Enrolment of first patient into trial of OBI-1 triggers $25m purchase by Ipsen of Inspiration's stock29 Nov 2011http://www.pmlive.com/pharma_news/cerenis_appoints_dr_john_paolini_as_chief_medical_officer_351433He will be responsible for the strategic planning and execution of the biopharmaceutical company's clinical trials 29 Nov 2011http://www.pmlive.com/pharma_news/nice_recommends_bms-pfizers_eliquis_after_fast-track_appraisal_351435Final draft guidance backs Bristol-Myers Squibb and Pfizer's anticoagulant to prevent venous thromboembolism in adults http://www.thedirectorylive.com/smart_thinking/smart_thinking_archive/eurovision/standing_on_the_shoulders_of_giantsHas a world where we are ring fenced by financial and legal scrutiny brought us to a safe area where over-cautiousness prevails? Max Jackson reflects on those who contribute a colourful sense of ingenuity and bravado… 29 Nov 201130 Nov 2011http://www.pmlive.com/pharma_news/fda_will_give_bms-pfizers_eliquis_a_priority_review_351555 US regulator the Food and Drug Administration grants Bristol-Myers Squibb and Pfizer’s oral anticoagulant an accelerated review<br>30 Nov 2011http://www.pmlive.com/pharma_news/lilly_appoints_new_corporate_affairs_director_for_ace_region_351561Richard Ascroft to head Australia, Canada and Europe at Eli Company &amp; Company30 Nov 2011http://www.pmlive.com/pharma_news/pharma_hopes_for_uk_budgets_r_and_d_tax_credits_plan_351616ABPI is positive proposals in Chancellor George Osborne's budget will encourage larger pharma firms to invest in development as the BIA calls for more measures to help smaller companieshttp://www.thedirectorylive.com/ad_lib/articles/tales_of_the_unexpected<p> Stephanie Berman reckons Roald Dahl’s storytelling can teach us much about creating ‘the unexpected’ and inspiring action </p>30 Nov 201130 Nov 2011http://www.pmlive.com/pharma_news/roche_signs_$500m_muscle_disease_research_deal_with_ptc_351621 Swiss firm teams up with US biopharmaceutical company PTC Therapeutics and SMA Foundation to research possible treatments for spinal muscular atrophy30 Nov 2011http://www.pmlive.com/pharma_news/pfizer_taps_brand_loyalty_to_protect_lipitor_from_generics_351622 Pharma firm&nbsp;launches&nbsp;series of measures aimed at encouraging prescribers and patients to stick with&nbsp;its biggest selling drug as its US patent expiry hits<br>30 Nov 2011http://www.pmlive.com/pharma_news/nice_gives_novartis_lucentis_a_final_no_for_diabetic_macular_oedema_351623Rules drug's use to treat the eye condition is not a good use of NHS resources 01 Dec 2011http://www.pmlive.com/pharma_news/novo_nordisk_to_limit_use_of_animal_testing_351641 Danish pharmaceutical company to stop the use of living animals to test medicine quality01 Dec 2011http://www.pmlive.com/pharma_news/new_chief_scientific_officer_at_rhythm_351647US-based biopharma names former head of obesity research at Merck, Dr Lex Van der Ploeg, as chief scientific officer01 Dec 2011http://www.pmlive.com/pharma_news/european_medicines_agency_to_revise_biosimilars_guideline_351649Regulator's advisors suggest clarifying the principles of biosimilarity 01 Dec 2011http://www.pmlive.com/pharma_news/ec_unveils_80bn_r_and_d_investment_programme_351678<EM>Horizon 2020</EM> scheme designed to tackle ‘innovation emergency’ welcomed by European Federation of Pharmaceutical Industries &amp; Associations 01 Dec 2011http://www.pmlive.com/pharma_news/medicines_patent_pool_marks_world_aids_day_with_pharma_progress_351680Begins sub-licensing Gilead Sciences' patents and is negotiating with Boehringer, BMS, Roche and ViiV 01 Dec 2011http://www.pmlive.com/pharma_news/novartis_spat_with_german_wholesalers_escalates_351681Pharma company halts supplies to Phoenix Pharmahandel, Sanacorp and Celesio subsidiary GEHE Pharma Handel01 Dec 2011http://www.pmlive.com/pharma_news/ranbaxy_begins_generic_onslaught_for_pfizers_lipitor_in_the_us_351682Launches the first competing generic version of Pfizer's biggest selling drug 02 Dec 2011http://www.pmlive.com/pharma_news/merck_kgaa_appoints_new_head_of_corporate_strategy_351752 Isabel De Paoli will lead global corporate strategy at the German pharma company and Merck also has a new head of corporate auditing02 Dec 2011http://www.pmlive.com/pharma_news/nice_still_set_against_novartis_ms_drug_gilenya_351779 Pharma company fails to sway the UK watchdog with a patient access scheme for its oral multiple sclerosis treatment02 Dec 2011http://www.pmlive.com/pharma_news/european_commission_consults_on_unique_identifiers_for_medicines_351875Seeks comment on concept paper that outlines anti-counterfeiting options, including a new barcode for pharma packaging 02 Dec 2011http://www.pmlive.com/pharma_news/astellas_boosts_us_antibody_centre_with_new_hires_351923Wolfgang Noe and Frank Hudson join pharma company's Santa Monica affiliate Agensys 02 Dec 2011http://www.pmlive.com/pharma_news/lilly_puts_diabetes_management_under_the_spotlight_351927Will fund major international study to explore why patients sometimes fail to reach their blood sugar targets 02 Dec 2011http://www.pmlive.com/pharma_news/gsk_submits_more_data_on_menhibrix_to_fda_351929Files additional information in a bid to get the marketing application for its meningitis vaccine back on track 05 Dec 2011http://www.pmlive.com/pharma_news/pfizer_finalises_deals_for_ferrosan_consumer_health_and_excaliard_352018US pharma company completes purchase of skincare specialist Excaliard Pharmaceuticals and dietary and lifestyle firm Ferrosan05 Dec 2011http://www.pmlive.com/pharma_news/aptiv_solutions_promotes_dr_phil_birch_and_carolyn_belcher_352029The US contract research organisation said the appointments fill key strategic posts<br>05 Dec 2011http://www.pmlive.com/pharma_news/uk_pledges_181m_for_life_sciences_overhaul_352168Prime Minister David Cameron announces reforms to build relationship between industry and the NHS05 Dec 2011http://www.pmlive.com/pharma_news/bms_and_tibotec_plan_all-oral_hepatitis_c_regimen_352169Bristol-Myers Squibb to partner with J&amp;J subsiduary&nbsp;for combination drug&nbsp;to elimate use of needles in HCV treatment05 Dec 2011http://www.pmlive.com/pharma_news/astrazeneca_gives_uk_researchers_access_to_compounds_352179 Pharma firm grants free access to 22 compounds as part of agreement with UK's Medical Research Council 05 Dec 2011http://www.pmlive.com/pharma_news/takeda_eyes_vaccines_growth_in_2012,_plans_new_business_launch_352180Japanese pharma company's new global vaccines division will be led by Dr Rajeev Venkayya 06 Dec 2011http://www.pmlive.com/pharma_news/ali_alloueche_to_lead_business_strategy_at_austrian_biopharma_affiris_352318 Former GSK and Novartis man Ali Alloueche will take over new chief business officer position established to deal with Affiris' growing pipeline of vaccines05 Dec 2011Langland and Torre Lazur McCann in New York Global Award wins<br> 06 Dec 2011http://www.pmlive.com/pharma_news/novartis_galvus_gets_new_european_approval_352389 Diabetes drug licensed for use in type 2 patients with moderate or severe renal failure06 Dec 2011http://www.pmlive.com/pharma_news/fda_report_questions_efficacy_of_pfizers_kidney_cancer_drug_inlyta_352432 Report comes ahead of advisory committee meeting to review the pharma company's marketing application for Inlyta06 Dec 2011http://www.pmlive.com/pharma_news/roche_acquires_german_diagnostics_company_verum_for_11m_352434Move is part of the Swiss pharma company's plans to build a comprehensive coagulation testing portfolio 06 Dec 2011http://www.pmlive.com/pharma_news/uk_industry_welcomes_life_sciences_reforms_352436Leading life sciences organisations say plans will increase research opportunities and speed access to drugs for patients 06 Dec 2011http://www.pmlive.com/pharma_news/merck_pledges_$1.5bn_for_china_expansion_352516Revels plans for a new drug discovery and development facility in Beijing 07 Dec 2011http://www.pmlive.com/pharma_news/merck_and_co_promotes_roger_pomerantz_to_knowledge_management_role_352551Former global head of infectious diseases assumes new role at the US pharma company 07 Dec 2011http://www.pmlive.com/pharma_news/mhra_launches_pharmacovigilance_consultation_352594Medicines regulator seeks views on draft regulations transposing EU rules into UK law 07 Dec 2011http://www.pmlive.com/pharma_news/uk_regenerative_medicine_projects_get_8.5m_boost_352660Cell Medica, Intercytex and Lonza Biologics among the companies to benefit 07 Dec 2011http://www.pmlive.com/pharma_news/nice_backs_two_novartis_cml_drugs_bms_denied_352679Glivec and Tasigna approved by UK authorities for use in the NHS for the treatment of chronic myeloid leukaemia as Sprycel turned down for lack of cost-effectiveness07 Dec 2011http://www.pmlive.com/pharma_news/ukraine_modifies_medicines_law_352693Data exclusivity protection for innovative medicines to be limited in line with international standards08 Dec 2011http://www.pmlive.com/pharma_news/china_plans_to_improve_drug_safety_352894Increased monitoring and new credit system planned to improve safety levels of pharmaceutical products in country with troubled record08 Dec 2011http://www.pmlive.com/pharma_news/more_job_cuts_for_astrazeneca_in_us_352949Around 1,150 sales jobs to go as company copes with patent cliff and changing approach to sales08 Dec 2011http://www.pmlive.com/pharma_news/fda_panel_backs_pfizers_inlyta_for_kidney_cancer_352950Unanimous recommendation from oncology panel for VEGF inhibitor&nbsp;despite previous reservations08 Dec 2011http://www.pmlive.com/pharma_news/deepak_khanna_to_take_over_as_abpi_president_352951Merck Sharp &amp; Dohme MD will assume additional role at the UK industry association in April 08 Dec 2011http://www.pmlive.com/pharma_news/russian_healthcare_reforms_the_implications_for_pharma_352963Clinical trials, pharmaceutical manufacturing, medical devices and sales activities all face changes in the country 08 Dec 2011http://www.pmlive.com/pharma_news/astrazeneca_to_buy_chinese_generics_firm_352964Acquisition of Guangdong BeiKang follows the Anglo-Swedish pharma company’s $200m investment in Chinese manufacturing facility09 Dec 2011http://www.pmlive.com/pharma_news/ec_proposes_centralised_procurement_for_european_vaccine_contracts_353078Announces wide ranging plan for dealing with cross-border public health threats09 Dec 2011http://www.pmlive.com/pharma_news/roches_dr_hagen_pfundner_elected_chairman_of_vfa_353082German pharmaceutical industry association also appoints Pfizer's Dr Andreas Penk as deputy chairman09 Dec 2011http://www.pmlive.com/pharma_news/novartis_afinitor_sees_positive_trial_results_in_breast_cancer_353140Data indicating extended progression-free survival in women bring cancer drug closer towards new indication09 Dec 2011http://www.pmlive.com/pharma_news/roches_pertuzumab_potential_major_advance_in_breast_cancer_353172Adding drug to regimen of Herceptin and docetaxel sees significant progression-free survival in phase III trial09 Dec 2011http://www.pmlive.com/pharma_news/eu_approval_for_takedas_once-daily_hypertension_drug_edarbi_353217Japan-based company to launch the high blood pressure treatment across Europe in 201209 Dec 2011http://www.pmlive.com/pharma_news/janssen_biotech_signs_$975m_deal_to_buy_into_new_oral_cancer_drug_353218US biopharmaceutical company Pharmacyclics could receive almost $1bn if all milestones are met 09 Dec 2011http://www.pmlive.com/pharma_news/pmlive_launches_healthcare_glossary_353234Search over 800&nbsp;terms covering&nbsp;the entire industry, from&nbsp;R&amp;D and pricing to digital and marketing12 Dec 2011http://www.pmlive.com/pharma_news/european_pharma_industry_calls_for_robust_hta_framework_353241Healthcare bodies including pharma association EFPIA seek a more transparent framework for health technology assessment12 Dec 2011http://www.pmlive.com/pharma_news/torbjrn_ye_steps_in_as_cfo_of_photocure_353246Norwegian biotech appoints interim replacement for Christian Fekete12 Dec 2011http://www.pmlive.com/pharma_news/fda_panel_backs_bayers_yazyasmin_warns_over_blood_clots_353384Advisory committee recommends label change for oral contraceptive to indicate increased risk of blood clots, but benefits still outweigh risks 12 Dec 2011http://www.pmlive.com/pharma_news/gsks_tykerb_misses_breast_cancer_trial_endpoint_353394Phase III trial doesn’t support use of rival to Herceptin for treatment in early-stage HER2-positive breast cancerhttp://www.thedirectorylive.com/smart_thinking/smart_thinking_archive/feature_articles/digital_hot_topicsAs the pharmaceutical industry enters 2012, what are the three main aspects that it should be considering when developing strategy in an increasingly social online space? 12 Dec 201112 Dec 2011http://www.pmlive.com/pharma_news/nice_wants_more_clinical_data_for_msds_daxas_353437UK cost-effectiveness body wants a new trial for the company's COPD drug12 Dec 2011http://www.pmlive.com/pharma_news/roches_anti-obesity_drug_xenical_faces_generic_competition_in_uk_353467Teva launches first generic version of orlistat 12 Dec 2011Ed Shorthose joins wooley pau gyro as managing director<br> 13 Dec 2011http://www.pmlive.com/pharma_news/where_does_pharma_stand_with_patient_engagement_353626Social media guidance, clarity of message and role of patient organisations revealed as concerns for UK industry13 Dec 2011http://www.pmlive.com/pharma_news/katherine_baicker_to_join_lillys_board_of_directors_353631 Former US government health policy adviser to serve on US pharma company's public policy and compliance committee13 Dec 2011http://www.pmlive.com/pharma_news/ema_and_fda_to_conduct_joint_pharma_manufacturing_inspections_353708Initiative will allow regulators to shift resources to other regions13 Dec 2011http://www.pmlive.com/pharma_news/roches_blood_cancer_antibody_outperforms_mabthera_353709GA101 (obinutuzumab)&nbsp;more effective than&nbsp;MabThera/Rituxan in a head-to-head study in patients with non-Hodgkin's lymphoma13 Dec 2011http://www.pmlive.com/pharma_news/ec_approves_first-in-class_antibiotic_dificlir_353718Astellas' treatment for Clostridium difficile infection granted marketing authorisation in the EU13 Dec 2011http://www.pmlive.com/pharma_news/abbott_agrees_$400m_chronic_disease_deal_with_reata_353736Will collaborate on oral treatments for pulmonary and central nervous system disorders and in immunology14 Dec 2011http://www.pmlive.com/pharma_news/ian_read_elected_chairman_of_pfizer_353786 Current president and CEO adds chairman of the board to his list of roles at the US pharmaceutical company<br>http://www.thedirectorylive.com/smart_thinking/smart_thinking_archive/thought_leaders/can_pharma_marketing_be_truly_agile_337835Why is it so difficult for pharma to understand the greatest advantage of the digital age? 13 Dec 201114 Dec 2011http://www.pmlive.com/pharma_news/elan_partners_with_university_on_biotech_leadership_programme_353837 Will help fund programme to develop the next generation of biotech business leaders14 Dec 2011http://www.pmlive.com/pharma_news/mercks_zolinza_clears_phase_iii_trial_in_multiple_myeloma_353882Skin cancer treatment improves progression-free survival when used with Takeda’s Velcade14 Dec 2011http://www.pmlive.com/pharma_news/roche_discounts_roactemra_but_only_gets_limited_nice_recommendation_353884Drug can be used for juvenile arthritis if previous treatments haven’t worked 14 Dec 2011http://www.pmlive.com/pharma_news/bms_signs_cardiovascular_research_deal_with_chinas_simcere_353886Companies widen their existing oncology collaboration in cardiovascular disease<br>http://www.thedirectorylive.com/smart_thinking/smart_thinking_archive/eurovision/following_yonder_star The legends tell us that this is the time of year when Wise Men look for meanings in the heavens, and long foretold prophesies come to life. So it’s a fitting season to once again look at the long foretold but so far elusive 'Information for Patients' legislation at the European Commission and Parliament… 14 Dec 201114 Dec 2011http://www.pmlive.com/pharma_news/fda_panel_backs_alexzas_inhaled_antipsychotic_drug_353900Narrow recommendation for Adasuve after re-filed marketing applicationhttp://www.thedirectorylive.com/ad_lib/articles/the_proof_is_in_the_pudding<p> Are we getting the message across asks Neil Padgett? Three ads and one falls short for Neil, who gives it a one-star rating</p> 14 Dec 201115 Dec 2011http://www.pmlive.com/pharma_news/astrazeneca_appoints_lisa_anson_uk_country_president_354004One of her priorities will be to build relationships with the NHS15 Dec 2011http://www.pmlive.com/pharma_news/european_commission_more_science_students_needed_in_europe_354024Invests €8.3m to increase numbers of maths and science students15 Dec 2011http://www.pmlive.com/pharma_news/bayer_files_three-year_contraceptive_device_in_us,_europe_354045Intrauterine system potentially low-hormone alternative to company's Mirena15 Dec 2011http://www.pmlive.com/pharma_news/report_suggests_gsk_on_brink_of_consumer_health_sale_354046US private equity firm Thomas H Lee Partners seen as lead candidate to take over various brands including Alli, Solpadeine and Zantac15 Dec 2011http://www.pmlive.com/pharma_news/almirall_launches_solaraze_in_spain_354047Pharma company says move strengthens its dermatology business strategy 15 Dec 2011http://www.pmlive.com/pharma_news/boehringer_makes_70m_manufacturing_investment_in_china_354048 German company to expand Shanghai facility in response to the growing Chinese market 15 Dec 2011http://www.pmlive.com/pharma_news/russian_market_for_lung_cancer_drugs_to_hit_$163m_by_2015_354060Analysts predict three per cent sales growth for non-small cell lung cancer drugs 16 Dec 2011http://www.pmlive.com/pharma_news/roche_promotes_sophie_kornowski-bonnet_to_head_of_partnering_354076The current general manager of Roche Pharma, France, Kornowski-Bonnet takes over from Dan Zabrowski who moves to a new role at the company<BR>16 Dec 2011http://www.pmlive.com/pharma_news/novartis_releases_trial_results_backing_gilenya_safety_profile_354124Data comes just days after a patient died after starting on the MS treatment<br>16 Dec 2011http://www.pmlive.com/pharma_news/vertex_appoints_jeffrey_leiden_ceo_354166He will start at the US pharma company in February 16 Dec 2011http://www.pmlive.com/pharma_news/azs_brilique_is_first_drug_backed_under_germanys_new_pricing_system_354208Federal Joint Committee gives positive opinion for drug in treatment of patients with acute coronary syndromes16 Dec 2011http://www.pmlive.com/pharma_news/ema_confirms_safety_profile_for_growth_hormone_354219Regulator investigated somatropin-containing medicines after study raised mortality fears16 Dec 2011http://www.pmlive.com/pharma_news/merck_and_roche_team_up_for_hepatitis_c_studies_354222Pharma companies to test marketed and investigational drugs in series of clinical trials19 Dec 2011http://www.pmlive.com/pharma_news/amgen_ceo_kevin_sharer_to_step_down_in_2012_354228 President and chief operating officer Robert Bradway will replace Sharer at the biotech in May19 Dec 2011http://www.pmlive.com/pharma_news/valeant_mounts_hostile_bid_for_ista_pharmaceuticals_354351Potential 12th acquisition for Canada-based pharma company in 201119 Dec 2011http://www.pmlive.com/pharma_news/gsk_and_pfizer_expand_pneumococcal_vaccination_programme_354352Discounted Prevenar 13 and Synflorix to be used by Global Alliance for Vaccines and Immunisation (GAVI)19 Dec 2011http://www.pmlive.com/pharma_news/chugai_sets_up_antibody_research_company_in_singapore_354353Chugai Pharmabody Research will focus on generating new antibody drugs 19 Dec 2011http://www.pmlive.com/pharma_news/roches_skin_cancer_drug_zelboraf_recommended_in_eu_354354CHMP gives positive opinion for drug's use in advanced melanoma19 Dec 2011http://www.pmlive.com/pharma_news/european_recommendation_for_galvus_monotherapy_license_354355CHMP issues positive opinion for Novartis' diabetes drug 20 Dec 2011http://www.pmlive.com/pharma_news/bayers_anticoagulant_xarelto_wins_new_european_indications_354386 Gets new approvals in thromboembolism, giving it a potential advantage over Pfizer and Bristol-Myers Squibb's Eliquis20 Dec 2011http://www.pmlive.com/pharma_news/konstantin_linnik_to_head_ip_strategy_at_idea_pharma_354393Former senior corporate counsel at Pfizer joins clinical stage strategy consultancy as general counsel and principal IP strategist20 Dec 2011http://www.pmlive.com/pharma_news/ex-head_of_ema_set_up_consultancy_while_still_in_office_354417Thomas Lonngren faces criticism from transparency pressure groups20 Dec 2011http://www.pmlive.com/pharma_news/fda_warns_over_heart_risk_of_multaq_354418US regulator adds safety warning for patients with atrial fibrillation to label of Sanofi’s drug&nbsp;following review20 Dec 2011http://www.pmlive.com/pharma_news/az_takes_$381.5m_hit_on_two_late-stage_trial_failures_354436 Will drop ovarian cancer treatment olaparib and scale back ambitions for depression drug TC-5214<br>21 Dec 2011http://www.pmlive.com/pharma_news/john_thievon_named_president_of_dey_pharma_354507 Former CEO of MiddleBrook Pharmaceuticals to help lead Mylan's integrated speciality pharmaceutical division<br>21 Dec 2011http://www.pmlive.com/pharma_news/ema_to_set_up_network_of_european_healthcare_professional_organisations_354515Plans to improve contact in order to get better advice on medical matters23 Dec 2011http://www.pmlive.com/pharma_news/antoni_villaro_joins_ferrer_as_chief_operating_officer_354521He will report to the Spanish pharmaceutical company's CEO Jordi Ramentol 21 Dec 2011http://www.pmlive.com/pharma_news/amgen-watson_to_collaborate_on_cancer_biosimilars_354539US biotech signs oncology deal with generics manufacturer22 Dec 2011http://www.pmlive.com/pharma_news/novocure_recruits_trio_of_ex-osi_pharmaceuticals_executives_354540Peter Melnyk, Angela Davies and Laura Benson join company's global commercialisation team 21 Dec 2011http://www.pmlive.com/pharma_news/novartis_hopes_of_blockbuster_status_for_rasilez_dashed_354578Promotion of aliskiren products&nbsp;in combination with an ACE inhibitor or ARB to cease after&nbsp;adverse events cause trial in high risk patients to end21 Dec 2011http://www.pmlive.com/pharma_news/gsk_fails_to_find_global_buyer_for_otc_brand_portfolio_354581Does £426m deal with Prestige Brands Holding for some US and Canada rights21 Dec 2011http://www.pmlive.com/pharma_news/trial_finds_sanofis_teriflunomide_no_better_than_rebif_354582Oral multiple sclerosis drug candidate fails to gain advantage over Novartis’ oral treatment Gilenyahttp://www.thedirectorylive.com/smart_thinking/smart_thinking_archive/thought_leaders/local_knowledge_is_power_337949Even the most advanced global strategy is liable to fail without local input and expertise 21 Dec 2011http://www.thedirectorylive.com/smart_thinking/smart_thinking_archive/thought_leaders/the_future_aint_what_it_used_to_be_338168Planning will ensure we won't lose momentum in the highly likely event of future digital changes 21 Dec 2011http://www.thedirectorylive.com/smart_thinking/smart_thinking_archive/thought_leaders/stop_talking_and_listen_to_the_numbers_338199Marketers need to filter out unnecessary digital discussions and focus on the evidence 03 Jan 201222 Dec 2011http://www.pmlive.com/pharma_news/daiichi_halves_profit_forecast_after_$500m_manufacturing_settlement_354680Issues at company’s Ranbaxy generic unit lead to US charge22 Dec 2011http://www.pmlive.com/pharma_news/az_moves_to_strengthen_diabetes,_cancer_pipelines_354694Asian deals come after setbacks for investigational cancer and depression treatments22 Dec 2011http://www.pmlive.com/pharma_news/bayer_points_to_four_blockbusters_in_portfolio_354695Company expects "substantial sales" from upcoming launches; invests in R&amp;D22 Dec 2011http://www.pmlive.com/pharma_news/merck_ends_alzheimers_deal,_partners_with_exelixis_354700Terminates agreement with Acumen and switches focus to R&amp;D programme for inflammation and oncology23 Dec 2011http://www.pmlive.com/pharma_news/takeda_expands_cancer_pipeline_with_intellikine_purchase_354772Gains two investigational compunds in $310m purchase23 Dec 2011http://www.pmlive.com/pharma_news/disappointment_for_bms_over_brivanib_phase_iii_failure_354835Drug unable to improved overall survival in form of liver cancer23 Dec 2011http://www.pmlive.com/pharma_news/eu,_canada_probe_rasilez_safety_after_study_termination_354836Investigation after Novartis drug linked to high levels of adverse events in high-risk patient trial23 Dec 2011http://www.pmlive.com/pharma_news/pharmas_biggest_news_stories_in_2011_354863What were the key events over the past 12 months for the pharmaceutical industry?http://www.thedirectorylive.com/smart_thinking/smart_thinking_archive/thought_leaders/the_importance_of_tradition_in_a_digital_world_338227How other business sectors show us the importance of marketing principles in our new digital world 10 Jan 2012http://www.thedirectorylive.com/smart_thinking/smart_thinking_archive/thought_leaders/braving_uncharted_waters_338236Low risk ways for pharmaceutical companies to keep a toe-hold in social media do exist 12 Jan 2012http://www.thedirectorylive.com/smart_thinking/smart_thinking_archive/eurovision/food_for_thought <p> By now most of us have eaten our last plate of cold turkey, recycled the Christmas tree, and exchanged the five identical sweaters given us by loving friends and family. So it’s timely, I felt, to come up with three resolutions that can help us bring our minds back to business, and our focus to the year ahead. </p> 04 Jan 2012http://www.thedirectorylive.com/ad_lib/articles/stop_advertising,_start_socialising! Social media thought leader, Ángel Gonzalez, reviews Lilly, Janssen and Leo Pharma eMarketing campaigns&nbsp; 05 Jan 2012http://www.thedirectorylive.com/smart_thinking/smart_thinking_archive/feature_articles/the_future_starts_here_agency_new_year_resolutionsA new year always gives a feeling of hope: on both a personal and business level. What should agencies be resolving for 2012? I reckon these three New Year resolutions stand out from the rest. &nbsp; 06 Jan 2012http://www.thedirectorylive.com/smart_thinking/smart_thinking_archive/feature_articles/How_to_build_a_website_for_use_in_a_pharma_marketing_strategyHow to execute digital:&nbsp;Faisal Ahmed explains&nbsp;how to&nbsp;build&nbsp;a website&nbsp;to&nbsp;represent your brand16 Jan 2012http://www.thedirectorylive.com/smart_thinking/smart_thinking_archive/eurovision/LifesaPitch<p> Our Spanish agency made 70 face-to-face pitches last year. So, are economical constraints pushing pharma marketers and their procurement colleagues to adopt an approach to tendering work that’s counterproductive? </p> 19 Jan 2012http://www.thedirectorylive.com/ad_lib/articles/the_role_of_a_creative_agency<p>Three five-star reviews from Bruno Cepollina, who thinks agencies risk becoming implementers rather than creative problem solvers. So which global campaigns inspired Bruno?</p>20 Jan 201220 Jan 2012<br>20 Jan 201223 Jan 201223 Jan 201223 Jan 201224 Jan 2012http://www.thedirectorylive.com/smart_thinking/smart_thinking_archive/thought_leaders/Why_is_it_so_difficult_to_get_strategic_planning_rightStrategy is about making choices where the end game is front of mind from the start 26 Jan 201226 Jan 2012http://www.thedirectorylive.com/ad_lib/articles/in_a_world_of_change,_its_back_to_basics<p>It’s James Atherton’s specialist area – so which of three digital campaigns gets his full five stars? And, read James’s tips for increasing digital effectiveness…</p>27 Jan 201230 Jan 201230 Jan 201230 Jan 201230 Jan 201230 Jan 2012<br> 31 Jan 2012http://www.thedirectorylive.com/smart_thinking/smart_thinking_archive/eurovision/Data_goes_into_overdrive<p> Suddenly – data might be getting a whole lot more complicated… Access to your data is big business – enough to have driven up the value of Facebook phenomenally. A recently published EU proposal may set out to protect your privacy, but there’s a twist in the tale. </p>01 Feb 201201 Feb 201201 Feb 201201 Feb 201201 Feb 201202 Feb 201206 Feb 201206 Feb 201207 Feb 2012http://www.thedirectorylive.com/smart_thinking/smart_thinking_archive/feature_articles/how_to_use_seo_correctly_355469How to execute digital: Faisal Ahmed discusses the best ways pharma companies can make sure their sites are picked up by search engines08 Feb 2012http://www.thedirectorylive.com/smart_thinking/smart_thinking_archive/feature_articles/investigating_globish_368214The drive to make adverts understandable around the world by using a reduced palette of words and images is diluting the message, so a brand champion is needed to maintain the spark 09 Feb 201209 Feb 2012http://www.thedirectorylive.com/ad_lib/articles/icon<p>Hotfoot from seeing Madonna at the New York Superbowl, Stephanie Berman gives us some inspired thoughts on the power of branding</p>15 Feb 2012http://www.thedirectorylive.com/smart_thinking/smart_thinking_archive/feature_articles/dissecting_the_anatomy_of_your_brand<p>Build a sustainable – and profitable – future for an established brand. The basics of brand development will put you on the right tracks…</p>13 Apr 201221 Feb 2012http://www.thedirectorylive.com/archive_articles/astrazeneca_caprelsa_approval_advanced_medullary_thyroid_cancer_377368 European Commission's decision makes Caprelsa the first drug to be approved in Europe for advanced medullary thyroid cancer<br> http://www.thedirectorylive.com/smart_thinking/smart_thinking_archive/thought_leaders/learn_to_speak_french_352969To avoid disappearing down a blind alley we must follow the inquisitorial French 21 Feb 201221 Feb 201222 Feb 201222 Feb 201223 Feb 201227 Feb 201227 Feb 2012http://www.thedirectorylive.com/smart_thinking/smart_thinking_archive/feature_articles/can_science_be_branded_and_sold<p>It may take a sharp mind and intellect to create compelling attributes around a product’s novel insight but leveraging the science can serve you well…&nbsp;</p> 27 Feb 2012http://www.thedirectorylive.com/ad_lib/articles/blowing_their_own_trumpets<p>How three agencies have ‘blown their own trumpet’ – Andy Bell takes a look at what makes for a winning sales pitch!</p>29 Feb 2012http://www.thedirectorylive.com/smart_thinking/smart_thinking_archive/eurovision/online_disease_management_white_knight_or_white_elephant<p>Online disease management and compliance tools are proliferating at a steady rate on the web. Everyone is investing heavily – but where is it all getting us, or indeed the online users?</p> 28 Feb 201228 Feb 201228 Feb 201229 Feb 201229 Feb 201206 Mar 2012<p>New study shows that there are over 500 mobile health projects globally and that 30 per cent of smartphone users are likely to use ‘wellness apps’ by 2015</p> http://www.thedirectorylive.com/smart_thinking/smart_thinking_archive/thought_leaders/miracles_and_mistakes_353030<p> What happens when we allow conscious thought and experience to cloud our thinking? </p>06 Mar 201207 Mar 2012 <p>Gloria Gibbons, president EMEA, AP &amp; Latina of Ogilvy CommonHealth Worldwide has been elected chairman of EACA’s Health Communications Council</p> http://www.thedirectorylive.com/smart_thinking/smart_thinking_archive/feature_articles/ten_commandments_for_using_ipads_in_pharma_salesNew shiny things are often overvalued. In all the excitement about iPads, these 10 tips could keep you grounded 12 Mar 201209 Mar 2012<p>The agency is moving its chief creative officer, Amir Kassaei, and its creative headquarters from New York to China</p> 12 Mar 2012Healthcare communications network Euro RSCG Life UK has announced three new appointments as part of its commitment to “strategic growth and unified expertise”. There have been nine other new recruits to the London team in recent months 12 Mar 2012 <p><a href="http://www.dasglobal.com/" target="_blank">Diversified Agency Services</a> (owned by the Omnicom Group) is to acquire a majority stake in the highly respected Japanese online medical communications agency, Medical Collective Intelligence</p> 13 Mar 2012<p>GlaxoSmithKline engages Infosys to tackle challenges in effective online engagement and to drive its global digital strategy</p> 13 Mar 2012<p>IPA suggests that while an update to the law on data protection is sensible, it does not consider a new European-wide Regulation necessary</p> http://www.thedirectorylive.com/ad_lib/articles/painful_ads<p>Chris Duncan feels like spiking two of the three campaigns he’s chosen to review. Harsh or fair?</p>14 Mar 2012http://www.thedirectorylive.com/smart_thinking/smart_thinking_archive/feature_articles/the_new_paradigm_in_beta_mode <p>Healthcare marketing will never be the same again. More accurately, whatever is coming is much more than a new scenario; it is complete change of paradigm… </p>15 Mar 2012http://www.thedirectorylive.com/smart_thinking/smart_thinking_archive/thought_leaders/strategic_planning_rocket_science_353612… but maximising opportunities does demand new concepts and ideas 19 Mar 201222 Mar 2012<p>PAN Advertising has made four new appointments since Jon Linscott took over as MD last month. Two new hires and two promotions have bolstered the agency team.&nbsp;</p> 22 Mar 2012<p>The Department of Health (DH) has appointed Draftfcb to support the Government’s commitment to recruit an extra 4,200 full-time health visitors across England by 2015</p> 26 Mar 2012<p>As part of the ongoing ‘Get Real. Get a Prescription’ campaign, Pfizer and partners have today launched a new poster advertising campaign using Alliance Healthcare pharmacy distribution vehicles.</p> 27 Mar 2012<p>The British Heart Foundation is running ads on digital hoardings at today’s FA Cup rematch between Tottenham Hotspur and Bolton Wanderers, following the collapse of Bolton midfielder Fabrice Muamba</p> 29 Mar 2012Pfizer has taken an 11-week Anadin breakfast promotion campaign on Heart 106.2 FM and 95.8 Capital FM radio to target their London listeners29 Mar 2012The healthcare agency TBWA\WorldHealth is forming a strategic alliance with healthcare communications agency, CAHG. Both are part of the Omnicom Grouphttp://www.thedirectorylive.com/ad_lib/articles/cut_above_the_rest<p>Chris Eich shares his thoughts – and an Edward de Bono quote – on what makes winning creative work. Find out who gets his “creative excellence” vote?</p>02 Apr 2012http://www.thedirectorylive.com/smart_thinking/smart_thinking_archive/feature_articles/glocal_with_a_local_spin_358529How centrally developed advertising campaigns can work in local markets and taking tips from motor industry campaigns can help increase brand engagement 04 Apr 2012http://www.thedirectorylive.com/smart_thinking/smart_thinking_archive/eurovision/Open_dialogue_and_the_industry__an_unpalatable_reality <p>With the closing of Janssen’s Psoriasis 360 Facebook page – Max explains why he believes that the social interaction websites are unsuited to prescription-only products. Add your comment, to say what you think.</p> 02 Apr 201203 Apr 2012<p>The Medicines and Healthcare products Regulatory Agency (MHRA) have not upheld a complaint regarding the current national TV advertising for Voltarol Pain-eze</p> 03 Apr 2012<p>The Medicines and Healthcare products Regulatory Agency (MRHA) is inviting comments on the draft of the latest Blue Guide, Advertising and Promotion of Medicines in the UK, published today</p> 04 Apr 2012New York based multichannel ‘healthwellness’ creative agency, The CementBloc has made a number of new appointments, including a new market access lead&nbsp; 04 Apr 2012<p>Life Healthcare Communications, the second largest independent healthcare agency in the UK, has appointed Nick Douglas as digital developer</p> http://www.thedirectorylive.com/smart_thinking/smart_thinking_archive/feature_articles/port_to_starboard<p>Is a switch from procurement to advertising agency a marriage likely to fail or a match made in heaven?&nbsp;</p> 12 Apr 201205 Apr 2012<p>The cold and flu relief OTC brand Vicks DayQuil and NyQuil liquid capsules has won a Grand Ogilvy at the US 2012 Advertising Research Foundation David Ogilvy Awards for use of research to leverage advertising</p> 10 Apr 2012This coming Friday, April 13, is the deadline for entering the MM&amp;M (Medical Marketing &amp; Media) Awards 201212 Apr 2012Hanson Zandi have announced that they have taken on Damion Hampton as account director and Will Elliott as creative director12 Apr 2012The British Heart Foundation’s TV ad showing Vinnie Jones doing ‘hands-only’ cardiopulmonary resuscitation (CPR) on a victim has been cleared after 20 people complained to the ASA16 Apr 2012<p>Euro RSCG Tonic has won two Effie Awards for work completed on behalf of its client VESIcare – it’s the first time a health and wellness brand has won in the Sustained Success category and the first Effie awarded in the Healthcare Rx section for four years</p> 16 Apr 2012Concentric Pharma Advertising has announced the appointment of Jennie Fischette, former senior vice president, managing director at New York agency <a href="http://www.agencyrx.com" target="_blank">AgencyRx</a>, as the new executive vice president and director of client services 16 Apr 2012<p>Biopharma company UCB has created a ‘Parkinson’s Well-Being Map’ – a visual tool to support communication of a person’s Parkinson’s status with their healthcare team</p> 18 Apr 2012<p>McCann Worldgroup’s CFO Tara Comonte has been named Industry Innovator by Advertising Women of New York. Comonte has been CFO since September 2010</p> http://www.thedirectorylive.com/ad_lib/articles/the_good_and_the_great <p>In the melee and rush of social media, how are print ads faring? Not especially well, suggests Reg Manser, who finds three made him look twice.</p> 20 Apr 2012http://www.thedirectorylive.com/smart_thinking/smart_thinking_archive/feature_articles/the_day_i_became_a_nightmare_client<p>It was the day Phil Bartlett learnt to step off the podium, to put the batten down and allow others to think through the challenges… </p><p><br></p>23 Apr 201224 Apr 2012<p>In support of the Government’s commitment to recruit a further 4,200 full-time health visitors across England by 2015, Draftfcb in London has launched an acquisition campaign aimed at both student and qualified nurses</p> 30 Apr 2012<p>The National Bone Health Alliance has launched a national US education campaign produced by inVentiv’s GSW Worldwide</p> 30 Apr 2012<p>The CementBloc’s founding partner has been named Advertising Person of the Year at the 2012 Manny Awards in New York</p> http://www.thedirectorylive.com/smart_thinking/smart_thinking_archive/feature_articles/burden_of_proof<p>The manifestation of responsible capitalism amidst a mini technological revolution and the most serious economic challenge for half a century – how are factors like these affecting how your products are received?</p> 03 May 2012http://www.thedirectorylive.com/smart_thinking/smart_thinking_archive/eurovision/the_revolution_of_the_digital_agency <p>It seems every ‘traditional’ agency has had to have one – if only by association or acquisition. But rather than the ‘interactive agency’ ruling the world, Max Jackson sees something of a sea change…</p> 01 May 201208 May 2012 <p>The Department of Health has launched a campaign featuring advertisements by M&amp;C Saatchi and fronted by real-life GPs in TV, radio, print and online media to raise awareness of the symptoms of lung cancer&nbsp;</p> 09 May 2012Saatchi &amp; Saatchi Healthcare Innovations, based in Pennsylvania and part of the Publicis Group, has rebranded to Saatchi Science, to drive forward its specialisation skills in ‘high-science, highly complex categories’ http://www.thedirectorylive.com/ad_lib/articles/competitive_and_compelling<p>“Trajenta and Cleni – where are your persuasive powers?” asks Dominic Owens as he reviews three campaigns</p>10 May 201214 May 2012<p>Full-service agency RAPP has just launched an informative guide for pharma that offers valuable, up-to-date digital insights for the marketer with European remit</p> 15 May 2012<p>56 Dean Street, the NHS sexual health clinic in Soho, London, is offering members of the gay community the chance to design an innovative HIV or sexual health awareness ad campaign</p> 15 May 2012<p>The IPA has now submitted its views to the Government’s Alcohol Strategy inquiry. The IPA report comes on the heels of responses from ISBA, the Advertising Standards Authority and the Portman Group</p> 15 May 2012<p>The US Food and Drug Administration’s outline for a new paradigm on the availability of certain drugs over the counter could establish an entirely new access pathway for patients and pharma marketers</p> 15 May 2012<p>Clear Channel, out-of-home advertising campaign experts, have created an innovative series of ads in roadside shelters which contain living plants, to raise awareness of GlaxoSmithKline’s Piri hayfever and allergy relief range</p>16 May 2012 <p>Market-leading global information services company, <a href="http://www.wolterskluwer.com" target="_blank">Wolters Kluwer</a>, has announced that it has sold its pharma-related Source Healthcare Analytics business to private equity firm <a href="http://www.symphonytg.com" target="_blank">Symphony Technology Group (STG)</a></p> http://www.thedirectorylive.com/smart_thinking/smart_thinking_archive/feature_articles/make_it_better_the_strive_for_progress <p>A successful campaign doesn't simply say that a brand is well championed. It's an essential in getting increasingly effective drugs prescribed, and the next generation through the pipeline</p>16 May 201216 May 2012<p>OPEN Health and market access and healthcare intelligence company Harvey Walsh are to join forces, with OPEN Health taking an initial 51 per cent stake in them</p> http://www.thedirectorylive.com/smart_thinking/smart_thinking_archive/feature_articles/valuing_creativity <p>Evidence suggests that this business asset is vital in driving forward a brand's commercial success</p> 18 May 201217 May 2012<p>Thirty-one agencies have been shortlisted for the 2012 IPA Best of Health Awards. Full list of shortlisted agencies follows</p> 22 May 2012<p>Fred Turok, chair of the Government’s Public Health Responsibility Deal physical activity network has challenged all businesses to encourage staff, customers and wider communities to get more active in a blog posted on the Department of Health website</p> 22 May 2012<p>A new digital NHS Information Service for Parents has been launched. It follows two other Government initiatives: to issue £100 vouchers for parenting classes in three trial areas in England last October, and from this July the trialling of subsidised relationship support services&nbsp;</p> http://www.thedirectorylive.com/smart_thinking/smart_thinking_archive/eurovision/digital_still_the_perceived_panacea<p>Is industry stepping back from its digital foray? Maybe not entirely, but General Motors’ (GM) recent decision to “reassess” its Facebook advertising could reflect a more rational regard for the use of technology within our industry too&nbsp;</p> 23 May 201224 May 2012<p>In the same week that the NHS launched its email and text tips for new parents, a new NHS Start4Live advertising campaign launches across cinemas. The adverts will run during screenings of the Hollywood film ‘What to expect when you’re expecting’ which hits cinemas tomorrow</p> 28 May 2012<p>Life Healthcare Communications has developed its client services team with two new appointments to further support the needs of its clients</p> 30 May 2012<p>OPEN Health has announced that it has entered into a joint venture with Carwyn Jones. Jones formerly ran Doctors.net.uk, the largest network of doctors in the UK</p> 30 May 2012<p>US-based biopharmaceutical company ViroPharma has launched a Family Tree Facebook Application to help those with the inflammatory disorder, hereditary angioedema (HAE)</p> 06 Jun 2012<p>Havas Worldwide Health – the umbrella company for Euro RSCG Life and Health4Brands – has taken a majority stake in Creative Lynx, the successful UK digital health shop</p> http://www.thedirectorylive.com/ad_lib/articles/one_look_is_worth_a_thousand_words<p>Zuleika Burnett’s sharp eye is on ‘information overload’ in the form of infographics. One of three choices hits the five-star rating</p>06 Jun 2012http://www.thedirectorylive.com/smart_thinking/smart_thinking_archive/feature_articles/the_mindset_of_todays_pharma_marketer <p>Sure you aren’t still making a ‘push sales pitch’ for your brand? Siting two examples of pharma applying 'pull marketing' best practice, the path nowadays to successful marketing practice is so very different… <br><br></p> 06 Jun 201206 Jun 2012<p>Indigenus, the largest independent global network of entrepreneurial healthcare creative agencies, has re-elected Rico Viray as chairman and newly elected Florian Bernsdorf as co-chairman at the global network’s biannual forum held in Japan</p> 08 Jun 2012<p>Boehringer Ingelheim and Cancer<i>Care</i> have announced the launch of a website collaboration whereby caregivers of those coping with cancer can create a community of friends and family to help coordinate support</p> http://www.thedirectorylive.com/smart_thinking/smart_thinking_archive/feature_articles/why_doesnt_otc_care<p>With expiries aplenty and pharma having to study more closely what its generic and OTC competition is doing – and of course much talk about engaging emotionally – even OTC branding hasn’t always got it right…&nbsp;</p> 12 Jun 201218 Jun 2012<p>Francesco Raimo joins Life Healthcare as digital director, making the move from Adventis Health</p> http://www.thedirectorylive.com/ad_lib/articles/if_youre_happy_and_you_know_it,_do_some_workDean Woolley has plenty to smile about. His three choices to critique have all got five-star praise…<strike></strike> 19 Jun 201219 Jun 2012<p>Ford have launched their 2012 programme for the car company’s ‘Warriors in Pink’&nbsp; breast cancer campaign. This year 11 cancer survivors are featured in the Ford Cares initiative</p> 19 Jun 2012<p>Euro RSCG Life UK has appointed Claire Dobbs as managing director. Dobbs was previously MD at PAN Advertising</p> 20 Jun 2012<p>McCann Healthcare Worldwide has changed its name and branding to McCann Health, to reflect the broadening of its business beyond pharma</p>http://www.thedirectorylive.com/smart_thinking/smart_thinking_archive/feature_articles/kitcheners_moustache_and_the_importance_of_contextualisation<p>Before all else, giving your brand language contextualisation will help make its relationship with your audience – professional or patient – that much more valid</p>21 Jun 2012http://www.thedirectorylive.com/smart_thinking/smart_thinking_archive/eurovision/talent_when_will_we_ever_learn<p>Are we losing our future talent pool? Max can see some similarities to the previous recession…&nbsp;</p> 20 Jun 201221 Jun 2012<p>WPP is to acquire the world’s leading digital agency AKQA; while its CEO awaits outcome on pay discussions</p>21 Jun 2012<p>Pan Advertising have appointed Julia Straker from TBWA\Paling Walters as head of strategic planning</p> 25 Jun 2012<p>A new survey by IBM of the marketing industry finds 60 per cent of marketers point to their lack of alignment with their company’s IT department as the biggest obstacle to reaching its consumers via mobile advertising</p> 25 Jun 2012<p>FDA has launched a project to determine if providing information on a disease state along with specific outcomes of a drug’s approved indication affects consumer perception of that specific product</p> 25 Jun 2012<p>Amgen has today launched a campaign involving breast cancer survivor and actress Maura Tierney. A video booth will travel across the US as part of the campaign to capture personal stories</p> 29 Jun 2012<i>The winners of the 2012 IPA Best of Health Awards were announced last night with two agencies</i>, Torre Lazur McCann and The Cement Bloc named as the prestigious ‘Best of Show’&nbsp; 28 Jun 2012<p>McCann Health, part of the Interpublic Group, has announced its acquisition of <a href="http://www.doublehelixconsulting.com" target="_blank">Double Helix</a>, the global market research and market access company as a step, they say, towards providing “best market research and market access offerings in the business”&nbsp;</p> 02 Jul 2012 <p>Specialist strategic branding &amp; communications agency, Creative Leap, has added Tim Brooks – former GlaxoSmithKline consumer healthcare marketing director – to its team</p> 02 Jul 2012<p>The Public Health Advocacy Institute has written a letter of complaint to the US Federal Trade Commission over Merck’s Madagascar 3 movie involvement for their Grape-Flavoured Chewable Children’s Claritin</p> 02 Jul 2012<p>Results of a new survey by Cegedim Strategic Data show that doctors in emerging markets are more open than their colleagues to using social networking sites for professional purposes. Doctors in Italy and France are particularly slow to adopt medical community sites</p> http://www.thedirectorylive.com/ad_lib/articles/the_language_of_laughter<p>Time to lighten up just a tad with Angelo Ghidotti and Mair Dilworth’s review of three campaigns&nbsp;</p>09 Jul 201211 Jul 2012<p>The new venture will bring together all 700 TBWA digital specialists</p>12 Jul 2012<p>Grey London’s Vinnie Jones ad wins two Bronze Awards at this year’s Cannes Lions</p>16 Jul 2012<p>Today GlaxoSmithKline’s first ever consumer-facing UK corporate advertising campaign will be shown on TVs throughout the UK, highlighting its role in drug-testing at the Olympics</p> 16 Jul 2012<p>Creative agency Insight, based in Australia and New Zealand, has become a member of the Indigenus global network</p> http://www.thedirectorylive.com/smart_thinking/smart_thinking_archive/feature_articles/the_strategic_role_of_the_agency<p>In this marketing environment there is no room for late developers. Find out why tapping into an agency's insights early may give the brand growth you need.</p> 18 Jul 2012http://www.thedirectorylive.com/ad_lib/articles/emotional_intelligence<p>Emma Price wants nothing less than an emotional reaction. One campaign passes this litmus test, but one doesn’t…</p>18 Jul 201218 Jul 2012<p>The Department of Health (DoH) has announced that an awareness campaign about specific cancers will run from the end of August through into 2013, with paid-for advertising hosted on NHS Cancer Networks websites</p> http://www.thedirectorylive.com/smart_thinking/smart_thinking_archive/feature_articles/A_brand_of_our_times When Stephen Page read Kush Rach’s piece The Strategic Role of the Agency, it got him thinking about what it really means to create a brand in these times... 27 Jul 201226 Jul 2012<p> US report predicts tablets becoming the primary platform for mobile advertising, above the use of the PC</p>27 Jul 2012<p>Life Healthcare appoints copywriter Elinor Washbrook who makes the move from nitrogen, Huntsworth Health</p>27 Jul 2012<p>Global marketing services agency VCG has been awarded PS 9000:2011 for the development of pharmaceutical packaging</p><br>http://www.thedirectorylive.com/smart_thinking/smart_thinking_archive/eurovision/is_europe_heading_for_irrelevance_in_global_pharma <p>It’s a disturbing thought but is Europe becoming more and more irrelevant in the global pharmaceutical arena?</p> 02 Aug 201202 Aug 2012<p>Digital expert makes a return to GlaxoSmithKline to work on customer engagement</p> 02 Aug 2012<p>Your entries for The 2012 Rx Club Awards need to be submitted by August 9</p>06 Aug 2012<p>WPP has paved the way to meet its target of 30-40 per cent revenue derived from digital by buying a majority stake in digital marketing agency Fortune Cookie</p> http://www.thedirectorylive.com/smart_thinking/smart_thinking_archive/feature_articles/making_a_name_for_yourself <p>In an overcrowded, generic-led world, it could well be time to put more emphasis on your corporate branding. Find out why...</p> 08 Aug 201208 Aug 2012<p>Despite flat market concerns, Publicis, WPP and Omnicom report rises in profit while Publicis denies bid for Interpublic</p> 10 Aug 2012<p>The VCCP Partnership has announced the launch of new data consultancy company, Conduit.</p> 10 Aug 2012<p>Eurocom progress new pharmacy ad campaign for IPS Specials as Department of Health puts value on agenda&nbsp;</p> 12 Aug 2012http://www.pmlive.com/appointments/marketing/2012/august/euro_rscg_life_uk_expands_account_services_team<p>Lucretia King has joined Euro RSCG Life UK as client services director</p> 14 Aug 2012<p>Get your advocates involved in the solution, says customer engagement director in the Havard Business Review</p> 15 Aug 2012<p>China set to be the second largest online ad spender by 2014, with the whole of Asia-Pacific predicted to overtake Western Europe by 2013 and overall ad spend in China in 2013 set to reach nearly $53bn</p> http://www.thedirectorylive.com/ad_lib/articles/focus_on_film<p> Turn off your mobiles, while Rob Sampson and Andy James review three film clips. One of them gets “a standing ovation for this box office smash” </p>16 Aug 2012http://www.thedirectorylive.com/smart_thinking/smart_thinking_archive/eurovision/euro_one_scoop_or_two <p>A parallel between local ice cream preferences and pharma brands will make you think twice against rolling out exclusive, one-for-all global marketing plans.</p> 23 Aug 201223 Aug 2012 <p> The IPA has today issued a one-page guidance document for agencies and clients regarding procurement-led pitches and the use of e-auctions</p> http://www.thedirectorylive.com/smart_thinking/smart_thinking_archive/feature_articles/why_our_metrics_dont_add_up<p>Michel Nakache is a man with a mission. With over 35 years’ experience in the healthcare communications’ business, he believes there needs to be a step-change in the way agencies and their clients in pharma understand and measure the effectiveness of advertising and communications campaigns</p> 28 Aug 201229 Aug 2012<p>Cancer Research UK and Channel 4 are joining forces to launch ‘<a href="http://www.standuptocancer.org.uk" target="_blank" title="Stand up to Cancer">Stand Up To Cancer</a>’ in the UK. Television, music and film stars will come together in October in a new national fundraising event to galvanise the public in the fight against cancer</p> 30 Aug 2012<p>Publicis is to merge its two digital agencies, Razorfish and Publicis Healthware International. The new enterprise will be called Razorfish Healthware as of immediate effect</p> 03 Sep 2012http://www.pmlive.com/appointments/marketing/2012/september/havas_appoints_ben_davies_as_european_ceo_421330<p> Havas Worldwide Health has appointed Ben Davies as the new CEO of its European division </p>http://www.thedirectorylive.com/smart_thinking/smart_thinking_archive/feature_articles/CLM_Brings_Supermarket_Savvy_to_Pharma <p> The technology is there – pharma can now individualise its communications – through the use of closed-loop marketing. It’s all a matter of engaging customer insights. Learn from your experience as a regular supermarket shopper and put in place a similar approach to align your marketing communications to specific customer needs </p> 14 Sep 201211 Sep 2012<p>Creative agency PAN celebrated 20 years in healthcare communications with a day out at HIV charity Body &amp; Soul’s centre in North London</p> 27 Sep 2012http://www.pmlive.com/pharma_news/havas_rebrands_euro_rscg_network_430480<p>Global rebranding exercise is intended to unify Havas agencies, with all Euro RSCG Life agencies now coming under a Havas Health (formerly known as Havas Worldwide Health) umbrella, and with Euro RSCG Life becoming Havas Life</p>http://www.thedirectorylive.com/ad_lib/articles/picture_this<p> Kevin Stokes flags up three campaigns that provide a perfect union of “mad creative, cool photography, and crazy CGI skills”&nbsp; </p>05 Oct 201205 Oct 2012http://www.pmlive.com/pharma_news/clear_channel_uk_teams_up_with_mens_health_charity_movember_434884The agency will use its digital advertising network to drive awareness of men’s health http://www.thedirectorylive.com/smart_thinking/smart_thinking_archive/feature_articles/pharma_comes_out_of_the_branding_dark_ages<p>Isn't it high time that the pharma industry takes branding seriously rather than leaving it purely to their portfolio powerhouses?</p>05 Oct 201208 Oct 2012<p>John Flaherty has been appointed to the role of European director at Kane &amp; Finkel Healthcare Communications</p>09 Oct 2012http://www.pmlive.com/pharma_news/harte-hanks_launches_health_and_wellness_brand_agency_435525<p>Harte-Hanks Direct Marketing is to establish a new healthcare brand agency called TRUE Health + Wellness with Anthony Rotolo, former Draftfcb Healthcare executive vice president/creative director as its chief creative officer</p>10 Oct 2012http://www.pmlive.com/appointments/marketing/2012/october/the_cementbloc_expands_its_team<p>The CementBloc announces 15 new hires for its New York office&nbsp;</p>10 Oct 2012<p>Alex Bogusky’s first ad since leaving his highly successful role in the agency world is an animation video released today about the effects on health of consuming excess sugary drinks. Parodying Coca-Cola’s well-known polar bears, the video theme hits out at the drinks company specifically</p>16 Oct 2012http://www.pmlive.com/appointments/marketing/2012/october/woolley_pau_gyro_appoints_andy_jones_as_creative_director<p>The appointment sees founder Dean Woolley becomes executive creative director</p>http://www.thedirectorylive.com/smart_thinking/smart_thinking_archive/feature_articles/what_makes_a_brand_iconic <p>For several weeks we’ve been running the Iconic Brands survey at <i>The Directory</i> in collaboration with InterbrandHealth. Here, the agency’s creative director takes a look at Humalog and Prozac and what we can learn from their positioning and brand values</p> 18 Oct 201222 Oct 2012http://www.pmlive.com/pharma_news/nhs_trust_uses_50s-style_ad_campaign_to_spread_flu_jab_message_442284<p>Collaborates with Liverpool-based agency Splinter on immunisation adverts</p>22 Oct 2012http://www.pmlive.com/pharma_news/movember_steps_up_reach_with_uk_out-of-home_advertising_442297<p>From today the Movember mens’ health campaign delivers its message via out-of-home advertising – a first for the charity</p>24 Oct 2012http://www.pmlive.com/appointments/marketing/2012/october/langland_appoints_new_non-executive_chairman_and_board_director <p>Graeme Arkell joins the UK advertising agency and Kate Spencer is promoted</p> 25 Oct 2012http://www.pmlive.com/pharma_news/coppafeel!_charity_invites_cinema_goers_to_do_just_that_442591<p>Agency ais London brings in Gavin &amp; Stacey star Mathew Horne for cheeky voice-over</p>http://www.thedirectorylive.com/smart_thinking/smart_thinking_archive/feature_articles/Who_Do_We_Think_We_Are<p>After all these years, are we still patronising our audience at our peril?</p>29 Oct 2012http://www.thedirectorylive.com/smart_thinking/smart_thinking_archive/feature_articles/dare_to_be_different<p>As R&amp;D struggles to deliver and generic competition soars, the opportunity to differentiate your brand has never been more crucial. But how you do it? Our author, an expert on insight-driven marketing and its applications in the challenging climate ahead, gives an informed perspective…</p>29 Oct 201231 Oct 2012<p>Agencies Ogilivy &amp; Mather Singapore and Mother London each clinch an award for campaigns in healthcare at last night’s London event&nbsp;</p>http://www.thedirectorylive.com/ad_lib/articles/call_to_action_hits_and_misses<p> Click onto the video links and PDFs – and find out which of these Sara Jones believes will get an audience past ‘go’… </p>08 Nov 201201 Nov 2012http://www.pmlive.com/pharma_news/uks_change4life_health_programme_launches_drinks_tracker_app_445330<p>New smartphone app will show impact of alcohol on health</p>http://www.thedirectorylive.com/profiles/healthcare-advertising/life/white_papers_and_resources/what_is_a_qr_codeA helpful infographic explaining the basics of QR codes.02 Nov 2012http://www.thedirectorylive.com/profiles/healthcare-advertising/life/white_papers_and_resources/lifes_guide_to_search_engine_marketingA helpful infographic on s.e.o.02 Nov 2012http://www.thedirectorylive.com/smart_thinking/smart_thinking_archive/feature_articles/the_empowered_patient_and_the_pharma_brand<p>With so much evolving in how healthcare is delivered, what are the implications for the pharma marketer? For a start, if you haven’t already, put away those Magic Markers…</p>06 Nov 201218 Dec 2012http://www.thedirectorylive.com/profiles/healthcare-advertising/life/press_releases/life_crowned_communications_agency_team_of_the_year!Life was thrilled to be named ‘Communications Agency Team of the Year’ at the PharmaTimes Marketer of the Year Awards in London last week. 18 Dec 2012http://www.thedirectorylive.com/profiles/healthcare-advertising/life/press_releases/life_wins_at_the_rx_club_showIt was a night to savour for Life on 28th November 2012 at the Rx Club Show in New York where they won a total of 7 awards.06 Mar 2013http://www.thedirectorylive.com/profiles/healthcare-advertising/life/press_releases/life_expands_digital_with_new_developerLife Healthcare Communications continues to expand its digital department with the appointment of a senior software developer, strengthening its digital credentials.12 Mar 2013http://www.thedirectorylive.com/profiles/healthcare-advertising/pan/press_releases/new_associate_director_for_pan2Sarah Verhoeff has joined PAN as an Associate Director from Havas Life. 14 May 2013http://www.thedirectorylive.com/profiles/healthcare-advertising/indigenus/press_releases/indigenus_announces_the_winners_of_the_2012_indigenius_awards2Indigenus, an independent global network of entrepreneurial healthcare creative agencies, announced the winners of the second edition of the annual indiGENIUS Awards at a gala celebration during the network’s biannual partners meeting in Japan.30 Apr 2013http://www.thedirectorylive.com/profiles/healthcare-advertising/life/press_releases/life_expands_client_service_with_new_executive_roleLife Healthcare Communications has appointed a new account executive as part of the expansion of its client service team.14 May 2013http://www.thedirectorylive.com/profiles/healthcare-advertising/indigenus/press_releases/indigenus_announces_new_leadership_team_at_the_global_networks_biannual_forumIndigenus, the largest independent global network of entrepreneurial healthcare creative agencies, announced the election of Rico Viray as Chairman and Florian Bernsdorf as Co-Chairman at the global network’s biannual forum. Mr. Viray and Mr. Bernsdorf take leadership of a network that provides pharmaceutical and healthcare companies with innovative multichannel global branding, advertising, medical education, and medical communications.14 May 2013http://www.thedirectorylive.com/profiles/healthcare-advertising/indigenus/press_releases/indigenus_agencies_honoured_at_2012_globals,_clios_and_rx_club_awardsAs the 2012 awards season draws to a close, there have been multiple wins for Indigenus agencies at three of this year's foremost events: The Global Healthcare Awards, CLIOs and The Rx Club.14 May 2013http://www.thedirectorylive.com/profiles/healthcare-advertising/indigenus/press_releases/the_cementblocindigenus_announce_expansion_of_global_relationship_with_ucbThe CementBloc announced that UCB has selected it as its worldwide agency of record for Cimzia. 14 May 2013http://www.thedirectorylive.com/profiles/healthcare-advertising/indigenus/press_releases/asking_what_if_indigenus_forum_taps_industry_leaders_for_innovative_solutions_to_todays_global_marketing_challengesIndigenus Forum taps industry leaders for innovative solutions to today’s global marketing challenges14 May 2013http://www.thedirectorylive.com/profiles/healthcare-advertising/indigenus/press_releases/indigenus_announces_new_global_partnership_with_insightIndigenus, the largest independent global network of entrepreneurial healthcare creative agencies, today announced that Insight, based in Australia and New Zealand, is now a member of the Indigenus family.14 May 2013http://www.thedirectorylive.com/profiles/healthcare-advertising/indigenus/press_releases/indigenus_announces_new_global_partnership_with_cpc_healthcareIndigenus, the largest independent global network of entrepreneurial healthcare creative agencies, today announced that CPC Healthcare Communications, based in Toronto, Canada, is now a member of the Indigenus family.14 May 2013http://www.thedirectorylive.com/profiles/healthcare-advertising/indigenus/press_releases/indigenus_agencies_claim_honors_at_2012_globals,_clios,_rx_club_awardsIndigenus, the largest independent global network of healthcare creative agencies, was well represented as the 2012 advertising awards season drew to a close, with multiple agencies within the network claiming honors.